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SUMMARY AND CONCLUSIONS
The metabolic response to trauma has been an area of intense 
clinical research since Studley's identification of an increase in 
postoperative mortality and morbidity in patients with preoperative 
weight loss (7). Consequently, considerable efforts have been made to 
modify the response, including the use of nutritional, pharmacologic 
and environmental manipulations, and have met with varying degrees of 
success. The concept of using intraoperative hypothermia to reduce 
the "stress response to surgery" was first postulated in the 1950s 
(8,9) but there has been little evidence to support this premise. 
Recently, however, a reduction in "post-traumatic proteolysis" 
following open-heart surgery, using a combination of moderate 
hypothermia (28°C) and high dose anaesthetic agents, has been reported 
(10) .
Cardiac surgery is a unique form of tissue injury. It combines 
conventional surgical trauma with the added insult of cardiopulmonary 
bypass (CPB) and perfusion cooling. CPB induces widespread activation 
of inflammatory mediators such as complement in the extracorporeal 
circuit resulting in the "post-perfusion syndrome", characterised by 
pulmonary, cardiac, renal, hepatic and haematological dysfunction 
(5,6). The systemic metabolic consequences of this "whole body 
inflammation" (5,6) are, however, poorly documented. Perfusion 
cooling is a standard part of the CPB technique, largely governed by 
the need to ensure adequate myocardial protection, but there is no 
consensus on the optimal level of intraoperative hypothermia and 
various temperatures from 30°C to 20°C have been proposed (11-14).
The aims of this thesis were to characterise the systemic 
metabolic sequelae of CPB and to determine the potential of profound 
intraoperative hypothermia (20°C) to modify these responses. Systemic
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hypothermia to 28°C was used in the "control" group as it is currently 
the most commonly used level of intraoperative hypothermia during CPB 
(11). The metabolic or "catabolic" response was characterised in 
terms of its four integrally related components, ie the acute phase 
response, the endocrine response, nitrogen balance and protein 
metabolism, and changes in energy expenditure. In examining the 
effects of profound intraoperative hypothermia (20°C) the primary 
objective therefore was to determine the feasibility of a therapeutic 
intervention at the time of tissue injury (in this case the use of 
systemic perfusion cooling) to modify fundamental pathophysiological 
responses to trauma. It was not the aim of these studies to prejudge 
whether modification of the response to trauma, nor the effects of two 
levels of hypothermia, might be beneficial or detrimental to clinical 
outcome.
Chapter 2. Historical Review. The first part of this chapter 
traces the development of the clinical application of hypothermia from 
its topical use in a variety of disease states, through the initial 
experience of surface cooling in patients undergoing heart surgery, to 
the modern era of perfusion cooling, and outlines key cardiovascular 
and physiological sequelae of the latter. The major components of the 
metabolic response to surgery are reviewed in Part Two, while 
deficiencies in the knowledge of these responses in relation to CPB, 
and in particular to the effects of hypothermia, are highlighted in 
Part Three. The role of pre-existing nutritional status in 
influencing postoperative morbidity and mortality is discussed in Part 
Four while Part Five summarises and classifies previous attempts to 
modify the metabolic response to surgery in environmental, nutritional 
and pharmacologic terms.
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Chapter 3. Methods. This chapter describes the patients 
studied and details the surgical procedure in terms of anaesthetic and 
operative techniques, management of CPB and postoperative fluid 
administration. Anthropometric measurements are described and the 
theoretical and practical considerations involved in protein turnover 
studies, indirect calorimetry and measurement of energy expenditure, 
using Doubly Labelled Water, are discussed in detail.
Chapter 4. Nutritional assessment. Pre-existing nutritional 
status is a major determinant of the magnitude of the metabolic 
response to injury and a high incidence of malnutrition has been 
reported in various hospital populations, including those with 
valvular heart disease. In contrast patients with ischaemic heart 
disease are generally regarded as being "overnourished1’ although there 
is little objective evidence to support this. Sixty-one male patients 
admitted for coronary artery surgery underwent biochemical and 
anthropometric assessment of nutritional status. Most biochemical 
parameters were within the normal reference range although modest 
elevations in C-reactive protein and gamma glutamyl transferase and 
low concentrations of serum zinc were common. Most anthropometric 
parameters implied that the patients were at or above their predicted 
ideal value, while triceps skinfold thickness measurements suggested 
that almost 60% of patients were malnourished. It was concluded that 
triceps skinfold thickness is the least reliable anthropometric 
measurement in patients with a tendency to obesity and that routine 
biochemical and/or anthropometric assessments of nutritional status 
are not justified in this population.
Chapter 5. Measurement and prediction of basal metabolic rate. 
Measurement of the basal metabolic rate (BMR) is useful in certain 
clinical situations and important in studies of alteration in energy
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expenditure. The current clinical "gold standard" measurement of BMR 
is by indirect calorimetry, although limited availability of 
appropriate equipment and expertise necessary for the technique in 
clinical practice have led to widespread use of predictive formulae. 
The BMR was measured in 20 patients with ischaemic heart disease by 
indirect calorimetry, and compared to that calculated from three 
predictive formulae. The measured BMR was 10-20% lower than that 
estimated by the predictive formulae and the discrepancy between 
measured and predicted values was greatest when BMR was related to 
lean body mass rather than weight. It is uncertain whether the lower 
than expected values for measured BMR in patients with ischaemic heart 
disease are due to the unsuitability of predictive formulae in this 
population, or a genuine phenomenon perhaps related to the effects of 
beta-blockade therapy on the autonomic nervous system.
Chapter 6 . Correction for haemodilution. In view of the large 
volumes of fluid administered during CPB and the perioperative period, 
the efficacy of four formulae ( three based on packed cell volume and 
one on alpha-2-macroglobulin) to correct for perioperative dilutional 
changes in serum albumin and caeruloplasmin was assessed in four 
patients undergoing coronary artery surgery and mimicked in an in 
vitro model. Predictive formulae could accurately correct for 
haemodilution in vitro but no formula consistently corrected for the 
effects of haemodilution in vivo. It was concluded that alterations 
in the concentrations of plasma proteins during CPB are not totally 
explained by haemodilution but also reflect different volumes of 
distribution. Correction for haemodilution in vivo is most easily 
achieved using serial changes in the PCV but limitations inherent in 
this method, particularly in the early post-CPB period, should be 
recognised.
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Chapter 7. The acute phase response. Part 1: Plasma proteins.
The plasma protein component of the acute phase response was 
measured in 20 male patients undergoing elective coronary artery 
surgery and randomised to an intraoperative blood temperature of 28°C 
or 20°C. The protein changes observed were typical of the acute phase 
response with increases in C-reactive protein, caeruloplasmin and 
ferritin and decreases in serum albumin, transferrin and prealbumin.
The magnitude of changes in concentrations of these proteins was 
greater than that described for other operations. There was a greater 
fall in serum albumin in the 28°C group during CPB and a trend towards 
a smaller postoperative increase in C-reactive protein in the 20°C 
group.
Chapter 8 . The acute phase response. Part 2: Trace metals and «
their protein binding ratios. Alterations in the serum concentrations 
of the trace elements iron, zinc and copper and in their binding 
ratios to their respective carrier proteins was examined in 20 male 
patients undergoing elective coronary artery surgery and randomised » 
to an intraoperative blood temperature of 28°C or 20°C. Changes in p 
serum iron have previously been described following cardiac surgery
but not changes in serum zinc or copper. Serial examination of
metal:protein binding ratios allows interpretation of changes in the 
affinity of trace metals for their carrier proteins irrespective of 
changes in the protein concentration and have not previously been 
described after operations. Typical decreases in serum iron and zinc, 
as part of the acute phase response, were preceded by early rises 
during CPB. Significant alterations in the molar binding ratios of 
metals to their carrier proteins preceded significant changes in the 
concentrations of the metals and occurred earliest with zinc:albumin 
binding. Changes in the latter constitute one of the earliest markers
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of the stress response, being apparent by the time of skin incision, 
and may be useful in serial estimation of the acute phase response. A 
similar pattern of response was observed in both temperature groups 
although elevations in the serum concentrations of iron and zinc were 
significantly less in the 20°C temperature group during CPB.
Chapter 9. The endocrine response. Part 1: Plasma hormones.
I
There has been no previous study of the effects of two levels of 
intraoperative hypothermia on the endocrine response to CPB. The 
plasma endocrine response was studied in 20 male patients undergoing 
elective coronary artery surgery and randomised to an intraoperative 
blood temperature of 28°C or 20°C. There was a progressive rise in 
adrenaline and noradrenaline during CPB in the 28°C group, similar to 
previous reports also using systemic hypothermia to 28°C. In * 
contrast, in the 20°C group there was no further rise in 
catecholamines after the start of CPB. The cortisol response showed 
an exaggerated response in comparison to that observed after surgical 
stress without CPB and was similar in both groups. There was a marked r 
fall in plasma T3 in both groups which may have implications for low 
cardiac output in the postoperative period. Thyroid stimulating 
hormone secretion increased in both groups during CPB implying 
preservation of pituitary function during pulsatile CPB. In summary 
the endocrine response observed in response to pulsatile CPB was 
typical of that following elective surgery. A more profound level of 
intraoperative hypothermia appeared to attenuate the plasma 
catecholamine response to CPB.
Chapter 10. The endocrine response. Part 2: Urinary excretion
of hormones. Measurement of plasma hormone concentrations is 
necessary to detect rapid or subtle changes in the endocrine response 
to surgery while timed urinary collections for excretion of hormones
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or their metabolites provide a more integrated assessment of the 
endocrine response. The effects of two levels of intraoperative 
hypothermia (28°C and 20°C) on the endocrine response to CPB were 
assessed by measuring the excretion of adrenaline, noradrenaline, 
dopamine and cortisol in 24 hour urine collections obtained 
preoperatively and on the first, second, third and seventh 
postoperative days. This demonstrated that a more profound level of 
intraoperative hypothermia attenuated the endocrine response to CPB 
with smaller increases in the postoperative excretion of adrenaline, 
noradrenaline, dopamine and cortisol which also returned to baseline 
excretion rates more quickly.
Chapter 11. Nitrogen balance and whole body protein turnover. 
Nitrogen balance and whole body protein metabolism were measured by ' 
standard techniques, pre and postoperatively, in 20 male patients 
undergoing elective coronary artery surgery and randomised to an 
intraoperative blood temperature of 28°C or 20°C. There was a 
significant postoperative increase in nitrogen excretion only in the ' 
28°C group. The preoperative rate of whole body protein synthesis 
(WBPS) and breakdown (WBPB) was similar within each group when 
calculated from the urinary enrichment of urea, ammonium and the end 
product average (EPA). Isotopic enrichment of urinary urea implied 
that the postoperative development of a negative nitrogen balance was 
due predominantly to a fall in WBPS and that this decrease could be 
attenuated with a more profound level of intraoperative hypothermia.
In contrast, isotopic enrichment of urinary ammonium suggested that a 
postoperative negative nitrogen balance was due to an increase in WBPB 
exceeding a concomitant rise in WBPS and that these changes were not 
attenuated with a more profound level of intraoperative hypothermia.
It was concluded that the stochastic concept of a single protein
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precursor pool is not tenable, at least in the postoperative 
situation. While the EPA may be a valid marker of protein turnover in 
the steady state, it obscures marked divergence in the visceral and 
peripheral protein precursor pools after surgery. In studies of WBPT, 
interpretation of protein metabolism based on the kinetics of a single 
end product is misleading and may account for some of the 
discrepancies regarding the aetiology of a negative nitrogen balance 
after surgery.
Chapter 12. Skeletal muscle metabolism. This study was 
performed simultaneously with the protein turnover studies reported in 
the previous chapter. The urinary excretion rates of three "markers'1 
of skeletal muscle breakdown, 3-methylhistidine (3MeH), zinc and 
creatinine were measured in the pre and postoperative period as their 
urinary excretion is increased after surgery and appears to be related 
to the degree of trauma. There was a significant postoperative 
increase in 3MeH excretion in both groups and this was greater in the 
20°C group. There was a postoperative increase in zinc excretion in 
both groups which was highly significant in the 20°C group but not 
significant in the 28°C group. Creatinine excretion increased 
significantly in both groups postoperatively and particularly so in 
the 20°C group. These findings were in accordance with the results of 
postoperative WBPB, as judged by isotopic enrichment of urinary 
ammonium, and implied that a more profound level of intraoperative 
hypothermia did not attenuate postoperative skeletal muscle breakdown.
Chapter 13. Alterations in postoperative energy expenditure. 
The effect of surgery on energy expenditure is controversial and there 
has been no report on the effect of cardiac surgery or hypothermia on 
energy expenditure. Total energy expenditure (TEE) was measured over 
10 day periods, pre and postoperatively, in 16 patients undergoing
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coronary artery surgery and randomised to an intraoperative 
temperature of 28°C or 20°C. TEE was measured with Doubly Labelled 
Water (DLW), a non-invasive stable isotope technique, which is 
theoretically simple, safe and of minimal inconvenience to the 
patient. DLW has only recently been introduced into clinical practice 
and this is the first study of the effect of uncomplicated major 
surgery on TEE. TEE gave a value for energy expenditure 30% higher 
than that calculated from the basal metabolic rate. There was a 
modest increase in TEE after surgery in both groups which was presumed 
to result from an increase in the basal metabolic rate as overall 
activity levels were reduced in the postoperative period.
Chapter 14. Clinical outcome. Clinical outcome was examined in 
sixty patients who were randomised to an intraoperative blood 
temperature of 28°C or 20°C. The temperature groups were well matched 
with respect to age and body weight but the 20°C temperature group
received significantly more grafts than the 28°C group. Despite the 
longer mean cross-clamp (by 11 minutes) and bypass times (by 19
minutes) in the 20°C group, the mean postoperative ventilation periods 
were similar in the two groups. Fewer patients in the 20°C group
required inotropic support and postoperative blood transfusion 
requirements were also less. There was no significant difference in
the incidence of postoperative complications between the groups except 
for a reduction in the incidence of atrial fibrillation in the 20°C 
temperature group (1 v 6 ; p< 0.05) presumably due to more effective 
myocardial protection in this group.
In summary, these studies have demonstrated that a more profound 
level of intraoperative hypothermia during CPB can modify changes in 
some aspects of the acute phase response, the endocrine response,
nitrogen balance and protein metabolism. The postoperative increase 
in TEE was minimally reduced in the 20°C group. In contrast, 
postoperative changes in skeletal muscle breakdown were less 
susceptible to modification by hypothermia implying that the latter 
may be a more fundamental response to trauma.
The "control" group experienced hypothermia to 28°C and it is 
possible that blood cooling to this level attenuates the metabolic 
response which would be observed following normothermic CPB. Indeed 
there is already some evidence that moderate hypothermia may itself 
modify "post-traumatic proteolysis" (10). In the light of standard 
CPB techniques and current knowledge regarding myocardial 
preservation, however, normothermic CPB would be considered 
prejudicial to the safety of the myocardium (7,8). To elucidate the 
effects of moderate hypothermia on the metabolic response to trauma 
would require a control population undergoing major general surgical 
procedures at normothermia. Such a comparison would not be stictly 
valid, however, as both intraoperative temperature and the nature of 
the inflammatory stimulus - including or excluding CPB - would differ.
The mechanism by which hypothermia may modify some components of 
the metabolic response not only during, but also in the week following
surgery, is uncertain. It is particularly surprising as the
temperature difference between the two groups existed only for the 
duration of the cross-clamp period (when the heart and lungs are 
excluded from the systemic circulation) which was less than 60
minutes. It implies that the mediators which determine the magnitude
and the duration of the metabolic response are present or are 
elaborated from the time of surgical insult. The complete control of 
this response is complex and not fully known but cytokine peptides, 
such as interleukin-1 , 6 and tumour necrosis factor, are strongly
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incriminated (21,22). The counter-regulatory hormones are also 
involved in the metabolic response to trauma since infusions of 
adrenaline, cortisol and glucagon can reproduce some aspects of the 
response in healthy volunteers (386-388). Furthermore, there is 
probably synergism between the cytokine mediators and the 
hypothalamic-pituitary-adrenal axis in stimulating the metabolic 
response (65).
Although the routine use of hypothermia to attenuate the 
metabolic response is impractical except in open heart surgery, these 
studies illustrate the potential of an intervention at the time of 
tissue injury to modify at least some components of the subsequent 
metabolic response. These studies were not designed to answer whether 
modification of the metabolic response to trauma is necessarily 
beneficial. The demonstration that postoperative morbidity and 
mortality correlate with loss of lean body mass (7) implies that 
prevention of the latter would be beneficial. Few would disagree that 
marked and persistent loss of large quantities of nitrogen, 
accompanied by overt loss of body mass, is detrimental to the severely 
injured or critically ill patient. On the other hand some aspects of 
the metabolic response presumably confer survival advantages, eg the 
acute phase response ensures synthesis of proteins which enhance 
bacterial killing and removal of toxic radicals while simultaneously 
altering plasma trace metal concentrations to deprive potential 
pathogens of essential elements for growth. As such, this component of 
the metabolic response is probably beneficial unless severe and 
protracted. Indeed almost two hundred years ago the Scottish surgeon 
John Hunter intimated in his "Treatise on the blood, inflammation and 
gun-shot wounds" (London, G.Nicol, 1794) that injury induced changes 
in the body that would provide "the means and disposition for cure of
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the injuries".
Interest in modification of the metabolic response to trauma is 
likely to continue from both the clinical and research viewpoints. 
Since Studley's report (7), there has been a marked fall in morbidity 
and mortality from surgery attributable to a number of factors
including improvements in the nutritional status of patients,
\
anaesthetic and surgical practice and perioperative care. Success in 
these areas has, however, led to application of major surgical 
techniques to an increasingly elderly and often sicker population, 
while improvement in resuscitation techniques outside the hospital 
environment have resulted in severely traumatised patients surviving 
to require prolonged and complex hospital care. Consequently, the 
search for techniques with the potential of attenuating the metabolic i 
response to trauma will continue. The studies described in this 
thesis have illustrated that hypothermia at the time of tissue injury 
can modify the subsequent metabolic response and it is likely that 
pharmacological manipulations would have at least similar potential.
CHAPTER 1
INTRODUCTION AND AIMS
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CHAPTER 1 
INTRODUCTION AND AIMS
"Surgery of the heart has probably reached the limits set by 
Nature to all surgery : no new method and no new discovery can
overcome the natural difficulties....... 1
Sir Stephen Paget 1896 (1).
The last twenty five years have witnessed an explosion in the 
number of coronary artery bypass operations since Sabiston's 
description of the first aortocoronary bypass graft, using saphenous 
vein, in 1962 (2). It is now estimated that approximately 770 such
operations per million of population are performed annually in the USA 
(3). In the United Kingdom's first consensus conference on the topic 
of ischaemic heart disease there were calls to double the annual 
number of coronary artery operations in the UK to 300 per million of 
population (4).
Cardiac surgery is a unique form of surgical insult combining 
standard operative injury with the additional trauma of 
cardiopulmonary bypass (CPB) and hypothermia. Coronary artery surgery 
requires the use of CPB to maintain systemic perfusion while the heart 
and lungs are excluded from the circulation. CPB is performed with an 
extracorporeal perfusion pump which causes "whole body inflammation" 
through systemic activation of inflammatory mediators, such as 
complement (5), resulting in the "post-perfusion syndrome" 
characterised by pulmonary, cardiac, renal, hepatic and haematological 
dysfunction (6). The effects of these additional insults on the 
systemic metabolic response to conventional surgical injury are poorly 
documented.
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Modification of the metabolic response to surgery has been an 
area of intense clinical research over the last 50 years in view of 
the increased morbidity and mortality which accompanies a protracted 
catabolic response (7). Attempts to attenuate the response using a 
variety of anaesthetic, nutritional and hormonal manipulations have 
met with equivocal results. The concept of using intraoperative 
hypothermia to reduce the “stress response1 to surgery was first 
mooted in the 1950,s (8,9) but until recently there has been little 
objective evidence to support this premise. In 1986 Wilmore/s group, 
at Harvard Medical School, reported that intraoperative hypothermia 
during open heart surgery reduces post-traumatic proteolysis (10). In 
addition to moderate hypothermia (28°C), however, these workers used 
anaesthetic agents in doses themselves capable of modifying the 
metabolic response to surgery.
Standard surgical practice for coronary artery disease now 
involves some level of systemic hypothermia for all but the shortest 
procedures. A large number of factors influence the chosen level of 
intraoperative hypothermia but of particular relevance is the need for 
adequate myocardial protection. There is, however, no consensus on 
the optimal level of intraoperative hypothermia and although 28°C is 
most commonly used (11) various temperatures have been advocated 
including 30°C (12), 25°C (13) and 20°C (14). There is no objective 
evidence to demonstrate the overall superiority of any particular 
intraoperative temperature and the potential of hypothermia to modify 
the systemic metabolic response to CPB is unknown.
The aims of this thesis were:
(a) To examine the metabolic response to CPB by assessing its four 
distinct, but integrally related, components viz :
1] The acute phase response
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2] The endocrine response
3] Whole body protein metabolism and nitrogen balance
4] Energy expenditure
(b) To determine if any component of the metabolic response could be 
modified at different levels of intraoperative hypothermia (28°C and 
20°C).
The basic objective of these studies therefore was to examine 
the feasibility of manipulating systemic pathophysiological responses 
to trauma by an intervention (in this case the use of hypothermia) at 
the time of tissue injury. It was not a primary aim of these studies 
to determine the effects of modification of the response to trauma or 
the effects of two levels of hypothermia on clinical outcome.
CHAPTER 2
HISTORICAL REVIEW OF THE LITERATURE
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CHAPTER 2 
HISTORICAL REVIEW OF THE LITERATURE
1 For this relief much thanks: ' t is bitter cold 
And I am sick at heart"
William Shakespeare (1564-1616). Hamlet 1.1.8
PART 1: HYPOTHERMIA
EVOLUTION OF THE CLINICAL USE OF HYPOTHERMIA
Systemic hypothermia reduces the metabolic requirements of all 
organs. Consequently its use during cardiopulmonary bypass (CPB) 
allows a reduction in flow rates and pressures generated by the 
extracorporeal circuit thus diminishing non-coronary collateral blood 
flow, which tends both to rewarm the myocardium and obscure the 
surgeon's operating field (15). In a study of 54 patients during CPB 
the maximum rate of non-coronary collateral flow was 6% of the cardiac 
output, being highest in patients with severe coronary artery disease 
followed by those with aortic stenosis and least in patients with 
mitral valve disease (16). A reduction in the mean arterial pressure 
and flow rate during CPB minimises "washing out" of cold cardioplegic 
solution from the coronary circulation by non-coronary collateral flow 
thus maintaining a cold flaccid myocardium (15). Furthermore, 
systemic hypothermia provides a safety margin in the event that the 
extracorporeal circuit should fail for any reason.
The earliest record of the use of therapeutic hypothermia is in 
the Edwin Smith papyrus, dated at around 3,500 BC, for wounds of the 
head and for infected or ulcerated breasts (17). There are numerous 
examples of the use of topical hypothermia over subsequent centuries
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as a panacea for many ailments.
A major incentive to the study of clinical applications of 
hypothermia was Smith and Fay's use of surface cooling to treat 
patients with advanced malignancy (18). Although topical hypothermia 
helped to control pain it did not increase longevity and subsequent 
post mortem examinations demonstrated no tumour regression (19). 
Other workers reported similarly negative findings and the clinical 
use of hypothermia fell into disrepute, particularly when Talbot 
reported that topical hypothermia had caused the death of two patients 
from heart failure (20). The use of topical hypothermia in various 
clinical problems had, however, stimulated Dill and Forbes to examine 
some of its metabolic and physiological consequences (21).
The first scientific evidence that hypothermia might have 
potential clinical application in the treatment of cardiovascular 
disease was the report by Bigelow and colleagues to the American 
Surgical Society in 1950 that surface cooling of dogs to 25°C allowed 
total arrest of circulatory flow for at least 15 minutes (22). The 
same authors showed a linear fall in oxygen consumption down to 20°C 
when oxygen utilisation was reduced by more than 80% in control 
animals (23). The implication that complete arrest of the circulation 
might allow intracardiac surgical procedures to be performed in a 
bloodless field, with temporary protection of the vital organs, was 
substantiated when Lewis and colleagues (24) reported the successful 
closure of atrial septal defects with the aid of topical hypothermia. 
Shortly after, Swan and colleagues reported the first series of 
patients undergoing open heart surgery for various congenital defects 
employing topical hypothermia and simultaneously documented a number 
of important physiological changes (25). Within a few years topical 
hypothermia was being used routinely during cardiac surgical
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procedures in many centres in Europe, America and Japan.
In view of the difficulties in providing effective surface 
cooling and the time-consuming nature of the procedure, which involved 
transferring the patient from the operating table to ice baths and 
back, other workers began to consider alternative methods of achieving 
cooling through systemic perfusion. Boerema and colleagues (26) and 
Delorme (27) described arteriovenous bypass systems whereby an 
animal's own arterial pressure was used to drive heparinised blood 
through a heat exchanger back to a vein. Subsequently Brock and Ross 
described the use of a hand driven rotor pump to deliver blood through 
a heat exchanger (28). The first description of a true veno-arterial 
pump oxygenator was by Dogliotti and co-workers in 1953 (29) . The aim 
of such systems was to provide a mechanism for achieving systemic
hypothermia and only subsequently did exclusion of the heart and
lungs, through the availability of pump-oxygenators, become the most 
important consideration. In America much pioneering work on the 
principles of pump-oxygenators was performed by Gibbon, a major force 
in the transition of cardiopulmonary bypass from an experimental to an 
invaluable clinical tool (30,31).
Such apparatus became rapidly and widely used in many centres 
because of the increased time it allowed to perform intracardiac
procedures than when topical hypothermia was used alone. The
employment of these systems allowed surgical intervention in many 
cardiac diseases which had previously been considered inoperable.
Hypothermia achieved by surface cooling differs considerably 
from hypothermia due to perfusion cooling. In the latter, cooling of 
the heart, liver, kidney and mid-oesophagus occurs quickly while the 
large muscular mass of the body remains warm (32) . This differential 
cooling results in internal temperature gradients between organs and
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cold blood perfusing warm tissue also results in an unfavourable 
oxyhaemoglobin dissociation curve, contributing to tissue hypoxia and 
progressive metabolic acidosis (32). Furthermore the difference 
between the core (cold) and peripheral (warm) tissues and the 
resulting acidosis may contribute to postoperative cardiac 
dysfunction. This problem was overcome by the introduction of more 
efficient heat exchangers, initially by Brown and colleagues, by which 
systemic hypothermia was more readily achieved (33). Effectively, 
systemic hypothermia and circulatory arrest, providing a clear 
operative field, had become the prime goal and the extracorporeal 
circuit merely a means of achieving this.
Standard cardiac surgical practice for coronary artery disease 
now involves some level of systemic hypothermia for all but the 
shortest procedures (11). In the USA more than 90% of surgeons -use 
cold cardioplegic arrest of the myocardium rather than intermittent 
ischaemic arrest (34). A large number of factors influence the chosen 
level of systemic hypothermia but of particular importance is the need 
for adequate myocardial protection. Systemic hypothermia permits a 
reduction in arterial pressure and extracorporeal flow rates with a 
consequent fall in non-coronary collateral blood flow which otherwise 
"washes out" cardioplegia, diminishing myocardial protection (15,16). 
There is, however, no consensus on the optimal level of systemic 
intraoperative hypothermia and various temperatures have been 
advocated including 30°C (12), 28°C (11), 25°C (13) and 20°C (14).
PHYSIOLOGY OF HYPOTHERMIA
Hypothermia reduces the metabolic, requirements of all organs and 
early studies suggested that the decline in metabolic rate bore a 
linear relationship to the fall in temperature (23). Subsequent
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studies demonstrated, however, that the fall in oxygen requirement 
associated with a decline in systemic core temperature is 
approximately exponential (35). At 32°C the reduction is by 25-30%,at 
30°C by 45-50%, at 28°C by 60%, at 25°C by 65-70%, at 20°C by 75% and
at 10°C oxygen utilisation is approximately only 10% of normal
(23,36). These figures are based on work derived mainly from animal
experiments and in man it has been estimated that at 26°C oxygen
requirements are reduced to 35-50% of normal (37). The variability in 
the reduction in oxygen requirements in response to hypothermia 
results from the shivering response to cold as shivering thermogenesis 
can triple oxygen consumption (21). The organs with the greatest 
metabolic rates such as liver, heart and muscle have the most 
significant reduction in metabolic rates with systemic hypothermia, 
particularly between 37°C and 30°C when the Van't Hoff-Arrhenius rule 
applies, viz. the rate of any chemical reaction doubles or halves for 
each respective 10°C rise or fall in temperature (38).
Cardiovascular system:
With modest levels of hypothermia, and in the absence of 
neuromuscular blockade, cardiac output is increased because of the 
rise in metabolic rate due to shivering thermogenesis. As systemic 
core temperature falls there is a parallel fall in heart rate whereby 
a sinus bradycardia will eventually progress to cardiac asystole (or 
ventricular fibrillation in the case of cardiac surgery) without 
further cooling. The progressive fall in cardiac output with
increasing hypothermia is mainly related to a fall in heart rate as
stroke volume remains relatively unchanged (39). Arterial blood
pressure may remain within a normal range until systemic core 
temperature falls to less than 26°C (40). Peripheral resistance
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increases with progressive hypothermia until 20°C when resistance 
decreases (41).
With progressive hypothermia the blood volume is reduced by up 
to 40% (42) and is accompanied by an increase in viscosity and red
cell sequestration (43). The white blood cell count initially rises 
with moderate levels of hypothermia but then falls progressively with 
increasing hypothermia (44). Platelet concentration decreases with 
temperatures below 30°C and a marked thrombocytopaenia occurs when the 
temperature falls below 25° C (44) and these changes are greater with 
systemic than with surface cooling (45). There is a progressive rise 
in whole blood clotting times down to 25°C when it is significantly 
prolonged (44).
Endocrine system:
A d r e n a l  g l a n d : Moderate hypothermia is a stressful insult
resulting in adrenal gland stimulation (46). With more profound 
hypothermia the adrenal gland becomes progressively unresponsive so 
that at temperatures below 28°C adrenal function is significantly 
inhibited and reported to be totally absent at temperatures below 25°C 
(47,48). Likewise there is a reduction in adrenaline and 
noradrenaline secretion with more severe levels of hypothermia 
(49-51). At lower temperatures noradrenaline becomes less effective 
as a pressor agent and the cold myocardium becomes unusually sensitive 
to adrenaline (51) and may explain, in part, the frequency with which 
ventricular fibrillation occurs in the cold heart .
T h y r o i d  g l a n d : Thyroid gland activity has been reported to
become progressively reduced at temperatures less than 34°C (52)
although the gland remains sensitive to exogenous thyroid stimulating 
hormone. At 15°C uptake of iodine 131 by the thyroid gland is
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inhibited (53,54).
P i t u i t a r y  g l a n d : There is a decline in pituitary function with
increasing hypothermia so that reduced secretion of antidiuretic 
hormone promotes a hypothermic diuresis (55). With progressive 
hypothermia there is a reduction in the production of thyroid 
stimulating hormone (52) and adrenocorticotrophin hormone (8,48,56).
P a n c r e a s : Both the production (57) and the physiological action
of insulin in reducing blood glucose concentration are inhibited 
(58,59) so that systemic hypothermia results in a relative 
hyperglycaemia.
PART 2: METABOLIC RESPONSE TO SURGERY
It is now more than half a century since Cuthbertson described 
the metabolic response to tissue injury, in patients with long bone 
fractures, as a progressive loss of body nitrogen, potassium and 
phosphorous (60). Cuthbertson subsequently described two components 
to this metabolic response: an "ebb phase", occurring for the first
several hours, characterised by a reduced metabolic rate while the 
circulating volume and tissue perfusion were restored; the "flow 
phase" occurring after restoration of perfusion and typified by 
generalised catabolism and heat production due to increased 
sympathetic activity and increased secretion of the counter-regulatory 
hormones (61). In the current era of modern surgical practice with 
strict control of fluid requirements, analgesia, and careful surgical 
technique, the ebb phase may not exist.
The realisation that a myriad of stereotyped physiological and 
biochemical events occur after any critical stress, culminating in 
increased energy expenditure and the development of a negative 
nitrogen balance, has stimulated much basic research into regulatory
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mechanisms. This "catabolic response" can be arbitrarily classified 
into four integrally related components: 
i) the acute phase response 
ii) the endocrine response 
iii) whole body protein turnover and nitrogen balance 
iv) alterations in energy expenditure
The most influential factors determining the magnitude of the 
catabolic response, and subsequent clinical outcome, are the severity 
of the injury and nutritional status of the patient.
ACUTE PHASE RESPONSE
The acute phase response is a stereotyped but non-specific 
response to tissue injury from any cause including trauma, surgery, 
sepsis, burns, malignancy or chronic illness. The exact role of the ‘ 
acute phase response remains to be fully determined but is believed to 
be an attempt to redress disturbed homeostasis after tissue injury 
through a variety of responses, including stimulation of the immune 5 * 
system and tissue repair. It is characterised by a dramatic increase : 
in the synthesis of the acute phase reactant proteins and profound 
alterations in the concentrations of the trace elements iron, zinc and 
copper. Furthermore the acute phase response is a generalised host 
response whether the initiating factor is localised or systemic in 
nature.
The acute phase response plays an important and diverse role in 
protection of the host following injury. It involves production of 
proteins with antiprotease activity (eg alpha-1-antitrypsin) which 
bind and inactivate proteolytic enzymes such as elastase and 
collagenase, thereby limiting further cellular damage. Other actions 
include protection against bacterial invasion, elaboration of
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coagulation factors such as fibrinogen and production of C-reactive 
protein (CRP) which promotes complement-induced opsonisation and lysis 
of bacteria.
The acute phase response is initiated and controlled primarily 
by a number of mediators generally referred to as cytokines. 
Knowledge about the cytokines is currently accumulating at a 
bewildering rate but amongst the most important are interleukin-1 
(62), interleukin-6 (63) and tumour necrosis factor (64). In addition 
to their individual actions the cytokines may have synergistic 
potential and also interact with corticosteroids and catecholamines 
(65).
The most important factor in the initiation of the acute phase 
response is probably interleukin-1, previously known as Leukocyte 
Endogenous Mediator, Endogenous Pyrogen and Lympocyte Activating 
Factor. Interleukin-1 is a peptide, or group of closely related 
peptides, synthesised mainly by cells of the reticulo-endothelial 
system, in response to a wide variety of stimuli, which can reproduce 
both laboratory and clinical features of the acute phase response 
(62). The main sources of interleukin-1 are blood monocytes, 
phagocytic cells of the lung, liver and spleen, and tissue 
macrophages, although some specialised epithelial cells including 
keratinocytes have the capacity to produce smaller amounts (62). 
Although interleukin-1 is primarily produced from phagocytic cells and 
its main actions are on local tissues, it probably also enters the 
general circulation and acts on distant organs such as liver and 
hypothalamus. The biological activities of interleukin-1 are protean 
and include the production of fever, stimulation of the immune 
response and alterations in acute phase proteins and serum trace 
metals (62) although recent evidence suggests that interleukin-6 may
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be the most important cytokine peptide (63). Interleukin-1, or a 
peptide fragment of the molecule, has also been incriminated in muscle 
proteolysis (66).
Plasma proteins and the acute phase response
In response to stress, the liver dramatically increases the 
synthesis of some proteins (the acute phase reactant proteins) while 
decreasing the production of others such as albumin, prealbumin and 
transferrin, thereby reversing the albumin:globulin ratio.
The acute phase reactant proteins increase in response to both 
transient and prolonged inflammatory stimuli and can be generally 
classified into two categories - i) proteins which are normally 
present in plasma but whose concentration increases several fold (eg. 
caeruloplasmin, ferritin, alpha- 1 antitrypsin, alpha- 1 acid 
glycoprotein, fibrinogen, haptoglobin) and ii) proteins which are 
normally absent or only present in minute concentrations in plasma but 
which increase several hundredfold in response to tissue injury (eg. 
CRP) .
CRP (whose name derives from its ability to precipitate with 
pneumococcal C-polysaccharide) is the classical acute phase protein 
(67). In response to most forms of tissue injury its plasma 
concentration increases several hundredfold, from barely detectable 
levels, within 24 to 48 hours. With resolution of the initiating 
stimulus the serum concentration rapidly declines (67). CRP is 
synthesised by hepatocytes under the influence of cytokines including 
at least interleukin-1 (68) and, although its exact role is uncertain, 
it appears to have a number of functions in host defence mechanisms 
including effects on agglutination reactions, phagocytosis, complement 
formation and cellular immune responses (67).
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Trace elements and the acute phase response
A decreased concentration of serum iron and zinc and increased 
concentration of serum copper are invariable consequences of the 
acute phase response whatever the initiating stimulus (69). A 
significant fall in serum iron is one of the earliest markers of the 
acute phase response and may even precede the development of fever 
(70). In response to any insult, including surgery (71), the serum 
concentration of iron may fall to barely detectable levels within 12 
hours and remain so for the duration of the stimulus (72). If an 
infectious process becomes chronic, the sequestration of iron can lead 
to the so called "anaemia of infection" (73). The rapid drop in iron 
is due to sequestration of the cation in storage sites within the 
liver, the reticulo-endothelial system and bone marrow in the form of 
ferritin or haemosiderin, making it unavailable for red blood cell 
production. This rapid shift of iron from plasma to liver is probably 
mediated by interleukin-1 as is the production of ferritin - a protein 
with a very strong affinity for free iron (62). The profound decrease 
in serum iron in association with tissue injury, particularly when 
mediated by infection, may be explained on a teleological basis as a 
non-specific host defence mechanism aimed at depriving micro-organisms 
of a trace element essential for growth, replication and toxin 
production (74).
In response to tissue injury there is a large flux of zinc from 
plasma to liver, mediated by cytokines such as interleukin-1 (62), 
where it is an essential co-enzyme for many of the metabolic pathways 
involved in synthesis of the acute phase proteins. Whereas serum iron 
falls to barely detectable levels, as part of the acute phase 
response, there is a less precipitous fall in serum zinc, to 
approximately 50% of normal concentrations (69). Unlike iron there is
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normally no intracellular protein which can bind zinc in a storage 
form and therefore the liver is stimulated into rapid synthesis of 
zinc binding metallothioneins (75). Like iron, zinc is essential for 
the growth and reproduction of invading micro-organisms and its rapid 
decline in plasma, as part of the acute phase response, may be another 
part of non-specific host defence mechanisms (76).
A slow rise in the concentration of serum copper accompanies the 
rapid falls in iron and zinc during the acute phase response. The 
increase in serum copper is due to an increased rate of synthesis of 
its binding protein caeruloplasmin, an acute phase protein whose 
synthesis is stimulated by interleukin-1 (77). Copper has
anti-inflammatory properties (78), is an essential requirement for 
immune competence (79), and may be important in the scavenging of 
oxygen free radicals (80). Because caeruloplasmin has a long 
half-life the return of elevated plasma copper concentration towards 
normal is prolonged during convalescence (69).
ENDOCRINE RESPONSE
Alterations in circulating levels of hormones (from the Greek 
word "hormaein" meaning to arouse or set in motion) following a wide 
variety of insults - including trauma, elective surgery, burns and 
myocardial infarction - are well documented (81). Numerous hormonal 
changes occur in response to stress and can be classified into those 
predominantly concerned with fluid and electrolyte balance, eg 
aldosterone, antidiuretic hormone, renin and angiotensin, and those 
with an important influence on body composition, eg insulin, 
catecholamines, cortisol, glucagon, thyroid and growth hormones. The 
latter hormones may be broadly classified, depending on function, as 
anabolic or catabolic. Insulin and growth hormone are anabolic
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hormones while cortisol, adrenaline, noradrenaline and glucagon are 
the major catabolic or counter-regulatory hormones.
I n s u l i n :  Insulin is released from the Beta cells of the
pancreas and promotes amino acid and nitrogen retention and the 
storage of lipids and carbohydrates. Plasma levels of insulin usually 
fall in the early stages of illness despite elevated blood glucose 
concentrations (82), although insulin concentrations eventually rise 
to an appropriate level for the degree of hyperglycaemia. In severe 
illness there exists an "insulin resistance" characterised by the 
failure of normally insulin-sensitive tissue, such as skeletal muscle, 
to utilise plasma glucose (83) probably because of a failure of 
carbohydrate transport. Insulin decreases the rate of protein 
catabolism in response to stress, both by providing glucose for cell 
oxidation, thereby sparing amino-acids, and by independently 
stimulating protein synthesis (84). Provision of glucose, insulin and 
potassium to critically ill patients has been shown, at least in the 
short term, to improve the function of various tissues, such as 
cardiac muscle, to correct the "sick-cell" syndrome, and to decrease 
nitrogen excretion (85).
C o r t i s o l :  Cortisol is a glucocorticoid, released from the
adrenal gland, and is essential for the survival of the stressed 
patient. Increased levels of plasma cortisol occur in response to a 
wide variety of stresses including surgery (86). The release of 
cortisol in response to stress is probably mediated via the 
hypothalamic-pituitary-adrenal axis. The predominant metabolic
effects of cortisol are to increase hepatic glycogenesis,
gluconeogenesis, and protein catabolism, i.e. an anti-insulin effect
which serves to raise blood glucose concentrations (although it may 
stimulate protein synthesis in liver in rats) (87).
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C a t e c h o l a m i n e s : Like cortisol, plasma catecholamines are
elevated in response to a wide variety of stresses and both plasma and 
urinary catecholamine levels can be correlated with an increased 
metabolic rate proportional to the severity of the stress (88). In 
addition to their effects on the cardiovascular system, plasma 
catecholamines exert metabolic effects including glycogenolysis in 
liver and skeletal muscle, mobilisation of fats (to free fatty acids 
and glycerol), stimulation of the metabolic rate (89) and synthesis of 
some acute phase proteins in rats. Catecholamines also have an 
anti-insulin effect, both by inhibiting release of insulin from beta
cells of the pancreas and by stimulating the release of glucagon from
Alpha cells (87).
G l u c a g o n : Glucagon is released from Alpha cells of the pancreas
when stimulated by B adrenergic activity and the elevation in its 
plasma concentration is usually proportional to the severity of the 
insult (90). Its metabolic actions include glycogenolysis, 
gluconeogenesis and lipolysis (91) and it occurs in higher 
concentrations in the portal than in the systemic circulation (91).
G r o w t h  H o r m o n e : Plasma levels of growth hormone increase in
response to stress, even in the presence of elevated concentrations of 
glucose which would usually suppress plasma growth hormone secretion 
(87). Current evidence suggests that growth hormone may play an 
important role in nitrogen retention and promote positive nitrogen 
balance (92).
NITROGEN BALANCE AND WHOLE BODY PROTEIN TURNOVER
The development of a negative nitrogen balance is the
predominant feature of the catabolic response to a wide variety of 
stresses including surgery, sepsis, burns and trauma. The loss of
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nitrogen following trauma is proportional to the magnitude of the 
insult, the age and sex of the patient (primarily reflecting lean body 
mass), and the pre-existing nutritional status of the patient (60).
Nitrogen balance studies reflect net gain or loss of body 
protein between a subject and the environment and give no insight into 
the dynamics of protein synthesis or breakdown which ultimately
determine nitrogen balance. Thus a negative nitrogen balance may
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result if protein breakdown rates increase while protein synthesis 
rates remain constant, or if protein breakdown rates remain constant 
while synthesis rates decrease. Alternatively, both the rates of 
synthesis and breakdown may increase but a negative nitrogen balance 
can still result from an increase in breakdown rates exceeding a 
concomitant increase in synthesis rates.
Whole body protein turnover is the sum of the metabolism 
(breakdown or synthesis) of many individual proteins in the same way 
that the basal metabolic rate reflects the oxygen consumption of many 
individual tissues. The original description of the use of amino 
acids, labelled with stable (and therefore non-radioactive) isotopes, 
to allow quantification of alterations in protein synthesis and 
breakdown rates was by Sprinson and Rittenberg in 1949 (93) and
further developed by San Pietro and Rittenberg in 1953 (94). Only
over the last 15 years, however, have isotopically labelled amino 
acids achieved widespread utilisation in the investigation of protein 
metabolism in malignancy, trauma, sepsis and elective surgery using 
the stochastic method of Picou and Taylor-Roberts (95).
Reduction of food intake in the normal individual causes a 
marked fall in protein synthesis within two days (96). Conversely, 
increasing nitrogen intake alone, above the usual requirements for a 
healthy adult, has no effect on body protein synthesis rates although
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these can be increased if excess energy substrate is added to a normal 
nitrogen intake (97). Nutritional therapy will increase protein 
synthesis rates in malnourished subjects, particularly children (95).
Exercise counteracts the fall in protein synthesis seen in 
immobilised individuals, particularly those in plaster casts (98). 
Strenuous exercise may cause an initial increase in rates of protein 
breakdown followed by an increase in the rates of synthesis (99).
The negative nitrogen balance observed in response to injury has 
classically been attributed to an accelerated breakdown of skeletal 
muscle (60) in accordance with the frequent clinical observation of 
wasting of the skeletal muscle mass. However protein turnover 
studies, using isotopically labelled amino acids, have demonstrated 
that the development of a negative nitrogen balance in patients 
undergoing general surgical procedures (100) and elective orthopaedic 
operations (101) results predominantly from a fall in protein 
synthesis with little or no alteration in protein breakdown, similar 
to the response known to occur in starved (97) and immobilised (98) 
patients. On the basis of their observations in patients undergoing 
orthopaedic operations, Crane and colleagues suggested that injury may 
produce a "block" in protein synthesis activity (101). Conversely 
following major elective surgical trauma (102), major skeletal trauma 
(103), burns (104) and sepsis (105), a negative nitrogen balance may 
result from an increase in protein breakdown exceeding a simultaneous 
increase in protein synthesis.
It has therefore been postulated that in "severe stress" a 
different mechanism for protein loss exists from that observed in 
response to surgery of moderate traumatic severity (106). Severe 
injury accelerates nitrogen turnover as both protein synthesis and 
breakdown are increased. In the fasted patient protein breakdown
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rates exceed those of synthesis and a negative nitrogen balance 
results. yihe rationale of nutritional support in severely stressed 
patients is to increase the rate of protein synthesis towards the 
accelerated rates of protein breakdown.
3-METHYLHISTIDINE (3MeH)
Evidence that skeletal muscle is involved in the catabolic
response to surgery, and in particular the development of a negative 
nitrogen balance, was demonstrated in the studies of Cuthbertson where 
an increased urinary excretion of potassium, zinc and creatine 
occurred during the flow phase of injury (60,107). Although evidence 
for the release of amino acids from muscle protein can be demonstrated 
by measuring arteriovenous differences in amino acid concentrations 
across a limb, the technique is difficult and interpretation of the 
results complicated by re-use of some amino acids (108).
Studies of the effects of trauma on skeletal muscle metabolism
were hampered by the lack of a specific marker of muscle protein
breakdown until the amino acid 3-Methylhistidine (3MeH) was identified 
as a constituent of the actin and heavy chain of myosin, in the
myofibrillar component of white muscle, by Asatoor and Armstrong 
(109). Since then 3MeH has achieved widespread clinical use as an 
indicator of muscle protein breakdown. Actin and myosin account for 
65% of muscle protein and approximately 35% of the total body protein 
pool (110). Skeletal muscle in man is estimated to account for 90% of 
the total body content of 3MeH with the remainder being equally 
derived from the gastrointestinal tract and skin (111). Radioactive 
tracer studies have confirmed that 3MeH is neither metabolised nor 
re-utilised for protein synthesis and is rapidly excreted in urine 
(112). Since the total body pool of skeletal muscle can be estimated
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from the rate of creatinine excretion, 98% of which is derived from 
skeletal muscle (113), then the ratio of excretion of 3MeH to 
creatinine can give an estimate of the fractional turnover of muscle 
protein. The fractional rate of muscle protein breakdown, as 
calculated by this ratio, has been investigated in a variety of 
clinical conditions including hyperthyroidism (114), trauma (115,116), 
burns (117), sepsis (118), malnutrition (119) and surgery (120).
Since 3MeH can be derived from ingested dietary muscle protein 
should be avoided in the diet for three days prior to any urinary 
collection (121).
From a theoretical point of view, Rennie has disputed the 
validity and clinical usefulness of 3MeH as a marker of skeletal 
muscle breakdown (122), suggesting that the smaller gastrointestinal ! 
pool of 3MeH may have a much more rapid turnover than skeletal muscle 
and may consequently provide a relatively greater contribution to the 
urinary excretion of 3MeH than would be anticipated from the size of 
the gastrointestinal pool. Nevertheless 3MeH is a valid marker of 1 
whole body protein breakdown (122,123) although it is not exclusively 
derived from skeletal muscle breakdown.
ENERGY EXPENDITURE AND SURGICAL TRAUMA
Total energy expenditure (TEE) consists of two components 
resting energy expenditure (REE) and activity energy expenditure 
(AEE). REE is that energy expended in maintaining body temperature 
and is relatively constant, while AEE depends on exercise and 
consequently is much more variable. REE can be further sub-divided 
into basal metabolic rate (BMR) and the energy expended in the 
digestion of food, known as the specific dynamic action of food, and 
is altered in disease states.
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The BMR results from essential metabolic processes necessary to 
maintain the cellular integrity and function of specific organs, and 
accounts for up to 90% of REE (124). Grande has shown that liver, 
brain, heart and kidney account for only 5% of body weight but 70% of 
the total BMR, while muscle accounts for 40% of body weight but only 
20-30% of the BMR (124).
The BMR correlates closely with body size and can be predicted 
from variables such as height, weight and body surface area corrected 
for age and sex. Although the BMR is reproducible in the same 
individual, the variability amongst individuals in large groups is 
approximately 5-10% (125). As the BMR is essentially a predictor of 
the "active cell mass” , differences attributed to age, sex and body 
composition largely disappear when differences in adipose tissue are 
taken into consideration (126).
The BMR is primarily controlled by thyroid hormones and, indeed, 
between 1920 and 1950 estimation of BMR was an important clinical 
investigation in patients with suspected thyroid disease. In the 
steady state there may be circadian changes in the BMR reflecting 
circadian alterations in hormonal status (127). The BMR is affected 
by food intake because of the energy expended in digestion and 
absorption of food (specific dynamic action of food) which accounts 
for approximately 10% of the former (128) and may be due to 
alterations in thyroid hormone metabolism (129). It appears that the 
the specific dynamic action of food is largely due to its protein 
content (130). In contrast, glucose must be given in considerable 
excess of normal requirements before increasing energy expenditure 
(129) and, conversely, REE falls in the fasting state by 10-20% 
(131,132).
Alterations in systemic temperature are amongst the most
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important determinants of the metabolic rate, so that an increase in 
body temperature of 1°C from any cause increases the metabolic rate by 
approximately 12% (133) .
Physical trauma, burns and sepsis, separately or in combination, 
can increase core temperature and energy expenditure. These increases 
are secondary to endocrine and metabolic changes resulting in an 
increased turnover of glucose, fatty acids and protein, and increased 
production of the counter-regulatory hormones. The magnitude of 
change in energy expenditure after trauma is dependent on the severity 
of the insult (132). Elective surgery may increase energy expenditure 
by up to 10%, major trauma by 20-30%, severe sepsis by 40-60% and 
third degree burns involving more than 20% of the body surface area by 
80-100% (132).
PART 3: METABOLIC RESPONSE TO CARDIOPULMONARY BYPASS
Cardiac surgery produces a unique form of tissue injury as it 
combines the additional insults of CPB and hypothermia with more 
conventional operative trauma. CPB promotes "whole body inflammation" 
through the activation of inflammatory mediators such as complement 
(5) resulting in the "post-perfusion syndrome" characterised by 
pulmonary, cardiac, renal, hepatic and haematological dysfunction (6). 
The effects of these cumulative insults on the catabolic response to 
surgical injury are poorly documented. Furthermore there are no 
prospective studies examining the effects of varying levels of 
intraoperative hypothermia on the systemic metabolic response to CPB.
THE ACUTE PHASE RESPONSE TO CARDIOPULMONARY BYPASS
There have been no detailed studies of the acute phase response 
following CPB although serial estimations of CRP following cardiac
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surgery have been reported to be useful predictors of sepsis (134) and 
outcome (135).
Fitzsimons and Ballantyne documented an increase in serum iron 
in the early stage following CPB (136) but did not investigate the 
effect of different levels of intraoperative hypothermia on these 
changes. There are no data on changes in the acute phase reactant 
trace metals zinc and copper in response to CPB.
THE ENDOCRINE RESPONSE TO CARDIOPULMONARY BYPASS
In contrast to the acute phase response, the endocrine response 
to CPB has been exhaustively investigated. Most studies have either 
been observational or have examined the effects of pulsatile and 
nonpulsatile extracorporeal perfusion on the response. No study has 
specifically addressed the effects of different intraoperative 
temperatures on the endocrine response during CPB or in the week 
following surgery. It is not known whether modification of the 
endocrine response by a more profound level of intraoperative 
hypothermia would result in a reduction in the catabolic response.
In contrast to the elevated plasma levels of cortisol seen in 
most forms of stress, cortisol concentration has been reported to fall 
in patients undergoing nonpulsatile cardiopulmonary bypass (137-139). 
Such adrenal hypofunction resulted in the empirical use of exogenous 
corticosteroids (140) despite the demonstration of adequate levels of 
circulating unbound, physiologically active, free cortisol (141). The 
reduction in plasma cortisol at the start of bypass has been 
attributed to haemodilution due to the priming fluid for the pump 
(138) and inhibition of the pituitary gland during bypass (139). 
Taylor and colleagues demonstrated that the use of pulsatile, as 
opposed to nonpulsatile, bypass preserved the plasma cortisol response
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to surgical injury and attributed this to an improvement in organ 
metabolism with pulsatile perfusion (142). The same workers reported 
that the absence of a pituitary response to thyroid stimulating 
hormone during nonpulsatile perfusion, could be restored by pulsatile 
perfusion (143). Taylor's work was performed at normothermia and in a 
historically .controlled study of normothermic and hypothermic CPB, 
Kuntschen and colleagues reported that cortisol levels were 
significantly lower at the end of hypothermic CPB (144).
Several investigators have demonstrated increased adrenal 
catecholamine release during CPB (145-147) but there has been no 
prospective study to examine the effects of different levels of 
intraoperative hypothermia on this response.
• i
NITROGEN BALANCE AND PROTEIN TURNOVER STUDIES
A number of studies have investigated nitrogen balance following 
cardiac surgery but are difficult to interpret in view of the
differing clinical and nutritional status of the patients and the
' -
nature of the cardiac operation performed. Manners reported a 
cumulative negative nitrogen balance of 48 grams, over a six day 
period in patients undergoing coronary artery surgery and emphasised 
the difficulties in obtaining accurate measurements (148). There has 
been no study of the effects of different levels of intraoperative 
hypothermia on postoperative nitrogen excretion and there are no data 
on the effects of CPB or hypothermia on the kinetics of whole body 
protein synthesis and breakdown.
ENERGY EXPENDITURE FOLLOWING CARDIOPULMONARY BYPASS
There has been no formal study of energy expenditure following 
cardiac surgical procedures although Savino and colleagues, as part of
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a larger study, reported the basal energy expenditure in three 
patients following coronary artery surgery as being between 1500 and 
2000 Kcal/day during mechanical ventilation (149).
PART 4: MALNUTRITION PREVALENCE AND ASSESSMENT
In 1936 Studley reported a mortality of 33% in 46 patients
undergoing peptic ulcer surgery who had lost more than 20% of their 
pre-illness body weight, compared with a mortality of 3.5% in patients 
with no weight loss (7). Subsequently Rhoads and Alexander
demonstrated an association between poor nutritional status and 
susceptibility to infection (150).
Numerous studies over the last decade have confirmed a 
relationship between malnutrition and increased morbidity and
mortality in hospital patients (151-154). Furthermore, a number of
reports have documented a high incidence of protein calorie
malnutrition in overtly nutritionally replete patients in general 
hospital wards (155-157) and those with valvular heart disease
(158-160).
The pathogenesis of cardiac cachexia has been well-described by 
Pittman and Cohen (161,162) where cardiac failure causes relative 
tissue hypoxia and anorexia but an increase in the metabolic rate due 
to increased catecholamine production. As a consequence, there is 
wasting of muscle protein and adipose tissue which may culminate in 
cardiac atrophy promoting further heart failure (163). There is ample 
evidence that malnourished patients with valvular heart disease have 
an increase in morbidity and mortality following surgery compared to 
nutritionally replete patients (158-160). In patients with ischaemic
heart disease Abel and colleagues (164) found little evidence of
malnutrition although there was a greater incidence of postoperative
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complications in male patients who were below their ideal body weight.
ASSESSMENT OF NUTRITIONAL STATUS
Numerous anthropometric, biochemical and immunological variables 
have been used to identify patients with evidence of protein calorie 
malnutrition. Baker and colleagues suggested that clinical 
examination could detect and assess malnutrition as accurately as 
laboratory tests (165) but their studies and interpretations have been 
criticised (166). Pettigrew and colleagues, in a prospective study of 
nutritional assessment, reported that even experienced clinicians on 
clinical examination alone could miss up to 50% of malnourished 
patients (167).
Anthropometry refers to the scientific measurement of body size, 
weight and composition, using measurements such as weightrheight 
ratio, triceps skin fold thickness, mid-arm circumference and 
calculated mid-arm muscle circumference. These parameters provide 
useful information in overt protein calorie malnutrition but are of 
limited value in more subtle forms (168). Anthropometric indices have 
also been successfully used to predict energy expenditure (169).
A large number of biochemical parameters have been used in an 
attempt to identify patients with less overt forms of protein calorie 
malnutrition. The most commonly used indices have been plasma
I
concentrations of albumin, transferrin, prealbumin and retinol 
binding protein. The same proteins can be used to assess the response 
to nutritional therapy depending on their half-lives of respectively 
30 days, 8 days, 2 days and 12 hours (170). More recently fibronectin 
has been proposed as a sensitive indicator of nutritional status 
(171). The use of plasma proteins as markers of nutritional status is 
complicated by the fact that their plasma concentrations are dependent
\
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on numerous factors including protein synthesis, catabolism and 
redistribution with proteins in the extravascular space.
Tests of delayed hypersensitivity have been recommended by some 
workers as useful parameters of nutritional status (172). These tests 
essentially examine cell-mediated immunity by the ability of the 
patient to mount an immune response to intra-dermally administered 
antigens such as purified protein derivatives, trichophytin, Candida 
and streptokinase streptodormase (172). The usefulness of such tests 
in predicting postoperative morbidity and mortality and the 
relationship of these to nutritional status is, however, disputed 
(173).
Despite the well-established relationship between malnutrition 
and an increase in postoperative morbidity and mortality, no single 
parameter or estimate of nutritional assessment has been shown to have 
a predictive value by itself. Consequently some workers have combined 
several different variables of nutritional status to try and improve 
prognostic accuracy. Buzby and Mullen (153) have recommended the use 
of four factors (serum albumin and transferrin, triceps skin fold 
thickness and delayed hypersensitivity) as having prognostic 
significance, while demonstrating that absolute changes in weight, p e r  
s e , do not correlate with clinical outcome. Indeed, recently Windsor 
and Hill have demonstrated that weight loss is a basic indicator of 
surgical risk only when associated with clinically obvious impairment 
of organ function (174).
PART 5: MANIPULATION OF THE METABOLIC RESPONSE
The recognition that the catabolic response to surgery results 
in the development of a negative nitrogen balance, through the loss of 
body protein (60,61,175), has stimulated intense research into
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techniques to attenuate the response. These can be conveniently
classified as environmental, nutritional and pharmacological.
ENVIRONMENTAL
Cuthbertson and colleagues demonstrated that nursing patients 
with long bone fractures at an ambient temperature of 28°C-30°C
resulted in a significant reduction in nitrogen excretion compared to 
patients nursed at 20°C-22°C (107). It was subsequently reported that 
nursing burn patients in a warm, dry atmosphere could reduce mortality 
(176) and was presumed to result from energy required to evaporate 
water from burned tissues being met from the warmed environment rather
than from the patient's own body fuels (177). Other workers
demonstrated no significant metabolic benefit in nursing patients 
undergoing elective abdominal surgery of moderate severity in an 
increased environmental temperature (178).
The concept of using intraoperative hypothermia to modify the 
"stress response" to surgery was first proposed in the 1950's (8,9)
but was abandoned when moderate topical hypothermia was found to 
produce a postoperative rebound increase in cortisol secretion. More 
recently Wilmore's group reported that "hypothermic anesthesia" during 
cardiac surgery reduces post traumatic proteolysis (10). This group, 
however, examined only moderate hypothermia (28°C) and used fentanyl 
anaesthesia in doses (100-200 ug/Kg) which can themselves modify the 
catabolic response to surgery ( v i d e  i n f r a ).
NUTRITIONAL
Since Studley's report (7) of increased mortality in 
malnourished patients undergoing peptic ulcer surgery, a large body of 
clinical evidence has confirmed the adverse effects of protein-energy
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malnutrition on clinical outcome (151-154).
As a consequence, the use of nutritional support to reduce 
postoperative complications in malnourished patients has been widely 
recommended (179). The rationale lies in the demonstration that 
nutritional support accelerates the rate of protein synthesis towards 
the accelerated rate of protein breakdown which accompanies the 
catabolic response, thereby sparing body protein (180). Nutritional 
support can be provided enterally or parenterally (Total Parenteral 
Nutrition) in the case of gastrointestinal tract failure.
Despite numerous studies there is no consistent evidence that 
perioperative nutritional support reduces the mortality of surgery 
(181). Some groups have reported a reduction in mortality and 
morbidity with postoperative nutritional support (182,183) but this is r 
disputed by others (184,185). Similarly there is no evidence that 
preoperative nutritional support reduces postoperative complications 
(186) although this may reflect too short a preoperative feeding 
regimen.
Apart from doubts over the efficacy of Total Parenteral * 
Nutrition in reducing postoperative morbidity and mortality, such 
feeding is expensive and has potentially serious side effects. In 
view of these complications some workers have promoted the concept of 
peripheral intravenous nutrition (187).
PHARMACOLOGICAL
Anaesthesia employing large doses of opiate-based preparations 
such as morphine (2-4 mg/Kg body weight) or fentanyl (50-100 ug/Kg 
body weight) can attenuate the early endocrine response to general 
surgical trauma but not that during CPB nor postoperative nitrogen 
excretion (188,189). The use of the sedative etomidate has been
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abandoned after demonstration of suppression of cortisol secretion in 
severely ill patients (190) with a consequent rise in mortality (191).
Regional neurogenic blockade, using epidural or spinal local 
anaesthetics, has been reported to modify the catabolic response to 
surgery with varying success. Brandt and colleagues (192) reported 
that epidural analgesia significantly improved postoperative nitrogen 
balance following hysterectomy while others found no such effect after, 
upper abdominal surgery (193). It is possible that while epidural 
anaesthesia can block both afferent and efferent autonomic pathways in 
the lower abdomen, the autonomic system is less effectively blocked in 
the upper abdomen. Some workers have reported that splanchnic nerve 
blockade can modify the stress response to surgery (194) although the 
cortisol response is not affected (195). ^
Naftidrofuryl has been reported to significantly reduce 4 
cumulative postoperative nitrogen excretion and its effect was 
presumed to be due to more efficient metabolism of endogenous 
carbohydrate and fat (196). These results have been disputed by 
others (197) who found no beneficial effect of naftidrofuryl on 
nitrogen balance after elective surgery.
Anabolic steroids have been reported to improve postoperative 
nitrogen balance (198) in both the catabolic (199) and anabolic 
components of the response to trauma (200). Their clinical usefulness 
has so far been limited by their tendency to cause virilising effects 
as well as water retention (201). Anabolic steroids have been 
reported to promote positive nitrogen balance in patients receiving 
parenteral nutritional support (202) but this has been disputed by 
others (201). There is, however, no evidence that any beneficial 
effect of steroids on nitrogen balance has led to a reduction in 
postoperative morbidity or mortality.
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Although plasma levels of insulin are elevated in response to 
trauma it appears to be less metabolically active than usual, giving 
rise to the concept of "insulin resistance" (83), and explaining the 
hyperglycaemia, losses of body nitrogen and potassium, and defects of 
cell membrane function (203) observed after severe injury. Some 
workers have reported that administration of exogenous insulin with 
glucose and potassium can reduce nitrogen and potassium losses in 
seriously burned patients (85,204).
Corticosteroids have been used to treat septic shock (205) and 
the adult respiratory distress syndrome (206) and although there has 
been no convincing evidence of a reduction in mortality, it has been 
postulated that this reflects their late administration to critically 
ill patients. The question of their efficacy remains unproven and 
trials are currently underway to determine if their administration 
earlier in the course of septic illness will favourably influence 
outcome. A large prospective randomised trial of steroids 
administered early in the course of the adult respiratory distress 
syndrome showed no beneficial effect on clinical outcome (207).
Growth hormone has been demonstrated to improve nitrogen and 
potassium retention in burn patients, presumably by increasing insulin 
levels (208). It is likely that the availability of growth hormone 
from genetically programmed bacteria will lead to further studies on 
its therapeutic potential. It has recently been reported that 
biosynthetic growth hormone maintained a positive nitrogen balance in 
ill patients undergoing major gastrointestinal surgery who received a 
hypocaloric and low nitrogen-containing (7 grams) intravenous feeding 
regimen (209).
CHAPTER 3
METHODS
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CHAPTER 3 
METHODS
Little flower- but if I could understand 
What you are, root and all, and all in all,
I should know what God and man is.
Alfred, Lord Tennyson (1809-1982). Flower in the crannied wall.
PART 1: POPULATION STUDIED
The patients studied in this thesis presented to the 
Cardiothoracic Unit of the Royal Infirmary in Glasgow, between August 
1986 and September 1988.
All were male patients in the age range 40-64 years, undergoing 
elective coronary artery surgery. They were expected to receive at 
least two coronary artery grafts using saphenous vein and/or internal 
mammary artery.
All patients studied had isolated ischaemic heart disease. 
Patients who had undergone major surgery in the preceding six months 
were excluded as were those with diabetes mellitus, hyper1ipidaemia, 
endocrine disorders and renal or hepatic impairment. No patient had 
unstable angina or was in cardiac failure.
In addition to normal hospital procedures a careful note was 
taken of anti-anginal medical therapy such as nitrates, beta-blockers 
and calcium antagonists.
Informed consent was obtained from all patients and the studies 
approved by the Hospital Ethical Committee.
Patients were randomised to one of two levels of intra-operative 
hypothermia (28°C or 20°C) on the morning of surgery. The surgical
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operations were performed by one of five consultant surgeons using 
standardised procedures.
PART 2: OPERATIVE PROCEDURE 
ANAESTHETIC TECHNIQUE
All patients were prescribed a benzodiazepine (20 mg temazepam) 
on the night before surgery.
On admission to the anaesthetic room the patient was given 
oxygen to breathe while ECG monitoring was commenced and the blood 
pressure checked. Anaesthesia was induced with a combination of an 
opiate (morphine), narcotic (fentanyl) and benzodiazepine (midazolam). 
Intubation was performed after administration of a non-depolarising 
neuromuscular blocking agent (pancuronium) and subsequently a radial 
artery cannula, central venous line (double lumen), nasopharyngeal 
temperature probe and urinary catheter were inserted.
Anaesthesia was maintained during surgery by a combination of 
morphine, fentanyl, midazolam (benzodiazepine), pancuronium and 
isoflurane (inhalational volatile anaesthetic). No patient received 
fentanyl in excess of 20 ug/Kg body weight or morphine in excess of 2 
mg/Kg of body weight.
During the surgical procedure all patients were continuously 
monitored for heart rate and rhythm, blood pressure, central venous 
pressure, temperature, and urinary output. Blood temperature was 
continuously recorded in the extracorporeal circuit.
At the end of the operation the patient was returned, 
ventilated, to the Cardiac Surgical Intensive Care Unit. The patient 
remained ventilated until fully rewarmed (as core temperature normally 
falls during closure of the sternotomy wound) and haemodynamically 
stable. Prior to extubation, usually eight to twelve hours after
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surgery, boluses of midazolam (2 mg) and morphine (2 mg) were used to 
provide adequate sedation and analgesia. Vercuronium (2-4 mg) was used 
to paralyse the patient if mechanical ventilation was not optimal. 
Dopamine was infused in inotropic doses (5-10 ug/ Kg/min) to maintain 
arterial blood pressure >100 mmHg when necessary. More commonly 
vasodilators (sodium nitroprusside and/or glyceroltrinitrate) were 
administered to prevent systolic arterial pressure rising above 140 
mmHg.
OPERATIVE TECHNIQUE
The surgical operation commenced with the opening of the chest 
via a median sternotomy, using a Stryker saw, while long saphenous 
vein was simultaneously harvested from one or both legs. When 
appropriate the internal mammary artery was dissected from the sternum 
with a diathermy blade.
After opening of the pericardium, purse string sutures were 
placed in the aorta and right atrium at the proposed sites of 
cannulation. Heparin was administered via the right atrium in a dose 
of 300 units/Kg of body weight and the ascending aorta was cannulated 
with a Sarn 8 mm cannula. The right atrium was cannulated next, either 
with two cannulae respectively placed into the inferior and superior 
venae cavae or a single, double lumen, cannula. If deemed necessary a 
pulmonary artery or aortic arch vent was then inserted to ensure 
optimal drainage.
CPB was commenced when the activated blood clotting time 
exceeded 400 seconds as measured by the Haemochron 400 (International 
Technidyne Corporation). Systemic cooling was commenced and pulmonary 
ventilation stopped when a satisfactory flow rate was obtained. After 
identification of the proposed sites for coronary artery grafting the
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ascending aorta was cross-clamped and 1 litre of cold cardioplegic 
solution (4° C) infused, in divided doses and under pressure, proximal 
to the cross-clamp to produce a rapid, flaccid paralysis of the 
myocardium. Topical cooling of the heart was achieved with 
physiological saline at 4°C.
The distal anastomoses were performed first by a continuous 
suturing technique for saphenous vein and an interrupted or continuous 
suturing technique for the internal mammary artery depending on the 
preference of the surgeon (210). The anastomoses were performed with 
7/0 Prolene. Shortly prior to completion of the last distal 
anastomosis, systemic rewarming was commenced and on completion of the 
last anastomosis the cross-clamp was released to allow myocardial 
reperfusion. During systemic re-warming a segment of the ascending 
aorta was isolated with a clamp and a disc of aorta removed using a 
Goosen punch. The proximal anastomoses were performed with a 
continuous suturing technique using 6/0 Prolene. On completion of the 
proximal anastomoses the patient was weaned from bypass and the atrial 
cannula(e) removed. When haemostasis was considered to be 
satisfactory, protamine (3 mg/Kg body weight) was administered to 
reverse the effects of heparin, as judged by the restoration of a 
normal activated clotting time, and the aortic cannula removed.
The sternum was approximated with steel wires over two drains 
placed in the pericardial cavity. The subcutaneous and subcuticular 
layers were closed with Dexon and the legs with subcutaneous Dexon and 
clips for skin.
CARDIOPULMONARY BYPASS (Figure 3.1,3.2).
CPB was performed using pulsatile perfusion (Stockert pulsatile 
roller pump, Stockert Instruments, Munich, West Germany), a Harvey
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H1700 bubble oxygenator (Bard Ltd., Pennywell Industrial Estate, 
Sunderland, UK) and a 40 micron pore size arterial filter (AF-1040C 
heparin-coated arterial filter, Edwards CVS Division, Bentley 
Laboratories Ltd., Wallingford Rd., Compton, Berkshire, UK).
The priming fluid for the extra-corporeal circuit consisted of 2 
litres of Ringer's lactate, 8,000 units of heparin, 50 mmol of sodium 
bicarbonate, 10 g of mannitol, 15 mmol of potassium chloride and 750 
mg of sodium cefuroxime.
Alteration in blood temperature in the extracorporeal circuit 
was achieved with a Normo-/Hypothermic heat exchanger (Stockert 
Instruments, Munich, West Germany) capable of decreasing or increasing 
blood temperature at approximately 1°C per minute. To obtain the 
selected blood temperature, circulating water in the heat exchanger 
was cooled to 20°C prior to CPB when the desired blood temperature was 
28°C and to 14°C when the desired blood temperature was 20°C. Shortly 
prior to completion of the last distal anastamosis, systemic rewarming 
was commenced and continued during completion of the proximal 
anastamoses until a core temperature of 37°C was attained.
The intraoperative blood temperature was continuously recorded 
in the extracorporeal circuit throughout the operation (Therm-A, 
Edwards CVS Division, Bentley Laboratories Ltd., Wallingford Rd. , 
Compton, Berkshire, UK). Simultaneously, core temperature was 
measured in the nasopharynx (Yellow Springs series 401 temperature 
probe, Siemens Ltd., Napier Court, Wardpark North, Cumbernauld, 
Scotland, UK) and continuously displayed, along with blood 
temperature, on a Siemens Sirecust 404 patient monitoring system 
(Siemens, Munich, West Germany).
The perfusion flow rate was calculated from the formula that at 
normothermia full flow was equivalent to 2.4 L m min (11). During
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intraoperative hypothermia the flow rate was reduced but did not fall
9 1below 1.5 L m min .
One litre of 4°C cardioplegic solution (St. Thomas's Hospital 
formula) consisting of 3.253 g of magnesium chloride, 1.193 g of 
potassium chloride and 273 mg of procaine hydrochloride in 1 litre of 
Ringer's lactate was administered in divided doses during the 
cross-clamp period. The heart was topically cooled with physiologic 
saline at 4°G.
It is current practice in this centre to control acid-base
status by "pH-STAT" management, which entails alterations in C02
during CPB depending on pH. This technique is based on the fact that
as body temperature falls during the hypothermic period of CPB, C02
solubility increases while the pH tends to rise because the 
dissociation constant of water (pKw), the primary source of H+ ions, 
falls. To maintain acid-base status during hypothermia, by pH-stat, 
requires increasing the total C02 content of blood either by addition 
of C02 or by hypoventilation, so that the pH remains at 7.40 even 
during hypothermia (211). There is, however, growing evidence that 
pH-stat management of acid-base balance during hypothermia leads to an 
uncoupling of cerebral blood flow and metabolism, so that below a mean 
arterial blood pressure of 55 mmHg there is loss of cerebral 
autoregulation and cerebral blood flow becomes pressure dependent. 
This subject has been extensively reviewed by Pearson who indicates 
the physiological superiority of "alpha-stat" management of acid-base 
balance, which maintains autoregulation of cerebral blood flow and 
therefore cellular metabolism, at a lower mean arterial pressure 
(212) .
On return to the Cardiac Intensive Care Unit boluses of morphine 
(1-2 mg), midazolam (1-2 mg) and vercuronium (2 mg) were used to
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maintain analgesia and permit mechanical ventilation until the patient 
was fully rewarmed, haemodynamically stable and ready for extubation.
POSTOPERATIVE FLUID REGIMEN
Fluid management was standardised in the perioperative period
(213). Fluid balance charts were used routinely for all patients, 
initially on an hourly basis (for the first 48 hours) and then on a 
daily basis, the aim being to keep each patient in a slightly negative 
fluid balance (200 - 500 ml) over each 24 hour period. Patients
received a standard fluid regimen consisting of 40 mis of 5% dextrose/ 
hour and 40 mis of 5% dextrose with 5 mmol potassium/ hour.
Additional volume was administered in accordance with haemodynamic 
criteria (arterial blood pressure, central venous pressure, skin/core 
temperature gradient and urine output) and was predominantly with
crystalloids unless required rapidly when colloid was administered. 
Blood loss was replaced with autologous blood from the "pump" or 
banked "packed cells" for excessive loss accompanied by a packed cell 
volume consistently less than 30%. Likewise blood was only
administered in the remainder of the postoperative period for a
persistently low haemoglobin (< 10 g/dl).
A positive fluid balance, in excess of 500 ml over a 24 hour 
period, was an indication for diuretic therapy (intravenous boluses of 
10 mg of frusemide).
PART 3: BIOCHEMICAL METHODS.
Biochemical methods are described in the relevant chapters.
PART 4: ANTHROPOMETRY.
The anthropometric assessments were performed by two experienced
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observers. Ms Rosemary Richardson (Research Dietitian, Department of 
Biochemistry, Royal Infirmary, Glasgow) performed the anthropometric 
assessments reported in Chapters 4 and 13. Ms Carol Lowis (PhD 
student, Department of Physiology, Glasgow University) performed the 
anthropometric assessments reported in Chapter 5.
The patients were weighed in light attire (pyjamas only) and 
heights were recorded without footwear. Mid-arm circumference (MAC) 
was measured in the dependent and non-dominant arm, with the elbow 
flexed to 90°, at a point midway between the acromion and olecranon 
process using Harpenden Skinfold Calipers (British Indicators, Holtain 
Ltd, Bryberian, Crymmych, Pembrokeshire, UK). Triceps skinfold 
thickness (TST) was based on the mean of three readings of a fold of 
skin, pinched between thumb and forefinger overlying the triceps, at j 
the point where MAC was measured.
Arm muscle circumference (AMC) was calculated from the formula 
AMC = MAC -(0.314 TST) where AMC and MAC are in cm and TST in mm
(214). AMC and TST were expressed as percentages of expected standard , 
where in males AMC=25.3 mm and TST =12.5 mm (215).
PART 5: PROTEIN TURNOVER STUDIES (Figure 3.3, 3.4).
THEORETICAL ASSUMPTIONS (Figure 3.3).
Whole body protein turnover rates were calculated by the 
stochastic method of Picou and Taylor-Roberts (95) . This method 
assumes the existence of a single metabolic pool of low molecular 
weight nitrogen compounds such as urea, amino acids and ammonia. The 
pool derives protein from two sources: from food intake (I) and from
the breakdown of body proteins (B); protein is lost from this 
metabolic pool either through the synthesis of new body proteins (S) 
or, after degradation, by loss as nitrogenous waste products (E)
74
mainly as urinary urea but also through faecal and skin losses. In
the steady state the amount of protein entering the pool is equal to
the amount being lost, ie. I+B=S+E. Total protein turnover (Q) is
equal to the amount of protein entering or leaving the pool per unit 
of time, ie. Q = I+B =S+E.
In the fasting state, since protein intake equals zero, the rate
of protein turnover (Q) is equal to the rate of protein breakdown
(Q=B) and the rate of protein synthesis equal to protein turnover less 
the nitrogen lost through excretion (S=Q-E).
The method of Picou and Taylor-Roberts (95) assumes that if an 
isotope is administered as a continuous infusion then a point is 
reached when the total amount of isotope entering the body's metabolic 
protein pool is equal to the amount leaving (ie. isotopic steady *
state). The specific activity of the pool can be estimated b y . ,
measuring the specific activity of one of the products of the pool (in 
this case the chosen end products of protein metabolism were urinary 
urea and ammonium). Protein turnover was calculated using the formula: j
Q = D / E  where Q= protein turnover
D= quantity of isotope infused per unit time
E= isotopic enrichment of chosen urinary end product
The method assumes that:
1) the size of the protein pool remains constant during the 
plateau period.
2) there is no significant re-entry of isotope into the protein 
pool during the plateau period (because relatively high levels 
of enrichment are achieved during the plateau, any isotope 
re-entering the pool is unlikely to significantly alter the 
final enrichment).
3) amino-acids from dietary sources are used in a similar way to
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those derived from breakdown of body proteins.
4) there is no discrimination against the isotope.
1 s5) the isotope labelled amino acid (in this case ■LJN glycine) is 
a valid tracer for total amino-nitrogen and is utilised in the 
same way as 14 nitrogen.
PRACTICAL CONSIDERATIONS (Figure 3.4).
Protein turnover studies were performed by the method described
by Sim and colleagues (216,217) using a primed, continuous 24 hour
infusion of the amino acid glycine labelled with the stable isotope
■^N. The use of a primed infusion has been shown to shorten the time
to plateau (216).
On the day prior to the study the patient ate a standardised
hospital diet. After an overnight fast the patient voided at •
approximately 07.00 hours and this urine was discarded. At 07.50 the
patient voided a second time and this urine specimen was retained for
1 sdetermination of baseline enrichment of N in urinary ammonia and i
1 5urea. At 08.00 a primed infusion of N glycine was commenced and 
simultaneously a 24 hour urine collection, in two 12 hour aliquots, 
was begun (216) . The ^ N  glycine was obtained from Amersham
International and sterilised by microfiltration. The priming dose of
1 c
N glycine was 50 mg and the 24 hour infusion contained a further 50
1 Smg in 1 litre of normal saline. The N glycine infusion was 
administered into a peripheral vein via a peristaltic infusion pump 
(Ivac, Harrow, UK).
The pre-operative study was performed in the 48-24 hour period 
before surgery. During this period the patient was allowed free 
access to non-sugar and non-milk containing fluids but not to solid 
food. The patient was permitted to perform minimum ward activities,
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eg. lying in bed or sitting watching television. The study was
repeated in the 24-48 hour post-operative period, after obtaining a
1 sbase-line specimen of urine to determine N enrichment of urinary 
urea and ammonium, while the patient was confined to bed.
Sample preparation
Total urinary nitrogen was measured on a Technicon autoanalyser
following kjeldahl digestion (218).
The isotopic enrichment of urinary urea and ammonium was
measured in urine collected over the 12-24 hour infusion period, as
Sim and colleagues have demonstrated that during this period plateau
isotopic enrichment occurs (216).
Ammonia was extracted from the urine specimen using a cation
exchange resin in the sodium/potassium form (Bio-rad Laboratories
Ltd., Hertfordshire, UK), in a modification of the technique initially
described by Read and co-workers (219), leaving an aliquot of
ammonium-free urine. The urea in this latter specimen was converted
to ammonium by hydrolysis with urease and then extracted using the
same type of cation exchange resin. Ammonium was liberated from the
dry resin by treatment with 2.5M KHSO4 and 50-100 uL subsamples
(approximately 1-4 umol N2) were pipetted into pre-frozen aluminium
combustion chambers and freeze-dried for subsequent analysis.
1 5N enrichment in urinary urea and ammonium was measured by 
continuous flow isotope ratio mass spectrometry (220). This consisted 
of a Roboprep biological sample convertor (Europa Scientific Ltd., 
Crewe, UK) interfaced directly to a MM 602 dual collector isotope 
ratio mass spectrometer (VG Isogas, Winsford, UK), by a simple 
variable leak valve. The sample preparation system and autosampler 
were computer controlled, making the isotopic analysis fully
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automatic. The coefficient of variation was 0.10% for these analyses.
1 SThe atom per cent excess of N in each sample was calculated 
from the mass 28 and 29 peak heights. By integrating and summing 
isotope peaks, the total elemental content of the analyte was 
quantified. The ^ N  atom per cent excess for ammonium and urea in 
each patient was derived by subtracting the measured baseline 
enrichment of each end-product prior to the study. This pre-infusion 
isotopic enrichment was subtracted not only from the preoperative 
measurement of whole body protein turnover (WBPT) and whole body 
protein breakdown (WBPB), but also from the postoperative measurement. 
This was done as the postoperative pre-infusion isotopic measurement
1 C
in urea and ammonium end-products reflected recycling of the N 
label.
Measurements were performed by Dr. T. Preston (Scottish 
Universities Research and Reactor Centre, National Engineering
Laboratory, East Kilbride) and Mr. D. McMillan (University 
Department of Surgery, Royal Infirmary, Glasgow).
PART 6 : MEASUREMENT OF ENERGY EXPENDITURE
Total energy expenditure consists of two components: a
relatively constant resting energy expenditure and a more variable 
activity energy expenditure. Resting energy expenditure is that 
energy used to maintain body temperature and can be further subdivided 
into basal metabolic rate (BMR) and energy expenditure due to food 
intake (specific dynamic action of food).
Energy expenditure can be calculated by measurement of heat loss 
(direct calorimetry) or estimation of heat production (indirect
calorimetry).
During direct calorimetry the subject is enclosed within a
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specially constructed chamber surrounded by water or ventilated by 
controlled air. Energy expenditure is calculated from the rise in 
temperature of the water or air, but the method depends on the subject 
being undisturbed for long periods and is therefore unsuitable in the 
clinical setting.
Indirect calorimetry provides an estimate of BMR. The
maintenance of cellular integrity and the function of specific organs
involves the combustion of body fuels which utilises oxygen (02) and 
produces carbon dioxide (C02). Measurement of gaseous exchange of 02 
and C02 through the lungs, by collecting all gases inspired from and 
expired into a canopy placed around the subject's head, provides an 
indirect estimation of energy expenditure. Furthermore the ratio of 
C02 production to 02 consumption (ie. the respiratory quotient: RQ)
is a useful indicator of the type of fuel being utilised. Useful 
measurements depend on the subject being undisturbed for at least 40 
minutes and this technique is therefore unsuitable in ill patients 
where easy and frequent access must be available to medical and
nursing staff.
Indirect calorimetry thus provides a factorial computation of
energy expenditure over 24 hour periods which is difficult to validate 
in the postoperative patient and whose relationship to true total 
energy expenditure remains uncertain.
INDIRECT CALORIMETRY (Figure 3.5)
The indirect calorimeter used in this study was a ventilated 
hood system, used over the last ten years in the Physiology Department 
at Glasgow University. It consists of a flexible plastic hood placed 
around the subject's head and shoulders. Room air of a known 02 and 
C02 concentration is drawn through the hood at a controlled rate (1
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litre per Kg of body weight per minute). A sample line from the hood 
outflow allows the mixture of inspired air and patient's expired gases 
to be continuously analysed for 02 and C02 content.
Technique
Calorimetry was performed at 08.00 after an overnight fast. The 
patient remained in bed after wakening and was not permitted to bathe 
or undergo any physical activity prior to a calorimetry run. A thirty 
minute acclimatisation period enabled the patient to become used to 
the apparatus and to reach a steady state before a thirty minute 
calorimetry run. Every 30 seconds the oxygen concentration of the air 
leaving the hood was recorded and the mean concentration in each ten 
minute period calculated. A sample of room air collected 
simultaneously and analysed at the end of each measurement period 
provided a mean estimate of inspired 02 content.
The gases were dehumidified using silica gel prior to 
measurement. Oxygen concentration was measured with a paramagnetic 
oxygen analyser (Servomex 570A, Servomex Ltd., Crowborough, Sussex, 
UK) and the C02 concentration by a single channel infra-red carbon 
dioxide analyser (Seiger Ltd., Poole, Dorset, UK).
After correction of 02 and C02 concentration for temperature and 
barometric pressure the oxygen consumption (V02) and carbon dioxide 
production (VC02) was calculated by comparing differences between room 
air and mixed expired gases.
The oxygen analyser was calibrated each morning using oxygen 
free nitrogen and inspired air and the C02 analyser using 0 .8% C02-
The integrity of the ventilated hood was established both before and 
after the study by means of a gas recovery test and was found to be 
accurate to +/- 2%.
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Calculation of oxygen consumption
oxygen consumption= vol 02 inspired - vol 02 expired
= Vi x 20.9 - Ve x %02e (1)
100 100 
where Vi =vol air inspired
Ve =vol air expired
20.9% =% oxygen in inspired air (measured in the current study)
%02e =% oxygen in expired air
therefore oxygen consumption = (20.9 - %02e’) x flow (2)
100
Calculation of metabolic rate
The calorific equivalent of oxygen is equal to the amount of 
heat released for every litre of 02 used and averages 5 Kcal/L.
The metabolic rate = 02 consumption x calorific equivalent of 02 
and taking equation 2 :
metabolic rate = (20.9 - %02e ) x flow x 5
100
= (20.9 - %02 e ) x flow (3)
20
This is known as the Weir equation (221) and assumes that Vi=Ve, 
which is only true when the Respiratory Quotient (RQ) -the ratio of 
C02 produced to the ratio of 02 used -is 1, and this is seldom the 
case (error 1). However the volume of nitrogen and inert gases in
inspired air always equals the volume of nitrogen and inert gases in 
exhaled air. Returning to equation 1 and re-writing:
metabolic rate = Vi x 20.9 - Ve x %02e x 5 (4)
100 100
It is apparent that assuming Vi=Ve when in fact Ve<Vi (RQ<1)
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will underestimate the volume of oxygen inspired, and will 
under-estimate the metabolic rate (error 1).
However the calorific equivalent of oxygen also varies depending 
upon the fuel being oxidised: fat has an RQ of 0.71 and a calorific
equivalent of 4.69 Kcal/L and protein an RQ of 0.81 and a calorific
equivalent of 4.60 Kcal/L. As the RQ falls the calorific equivalent
of oxygen falls, and assuming the calorific equivalent to be 5, as in 
equation (4), will over-estimate the metabolic rate (error 2).
Under normal circumstances these two errors cancel out and the 
de Weir equation gives an accurate assessment of metabolic rate.
The most widely used formula for calculating BMR is that of de 
Weir (221).
BMR= 1.44 (3.941 V02 + 1.106 VC02) - 2.17 (UN)
where BMR = Basal Metabolic Rate in Kcal/24 hours 
V02 = Oxygen consumption in ml/min 
VC02= Carbon dioxide production in ml/min
UN = Total urinary nitrogen excretion in grams/24 hours 
Several researchers have shown that omitting to measure urinary 
nitrogen results in an error of less than 2% (222) so that:
BMR= 1.44 (3.941 V02 + 1.106 VC02)
Under steady state conditions VC02/ V02 = RQ and by substituting 
(RQ x V02) for C02 the formula becomes 
BMR= 1.44 (3.941 V02 + 1.106[RQ x V02]) Kcal/24 hours 
BMR= 1.44 V02 (3.94 + 1.11 RQ) Kcal/24 hours
If the RQ is 0.7 (when fat is being predominantly oxidised) then
assuming a patient has an oxygen uptake of 250ml/min:
BMR= 1.44 x 2 5 0  ( 3 . 9 4  + [ 1 . 1 1  x 0 . 7 ] )  = 1 6 9 8  K c a l / 2 4  h o u r s
If the RQ is actually 1.0 then assuming the same patient has an 
oxygen uptake of 250ml/min
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BMR= 1 . 4 4  x 2 5 0  ( 3 . 9 4  + [ 1 . 1 1  x  1 . 0 ] )  =  1 8 1 8  K c a l / 2 4  h o u r s
The usual figure for RQ in clinical practice, after an overnight 
fast, is in the region of 0.80-0.85. Assuming a value of 0.85 then 
BMR= 1 . 4 4  x 2 5 0  ( 3 . 9 4  + [ 1 . 1 1  x  0 . 8 5 ] )  = 1 7 5 8  K c a l / 2 4  h o u r s
This is approximately 3% different from the value which would be 
obtained with an RQ of 0.7 or 1.0. Errors of this magnitude have no 
clinical significance and by using estimated RQ values, the necessity 
to measure VC02 is avoided simplifying all measurements.
DOUBLY LABELLED WATER TECHNIQUE
The Doubly Labelled Water (DLW) technique for calculating energy
O
expenditure entails the administration of two stable isotopes, H and 
and in the form of labelled water (ie ^H20 and H2^ 0 ) and is
based on the observation that oxygen in respired C02 is in equilibrium 
with oxygen in body H20 through the action of carbonic anhydrase
O
(223). After mixing with body water H is lost from the body as water 
1 8whereas 0 is lost both as water and carbon dioxide. The difference 
in the rate of excretion of the two isotopes from the body is 
therefore due to C02 production from which energy expenditure can be 
calculated (224). Thus whereas indirect calorimetry provides a 
factorial computation of total energy expenditure, by extrapolation 
from a brief measurement of BMR, the use of DLW allows calculation of 
integrated estimates of total energy expenditure over fixed periods.
The DLW method was described in 1955 (224), used for the study 
of energy expenditure in small animals from then (225), and applied to 
man by Schoeller and van Santen in 1982 (226). The DLW technique has 
been demonstrated to have an accuracy to within 2%-5% of C02 
production rates calculated by whole-body indirect calorimetry 
(227-230).
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The initial dilution of either isotope in body water reflects 
the body water pool size and therefore allows estimation of body 
composition (see Calculations, page 83).
Methodology
Patients presented ten days prior to surgery and, after passing 
a baseline urine sample to determine background enrichment, received
1 O lO
75 mg 0 per Kg body weight (8.7 atom% 0, Delta Isotopes, Crewe,
UK) mixed with deuterium (25 mg H per Kg body weight, 99.8 atom 
percent excess, MSD isotopes, Montreal, Canada). Patients were 
allowed home and daily urine samples (20 ml) were collected until 
surgery.
A second identical dose of DLW was administered six hours after 
surgery with residual levels of oxygen and hydrogen enrichment being 5 
calculated from the pre-surgery isotope decay curves. Daily morning 
20 ml urine samples were collected for a further 10 days following 
surgery. ^
A final dose of deuterium alone (10 mg per Kg body weight, - 
99.8 atom percent excess) was administered on the tenth postoperative 
day and 4 accurately timed urine samples obtained in the subsequent 
eight hours, to be analysed if deemed necessary for a third and final 
determination of total body water (TBW).
Patients kept a daily diary before and after surgery to record 
both dietary intake and activity levels.
180 Analysis
1 8All urine samples were analysed for 0 enrichment by continuous 
flow isotope ratio mass spectrometry (CF-IRMS) (231). 1.5 ml samples
of urine were equilibrated with C02 (18.5 ml of 10% C02) in a
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vacutainer at 25°C for 72 hours. 1 ml gas samples (100 uL C02) were
then injected into a CF-IRMS (Roboprep-CN Sample Convertor, Europa
Scientific, Crewe, UK) interfaced to an MM602 IRMS (VG Isogas,
Middlewich, UK) via a septum inlet where the gas was in turn dried,
purified by gas chromatography and bled into the IRMS. The mass ratio
46/44+45 was measured automatically and the instrument calibrated
1 8against distilled water standards of known 0 enrichment. The 
coefficient of variation for replicate urine samples was less than 
0.2%. Accuracy was within 1% over the calibrated range (0-350 ppm 
above background).
o
Deuterium ( H) analysis
1 8Baseline urine samples, samples showing maximum 0 enrichment 
and those every second day from those samples, were analysed for 
deuterium enrichment by conventional dual batch inlet gas source IRMS, 
after reduction to hydrogen gas over depleted uranium (232).
The vacuum rig for the preparation of hydrogen and deuterium gas 
from urine specimens has two components, the first for distilling 
water from urine and the second for reducing water vapour to hydrogen 
gas. Urine is heated to vaporise the water which eventually freezes 
into a cold trap. Non-condensible gases are pumped away to leave a 
pure water sample. During this process the uranium furnace is heated 
to 800°C and the hydrogen gas collection vessels are evacuated and 
cooled with liquid nitrogen. Water from the initial urine specimen 
warms, vaporises and passes through to the uranium furnace where it is 
reduced by the uranium to release hydrogen/deuterium gas which adheres 
to the activated carbon in cold hydrogen gas collection vessels.
Each sample was analysed with reference to a calibrated hydrogen 
working standard and the internal precision of deuterium analysis at
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natural abundance was 0.05 parts per million (1 SD).
Calculations
The fractional turnover rate of each isotope for both pre and 
post surgery phases was equivalent to the gradient of the plot of the 
natural logarithm of the baseline-corrected isotope enrichment against 
time in days.
1 8Total body water (TBW) was estimated by extrapolating the 0
enrichment of the first five samples from the dose time to zero time.
TBW at the time of surgery was calculated in a similar fashion after
1 Rcalculating by extrapolation the residual isotope from the first 0
1 8dose. It was assumed that 0 overestimated TBW by 1% (226).
Fat free mass (FFM) was calculated assuming constant hydration: 
FFM = TBW/0.73 assuming that lean tissue contains 73% water and fat 
tissue negligible amounts (233). The fat mass (FM) was calculated by 
the difference in body mass (BM) and FFM, ie FM= BM-FFM.
Changes in baseline enrichment of either isotope during the 
experimental period could introduce significant error. Variations in
p
the H baseline due to fluid source variation was more likely than
1 8 9changes in 0 baseline. However, analysis of H natural abundance in
urine of patients undergoing the same surgical procedure and receiving
fluids from the same source, but not receiving deuterium, showed only
minor variations (142 sd 2 parts per million).
As there was some evidence of deviation from a simple regression
line in both isotopes, especially after surgery, it was considered
1 Rdesirable to compare the regression of only the 0 samples equivalent
P 1 o
to each H sample analysed, rather than analysis of the full 0 data
1 8set. The probability of the regression coefficient for 0 was 
typically <0.05 for five points and <0.0005 for the full data set.
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Energy expenditure was calculated using the formula of Lifson 
and Mclintock which includes a 4% correction for isotope fractination
assuming that 50% of water loss is insensible (224,234):
r C02 = N (ko-kD) - 0.015 kD N
2(1.04)
r C02 = moles of C02 per day
N = the size of the body water pool in moles
2 = a constant equating two atoms of oxygen in each molecule 
of C02 with one in each molecule of water 
ko = the fractional turnover rate of oxygen 
kh = the fractional turnover rate of hydrogen 
1.04 and 0.015 are correction factors for isotopic fractionation 
assuming that 50% of water output is lost as vapour.
Energy expenditure was calculated from Weir's fromula (221), 
explained on Page 80, by converting moles of C02 to the volume of C02
in litres (VC02 = rC02 x 22.4) and by assuming a mean RQ of 0.85 over
the whole study periods (see Chapter 13).
PART 7: STATISTICAL METHODS
The statistical methods are described in each experimental 
chapter.
FIG 3.1 Operative setting for cardiopulmonary bypass
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CHAPTER 4
NUTRITIONAL ASSESSMENT OF CARDIAC SURGICAL PATIENTS
Let me have men about me that are fat,
Sleek-headed men, and such as sleep a-nights
Yond Cassius has a lean and hungry look;
He thinks too much: such men are dangerous.
William Shakespeare (1564-1616). Julius Caesar I. ii. 192. 
INTRODUCTION
Pre-existing nutritional status is one of the major determinants
of the magnitude of the catabolic response to surgery (60,235).
Although obesity is a recognised risk factor for ischaemic heart 
disease, there is little objective evidence regarding the nutritional 
status of patients undergoing coronary artery surgery. Biochemical 
and anthropometric assessment was performed in a group of unselected 
male patients admitted for elective coronary revascularisation.
PATIENTS and METHODS
Sixty one consecutive, unselected, preoperative male patients 
admitted for elective coronary artery surgery over a 3 month period
underwent biochemical and anthropometric assessment of nutritional 
status. All patients studied were otherwise healthy and, in
particular, patients with diabetes mellitus, endocrine abnormalities, 
lipid disorders, anaemia and renal or hepatic impairment were 
excluded.
All blood samples for the nutritional screen were withdrawn 
between 0800 and 1000 hours and the biochemical assessment consisted
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of 32 parameters including urea and electrolytes (sodium, potassium, 
chloride, bicarbonate, urea and creatinine), blood glucose, calcium 
and adjusted calcium, phosphate, liver function tests (bilirubin, 
alkaline phosphatase, aspartate transaminase, alanine transferase, 
gamma glutamyl transferase), proteins (albumin, globulin, transferrin, 
C-reactive protein), trace metals (magnesium, zinc, copper, iron), and 
vitamins (A, E, C, Bl, B2, B6 , B12, plasma and red cell folate).
Anthropometric assessments were performed in 59 of these 
patients by one experienced observer (Ms. Rosemary Richardson,
Research Dietitian, Dept. of Biochemistry, Royal Infirmary, Glasgow). 
The parameters recorded in addition to age were height, weight, 
percentage ideal body weight, mid-arm circumference (MAC) and triceps 
skin fold thickness (TST). Arm muscle circumference (AMC) was 
calculated from the latter two measurements as described in Chapter 3. 
The patients were all weighed in light attire (pyjamas) and MAC was 
measured in the dependent and nondominant arm at the mid point between 
the acromion and the olecranon processes. TST was measured at the 
same level using Harpenden calipers (British Indicators, Holtain Ltd, 
Bryberian, Pembrokeshire, UK) and the mean value calculated from three 
readings.
Standards for weight/height, AMC, TST and serum albumin were 
obtained from a generally accepted source (214,215). Moderate 
depletion is defined as 60% to 90% of standard, and severe depletion 
60% of standard and below. A serum albumin between 28 g/L and 35 g/L 
indicates moderate depletion and below 28 g/L severe depletion.
RESULTS
The patients studied were all within the age range 34-64 years 
(mean age 53.3 years, SD 6.4 years, SE 0.9 years) with uncomplicated
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ischaemic heart disease. In particular, patients with diabetes 
mellitus and/or evidence of hepatic or renal disease were excluded.
All patients were receiving regular anti-anginal medication 
consisting of a beta-blocker, calcium antagonist and nitrate, alone or 
in combination. In addition 10 patients had been prescribed a modest 
dose of diuretic (frusemide, 40 mg/day), seven a vasodilator and three 
digoxin. Twenty three patients were receiving "triple therapy" 
(beta-blocker, calcium antagonist, nitrates), 14 a beta blocker and 
nitrate, 10 a calcium antagonist and nitrate and eight a beta blocker 
and calcium antagonist. Six patients were receiving single 
anti-anginal therapy ( three beta-blockers, two calcium antagonists 
and one nitrates). It was in this latter group that there was usually 
concomitant administration of vasodilators or diuretics.
NUTRITIONAL SCREEN (Table 4.1)
The nutritional screen consisted of 32 biochemical parameters 
including urea and electrolytes and the results are summarised in
Table 4.1, indicating the number of patients with a value above or
below the limits of the normal reference range. The mean value for
all biochemical indices was within the normal reference range.
The majority of patients had normal urea and electrolytes
although in six patients (10%) the plasma chloride was slightly
elevated (108-109 mmol/L).
No patient had a plasma albumin below 35 g/L although six
patients had a total globulin concentration between 19 and 21 g/L 
(lower limit of reference range 22 g/L). Two patients had modestly 
reduced serum transferrin concentrations (respectively 1.9 and 1.7 
g/L) , one of whom also had a low serum iron. In neither patient was 
there any other clinical or anthropometric evidence of mainourishment.
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In most patients the plasma concentrations of total proteins, 
calcium, phosphate and random glucose were within the normal reference 
range.
Liver function tests were normal in most patients with the 
exception of gamma glutamyl transferase which was elevated in 24 of 60 
(40%) patients. An isolated elevation in gamma glutamyl transferase 
concentration is often a reflection of recent alcohol intake. Four
patients had slightly elevated bilirubin concentrations (23-24 
umol/L). A fifth patient had a serum bilirubin level of 43 umol/L 
accompanied by a high C-reactive protein concentration (60 mg/L), a 
high concentration of serum copper (30.5 umol/L), and a low serum 
concentration of iron (6.5 umol/L) consistent with an ongoing 
inflammatory response. There was, however, no obvious focus of 
inflammation on clinical history or examination. This patient had a 
stormy postoperative course due to low cardiac output and eventual 
hospital discharge was delayed until the 12th postoperative day 
(against a mean postoperative stay of nine days).
C-reactive protein was minimally elevated in another 15 patients 
lying between 10-20 mg/L (upper limit of normal reference range 10 
mg/L) but in none of these patients was there any other evidence of 
infection or inflammation.
Serum magnesium, iron and copper were within the normal 
reference range for most patients. In contrast serum zinc
concentration was modestly reduced in nine patients (15%). As 80 % of
serum zinc is bound to albumin, a molar ratio can be calculated as 
explained in Chapter 7. Assuming albumin has a molecular weight of 
69,000 then the zinc:albumin molar ratio should be within the range
0.0236-0.0226 (normal reference range of zinc of 12-18 umol/L and 
albumin 35-55 g/L). Nineteen patients in this study had a
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zinc:albumin molar ratio less than 0 .020.
The mean concentration of each plasma vitamin was within the 
normal reference range although a considerable number of patients had 
elevated plasma concentrations of vitamin A and E. Plasma vitamin A 
was elevated in 19 patients (31%), of whom only three also had a 
simultaneously elevated retinol binding protein concentration. Plasma 
vitamin E concentration was elevated in 27 patients (44%), of whom 
two-thirds had a plasma cholesterol or triglyceride concentration 
above the upper limit of the normal reference range.
There was an impairment in vitamin B2 status (six patients; 10%) 
and in vitamin B6 status (five patients; 8%) as defined by increased 
activation in vitro of the red blood cell enzymes glutamase reductase 
and aspartate transaminase, respectively. Vitamin C concentration was 
low in five patients (20%) while plasma and red cell folate 
concentrations were normal in all patients, except one.
ANTHROPOMETRIC ASSESSMENT (Table 4.2, Table 4.3)
The results of the anthropometric measurements are presented in 
Table 4.2 and summarised in Table 4.3. 90%-120% of predicted values
was considered to be normal, moderate depletion was 60% - 90% of
standard and severe depletion 60% of standard and below (214,215). 
Values greater than 120% of predicted were considered to indicate 
obesity.
The mean percentage ideal body weight (IBW) was 113.7% (SD 
11.6%). Percentage IBW figures revealed that 72% of patients had a 
body weight within normal limits and a further 29% were obese (Table 
4,3).
The mean arm muscle circumference (AMC) was 106% (SD 8.2%) of 
predicted and percentage AMC indicated that 93% of patients were
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within the normal range and a further 7% obese (Table 4.3).
The mean triceps skinfold thickness (TST) was 90% (SD 27.7%) of 
predicted and percentage TST implied that almost 60% of patients were 
malnourished, one third severely so, while 29% of patients were within 
the normal range and 14% obese (Table 4.3).
DISCUSSION
The clinician's awareness of the importance of nutritional 
status has been reinforced by three related events over the last 15 
years. Firstly, in the early to mid 1970s a series of publications 
drew attention to the poor nutritional status of many hospitalised 
patients, implying that up to 50% of patients in medical and surgical 
wards were malnourished (155-157). Secondly, there was growing 
awareness of an increased morbidity and mortality in malnourished 
hospital patients (152-154) initially reported by Studley in 1936 in 
patients undergoing peptic ulcer surgery (9). Finally, some workers 
reported that nutritional intervention had a favourable effect on 
outcome in malnourished patients (182,183) and, although this was not 
a universal observation (184,185), there is some evidence that 
nutritional support, commenced prior to surgery in high risk patients, 
may reduce postoperative morbidity (186).
There were two cogent reasons for determining nutritional status 
in cardiac surgical patients. Cuthbertson, in the 1930*s, recognised 
that preceding nutritional status was a major determinant of the 
magnitude of the metabolic response to injury (60) and this has been 
reiterated recently (235). Indeed the cachectic patient faced with an 
acute stress may be better adapted to semi-starvation in contrast to 
the nutritionally replete patient faced with an acute illness. It 
therefore follows that before an investigation into the effects of
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cardiopulmonary bypass and hypothermia on the metabolic response to 
surgery, the nutritional status of the population should be clearly 
defined. A failure to quantify the nutritional status of patient 
populations explains, . in part, conflicting reports regarding the 
benefit or otherwise of some therapeutic modalities and this is 
exemplified / in the conflicting evidence regarding the benefits of 
nutritional support (182-186).
Secondly, most assessments of nutritional status in cardiac 
surgical patients have been in patients with "cardiac cachexia" which 
may accompany end stage valvular heart disease (158-160). The 
pathogenesis of cardiac cachexia was first described in the classic 
reports of Pittman and Cohen (161,162) where cardiac failure caused 
relative tissue hypoxia and anorexia but a concomitant increase in the 
metabolic rate due to increased catecholamine secretion. Despite the 
paucity of objective information regarding the nutritional status of 
patients undergoing elective coronary artery surgery, these patients 
are generally considered to be "overnourished" (164)..
Biochemical and anthropometric measurements are commonly used to 
define nutritional status. A broad spectrum of biochemical parameters 
has been advocated, and although no single indicator has consistently 
proved superior to any other, albumin and transferrin have been most 
widely used (236). More recently albumin and transferrin have again 
been recommended, along with weight loss, as providing a quick, 
inexpensive and reliable method of preoperative identification of 
high-risk patients (237). In the current study not one of 61 patients 
had a serum albumin less than 35 g/L and only two a serum transferrin 
less than 2 g/L.
Of the 32 biochemical parameters measured in 61 patients the 
majority were within the normal reference range. Modest elevations in
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C-reactive protein were common and not associated with a complicated 
postoperative recovery as previously reported (135), although the one 
patient with a significantly elevated CRP (60 mg/L) did have a stormy 
postoperative recovery.
There was a mild elevation in gamma-glutamyl transferase in 40% 
of patients which, in the absence of other abnormalities of liver 
function tests, is commonly an indication of recent alcohol intake 
(238).
Fifteen percent of patients had serum zinc concentrations 
immediately below the lower limit of the normal reference range. As 
at least 80% of serum zinc is albumin bound, calculation of a 
zinc:albumin ratio should allow more accurate estimation of the "true" 
serum zinc concentration. The use of this ratio demonstrated low 
zinc .'albumin molar ratios in 19 patients in this study. There is 
circadian variation in serum zinc concentration with highest 
concentrations in the morning (239), and all blood samples in the 
current study were withdrawn between 0800-1000. It is interesting to 
note that in a recent nutritional survey of 157 patients in a general 
surgical ward in Glasgow, 68% had a low serum zinc concentration of 
whom approximately one third had concomitant anthropometric or 
biochemical evidence of malnutrition (240).
A significant number of patients had elevated concentrations of 
Vitamin A (31%) and E (44%) even when respective concentrations of 
retinol binding protein, cholesterol and triglycerides were 
considered. Vitamins A and E are considered to have antioxidant 
properties and low concentrations have been implicated in the 
aetiology of both ischaemic heart disease and malignancy (241). The 
current results were unexpected as both vitamins have been reported to 
be low in Scottish patients with ischaemic heart disease (240).
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Whether any of these biochemical abnormalities may be related to 
drug therapy is uncertain. Diuretics are known to increase urinary 
excretion of trace metals (239) but only two of the 10 patients 
receiving diuretics in this study had a modestly reduced zinc 
concentration. The vitamin abnormalities may be related to
disturbance of the plasma lipoprotein profile which can occur with 
frequent use of B-blockers (242,243).
The most commonly used anthropometric data in the clinical 
setting are height, weight, ideal body weight (expressed as %), mid
arm circumference, arm muscle circumference and triceps skin fold 
thicknness (244). One problem in interpretation of anthropometric 
data in hospital patients is that standard tables are based on healthy 
populations in various parts of the world and may therefore 
nutritionally misclassify an elderly European population (245).
The most surprising observation in the current study was the 
contrast between percentage IBW and AMC which both implied that most 
patients were within the ideal body weight range or obese, while 
percentage TST suggested that two-thirds of the patients were 
malnourished (and one-third severely so). All measurements were made 
by the same experienced research dietitian (RR) as errors in 
anthropometric measurements can occur with different observers (246). 
It is interesting that Abel and colleagues (164) describing the
anthropometric data in 100 cardiac surgical patients (91 of whom had
coronary artery disease) found TST below normal in 29% and implied 
that this represented genuine malnourishment. Ruiz and colleagues 
have drawn attention to sources of error in the measurement of TST in 
obese patients (247) and this is the most likely source of error in 
the current study, particularly as there was no other biochemical or 
anthropometric evidence of malnutrition in these patients. Harries
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and co-workers have suggested that MAC is the most reproducible arm 
measurement since it does not depend on estimation of TST which is 
prone to errors in the obese where landmarks are obscured (248).
SUMMARY and CONCLUSIONS
A nutritional assessment, using biochemical and anthropometric 
parameters, was made in 61 male patients admitted for elective 
coronary artery surgery.
In the majority of patients most biochemical indices were within 
the normal reference range although modest elevations in CRP and 
gamma glutamyl transferase were common. Low concentrations of serum 
zinc were common even after correction for albumin binding.
A surprising observation was the frequency of high 
concentrations of vitamins A and E which have previously been reported 
to be reduced in patients with ischaemic heart disease. It has been 
suggested that this may be due to altered vitamin binding to lipids as 
a consequence of drug therapy.
There was a discrepancy in nutritional assessment between 
anthropometric indices: percentage IBW and AMC suggested the majority
of patients were nutritionally replete or even "overnourished". In 
contrast, percentage TST impied that 60% of patients were malnourished 
and it was concluded, in the absence of any other biochemical or 
anthropometric evidence of malnutrition, that this presumably 
reflected errors in the measurement of TST which are particularly 
prone to occur in the obese.
In conclusion routine biochemical and anthropometric nutritional 
screening is not justified in this population and the tendency for 
percentage TST to nutritionally misclassify these patients should be 
recognised.
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CHAPTER 5
MEASUREMENT AND PREDICTION OF BASAL METABOLIC RATE 
"Physical fitness goes with mental fitness. It goes with energy."
John F Kennedy (1917-1963). Interview January 13, 1963.
INTRODUCTION
Determination of energy expenditure may be desirable in surgical 
practice both from the clinical and research point of view. Energy 
requirements can be estimated from the basal metabolic rate (BMR),
measured by indirect calorimetry (132) or from predictive formulae
based on body composition (249-251). There is no report in the 
literature of the BMR in a cardiac surgical population.
In this study the BMR was measured in 20 patients with ischaemic
heart disease by indirect calorimetry and compared to that predicted 
by the Harris-Benedict (249), Cunningham (250) and Bogardus formulae 
(251).
PATIENTS and METHODS
20 patients admitted for elective coronary artery surgery or 
coronary angiography were studied. All patients had isolated 
ischaemic heart disease and in particular diabetes, hyper1ipidaemia, 
anaemia and endocrine disease were excluded. No patient had undergone 
a change in body weight of >10% in the six months preceding the study. 
All patients were taking anti-anginal medication consisting of a 
beta-blocker and/or calcium antagonist and/or nitrate.
Anthropometric data, including height, weight, and skinfold 
thickness, measured in four areas (biceps, triceps, supra-iliac and
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subscapular) were collected in all patients. Measurement of skinfold 
thickness allows estimation of lean body mass as described by Durnin 
and Womersley (214,252).
The basal metabolic rate (BMR) was determined by four methods:
1) Indirect calorimetry as detailed in Chapter 3
2) The Harris-Benedict formula based on weight, height
and age: males= 66.473 + 13.752 (Wt) + 5.003 (Ht)- 6.755 (A) (249)
3) The Cunningham formula based on lean body mass:
males= 501.6 + 21.6 (LBM) (250)
4) The Bogardus formula based on lean body mass:
males= 489 + 2 2 . 8  (LBM) (251)
where A = age in years
Wt = body weight in kilograms 
Ht = height in centimetres 
LBM = lean body mass (fat free mass)
STATISTICAL ANALYSIS
The BMR, measured by indirect calorimetry, was compared to the 
BMR predicted by the formulae using a Wilcoxon sign rank test. Linear 
regression analysis was performed using the method of least squares 
and correlation (r) coefficients determined. Linear regression 
equations are in the form :
y = a + bx 
where a is the intercept on the y axis 
b is the gradient of the line.
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RESULTS
The mean age of the 20 patients undergoing indirect calorimetry 
was 55 (SD 6), similar to the mean age of the other groups described 
in this thesis (Table 5.1).
Anthropometric data, including height, weight, and skinfold 
thickness measured in four areas (biceps, triceps, supra-iliac and 
subscapular) is given in Table 5.2. The mean percentage body fat, 
derived from the sum of the skinfold thickness by a standard method 
(214,252), was 26.4% (SD 4.2%). The mean TST of 12 mm was 96% of 
predicted and similar to the population described in Chapter 4.
BMR measured by indirect calorimetry and calculated by the 
predictive formulae is summarised in Table 5.2. The mean BMR 
measured by indirect calorimetry was 1545 Kcal/day and 1678 Kcal/day 
when calculated from the Harris-Benedict formula. The Harris-Benedict 
formula overestimated measured BMR, by a mean of 9.5%, in 16 of the 20 
patients (p=0.003 by Wilcoxon sign rank test). The mean BMR 
calculated from Cunningham's formula was 1785 Kcal/day which 
overestimated measured BMR by a mean of 17.7% in 19 of the patients
(p=0.00009 by Wilcoxon sign rank test). The mean BMR calculated from
the formula proposed by Bogardus was 1843 Kcal/day which was 20.7% 
greater than the mean measured BMR. This formula overestimated the 
measured BMR in all patients (p=0.0001 by Wilcoxon sign rank test).
Linear regression equations for measured BMR against calculated 
BMR, by the three formulae, are illustrated in Figs 12.1, 12.2 and
12.3. The regression equations are in the form y = a + bx, where a is 
the intercept on the y axis and b the slope:
Harris-Benedict: y= 888.4 + 0.510x (p=0.004, r=0.609; r^=37%) 
Cunningham : y= 1203 + 0.376x (p=0.009, r=0.680; r^=46%)
Bogardus : y= 1227 + 0.399x (p=0.009, r=0.682; r^=46%)
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The BMR values derived from the predictive formulae correlated 
in a highly significant manner with the BMR measured by indirect 
calorimetry. The correlation coefficients were low, however, 
suggesting that while the predictive formulae provide a good mean 
estimate for the group as a whole they are less useful in predicting 
BMR for the individual.
DISCUSSION
There has been a resurgence of interest in measuring energy 
expenditure in the clinical situation, over the last decade, since the 
classic studies of Dubois (133) and Harris Benedict (249) in the first 
quarter of this century. This renaissance has been prompted by 
efforts to elucidate the pathophysiology of changes in body 
composition in terms of energy imbalance in obesity, malnutrition, 
cancer cachexia and following trauma. From the clinical standpoint 
estimation of energy requirements is helpful in determining optimal 
feeding regimens when nutritional support is desirable (253). 
Inadequate provision of calories fails to prevent loss of body mass 
while hyperalimentation may produce a number of metabolic problems 
such as increased oxygen consumption, carbon dioxide production, 
lipogenesis and hepatic dysfunction (254).
A number of methods have been used to estimate energy 
requirements in surgical patients but the "gold standard" is still 
indirect calorimetry which measures the BMR. BMR is strongly 
correlated with body composition and accounts for up to 75 % of energy 
expenditure in sedentary adults (255).
BMR can be measured with a fixed indirect calorimetry system (as 
in the current study) or a mobile "metabolic cart". Both systems 
require considerable technical expertise and are confined to
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relatively few centres. Even when physically available, some patients- 
particularly after surgery -are unable to tolerate the nose clips or 
ventilated hoods associated with the procedure (256).
Consequently a number of formulae for predicting energy 
expenditure, based on body composition, have been developed (249-251). 
The formulae all presuppose that use of anthropometric parameters can 
reflect the metabolically active portion of the body. The most 
commonly used formula in clinical practice is the Harris-Benedict 
formula (249) which was derived from indirect calorimetry measurements 
in 239 healthy individuals. That study assumed that measurement of 
oxygen utilisation and carbon dioxide production could be used to 
indirectly calculate the rate of thermogenesis and that 24 hour energy 
expenditure could be predicted from such measurements made over 5-15 
minute periods in the early morning. This formula takes account of 
height, weight and age but does not attempt to directly estimate lean 
body mass (LBM).
On the basis that it is the active protoplasmic mass which 
largely determines oxygen consumption, a number of formulae have been 
developed which relate BMR to LBM (250,251). Cunningham re-analysed 
the data of Harris-Benedict and showed that the most important
component dictating BMR was LBM and that age and sex were of little
importance (250). Bogardus independently reached the same conclusion
from studies on 130 American Indians and proposed a formula (251) 
similar to that of Cunningham.
Durnin and Womersley demonstrated that the logarithm of skinfold 
thickness measurements, which anthropometrically estimate subcutaneous 
fat, bear a linear relationship to the fat mass of the body as,
calculated by body densitometry measurements (214,252). The 
relationship remains valid even in the obese (252) and permits easy
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calculation of LBM (LBM = body weight - fat mass) in the clinical 
setting. In the current study, measurements of TST were similar to 
those in the population described in Chapter 4.
The BMR values derived from the predictive formulae correlated 
in a highly significant manner with measured BMR. The correlation 
coefficients were low, however, implying that the predictive formulae 
provide a good mean estimate for the group as a whole but are less 
predictive for the individual. The current study demonstrated that 
measured BMR is considerably lower than that estimated by the three 
predictive equations. The measured BMR was 9.5% lower than that 
predicted by the Harris-Benedict formula and almost 20% lower than 
that predicted by the Cunningham and Bogardus formulae. The 
discrepancy amongst the predictive formulae is accounted for by the 
fact that the former is based on weight and the latter two on LBM. As 
patients with ischaemic heart disease tend to be overweight with an 
excess fat mass (see Chapter 4), then the measured BMR appears even 
lower when accounted for by LBM as opposed to body weight.
There are two possible explanations for the discrepancy between 
measured and predicted BMR in this population. It is possible that 
the predictive formulae overestimate BMR and indeed Daly and 
colleagues reported that the Harris-Benedict formula overestimated BMR 
in 127 healthy volunteers by a mean of 12.3% (257). The estimation of 
LBM in the cardiac surgical patients was based on a well-established 
anthropometric technique which remains valid regardless of body fat 
content (214,252). It is therefore surprising that the two formulae 
based on LBM, the Cunningham and Bogardus formulae, and derived 
independently from different populations, both overestimate BMR to 
such a similar extent.
This observation therefore raises the possibility of a true
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reduction in BMR in a population with ischaemic heart disease. The
autonomic nervous system, and in particular, the sympathetic 
component, are involved in regulation of energy balance and fat 
metabolism (258,259) and administration of beta adrenoreceptor
agonists has been shown to promote weight loss (260). It is possible
that chronic beta-blockade therapy produces a reduction in BMR. If 
so, this is of considerable epidemiological importance in view of the 
widespread use of such therapy for ischaemic heart disease and 
hypertension. Currently an age and sex matched population is being 
recruited by the Department of Physiology at Glasgow University to
answer this question.
SUMMARY and CONCLUSIONS
In this study the basal metabolic rate was measured in 20 
patients with ischaemic heart disease by indirect calorimetry and 
compared to that predicted by the Harris-Benedict (249), Cunningham 
(250) and Bogardus formulae (251).
BMR, measured by indirect calorimetry, was 10-20% lower than 
that estimated by the predictive formulae. The discrepancy between 
measured and predicted BMR was greatest when BMR was related to LBM 
rather than weight.
It is not known whether the low values for measured BMR in 
patients with ischaemic heart disease is a genuine phenomenon, perhaps 
related to beta-blockade therapy, or due to unsuitability of the 
predictive formulae in this population. This point underlines the 
importance of using the most suitable predictive formula for a 
particular group of patients even if this necessitates the development 
of a specific formula for that group.
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FIG 5.1 Measured and predicted (Harris-Benedict formula) 
illustrating 95% confidence limits (dotted lines).
Regression equation (solid line): y= 888.4 + 0.510x
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FIG 5.2 Measured and predicted (Cunningham formula) BMR illustrating 
95% confidence limits (dotted lines).
Regression equation (solid line): y- 1203 + 0.376x
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Regression equation (solid line): y= 1227 + 0.399x
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CHAPTER 6 
CORRECTION FOR HAEMODILUTION
Blood is thick, but water’s thin.
Sir William Schenwick Gilbert (1836-1911). Iolanthe.l.
INTRODUCTION
Alterations in the concentrations of plasma proteins, especially 
albumin, have important therapeutic (261) and prognostic significance 
(262). Moreover, comparative studies of the effects of surgical trauma 
may require evaluation of the magnitude of the acute phase response of 
plasma proteins (263,264). Interpretation of such changes may however 
be complicated by changes in fluid balance.
The effect of haemodilution on the concentration of plasma 
constituents, due to perioperative transfusion of fluids, can be
corrected by a number of formulae (263-265) based on alterations in 
the packed cell volume (PCV) . Alpha-2 macroglobulin may also be 
useful in elucidating the effects of haemodilution as its 
concentration appears to remain constant despite surgical injury
(256). Cardiac surgery, involving cardiopulmonary bypass, provides an 
exacting test of the ability of any formula to correct for marked 
haemodilution as a large volume of fluid is added to the circulation 
in a relatively short period of time. The efficacy of four 
correctional formulae to adjust for the effects of haemodilution in
patients undergoing coronary artery surgery and to correct for the
effects of dilution in a closed, in vitro, system was examined.
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PATIENTS and METHODS
The PCV and plasma concentrations of albumin, alpha-2 
macroglobulin and caeruloplasmin were measured in four patients 
undergoing coronary artery surgery. Blood was withdrawn prior to 
anaesthesia, one minute after the commencement of cardiopulmonary 
bypass and subsequently at two, 12, 24, 48, and 72 hours and on the 
seventh postoperative day. All blood samples were withdrawn when the 
patient had been in the supine position for at least one hour.
Full details of the surgical procedure and perioperative fluid 
management are detailed in Chapter 3. Essentially the extracorporeal 
circuit was primed with 2 litres of Hartmann's solution (containing 
8,000 units of sodium heparin, 50 mmol of sodium bicarbonate, 55 mmol 
of mannitol, 15 mmol of potassium chloride and 750 mg of cefuroxime) 
which was added to the circulation at the commencement of 
cardiopulmonary bypass. A few minutes later 1 litre of cardioplegic 
solution (1 litre of Ringer's Lactate containing 16 mmol of potassium 
chloride, 34 mmol of magnesium chloride and 1 mmol of procaine 
hydrochloride) was infused into the aortic root to produce flaccid 
paralysis of the myocardium.
This situation was simulated, in vitro, by adding 0, 1, 2, 3, 4 
and 5 ml of a 2:1 mixture of priming fluid and cardioplegic solution 
to six lithium heparin tubes, each containing 5 ml of blood from a 
volunteer, and again measuring the concentrations of albumin, alpha-2 
macroglobulin and caeruloplasmin.
All samples from a given patient were assayed within the same 
batch for all analytes. Plasma albumin and alpha-2 macroglobulin 
concentrations were measured by immunoturbidimetry (Baker, Encore R) 
using sheep anti-human albumin antisera (Scottish Antibody Unit, 
Carluke) and goat anti-human alpha-2 macroglobulin antisera (Atlantic
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Antibodies). Caeruloplasmin was measured by an immunoturbidimetric 
method on an Encore centrifugal analyser (Baker Instruments) using 
antisera obtained from Atlantic Antibodies, Scarborough Main, USA.
The PCV of each sample was measured by microcentrifugation.
The correctional formulae employed were:- 
Normalised concentration (of plasma protein) =
Formula A: Measured concentration X initial PCV
new PCV
Formula B: Measured concentration X [1-new PCV]
[1-initial PCV]
Formula C: Measured concentration X [1-new PCV] X initial PCV
[1-initial PCV] X new PCV 
Formula D: Measured concentration X initial [A-2 macroglobulin]
new [A-2 macroglobulin]
RESULTS
Alterations in PCV from the in vitro study are shown in Fig 6.1. 
The decrease in PCV with haemodilution was similar to that expected 
from arithmetical calculations as demonstrated in Fig 6.2.
Measured and corrected plasma albumin and caeruloplasmin
concentrations, from the in vitro study, are shown in Figs 6.3 and 
6.4. Formulae A and B fail to correct for haemodilution and their 
inability to do so increases with the volume of diluent added.
Formulae C and D correct the diluted albumin and caeruloplasmin
concentrations back to the pre-dilution value at all levels of
haemodilution.
In vivo, immediately after the commencement of CPB bypass, there 
was a 41% decrease in the PCV (Fig 6.5) from 44% to 26%. This is of a
(263)
(264)
(265)
(266)
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magnitude that would be expected by the addition of 3 litres of
crystalloid to a 5 litre vascular volume as shown in Fig 6.2. The PCV
returned towards the preoperative value by 12 hours but decreased 
again during the subsequent 24 to 72 hour period.
In vivo changes in measured and corrected plasma albumin and 
caeruloplasmin concentration are illustrated in Figs 6.6 and 6.7. In 
the early bypass period formula A underestimates the pre-bypass plasma 
albumin concentration by 28% but plasma caeruloplasmin concentration 
by only 3%. Formula B underestimates pre-bypass plasma albumin and 
caeruloplasmin concentrations by, respectively, 40% and 30%. Formulae 
C and D correct for the immediate effects of haemodilution, at the 
onset of bypass, but subsequently overcorrect. This overcorrection is
apparent by two hours, increases to a peak at 12 hours, and is still
apparent by the third postoperative day.
DISCUSSION
The aim of this study was to determine the most appropriate 
method of correcting plasma protein concentrations for the effect of 
haemodilution, so that concomitant or subsequent n o n - d i l u t i o n a l  
changes, resulting from surgical trauma, could be detected. The 
ability to correct for the effects of haemodilution is, however, more 
than an academic exercise as the plasma albumin concentration may be 
used as an indicator of the need to provide albumin supplements (261), 
while sequential changes in plasma albumin in critically ill patients 
have been reported to have prognostic value (262). Furthermore 
postoperative alterations in the acute phase response proteins can be 
used to quantify surgical trauma (263,264).
Apart from the effects of fluid transfusion, a large number of 
factors influence the concentrations of plasma proteins under normal
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circumstances. These include posture, exchange with proteins in the 
the interstitial space, synthesis and catabolism. Approximately 10 % 
of the intravascular pool of albumin is replaced by synthesis or 
catabolism each day, while almost ten times this amount is exchanged 
with albumin in the tissue spaces (267). The transcapillary escape
rate of albumin increases within a few hours of surgery (268) and
plasma albumin concentrations usually fall by approximately 10% within 
three days of uncomplicated surgery taking up to three weeks to return 
to preoperative values (266). In contrast Skillman has demonstrated 
that 10-20% of extravascular albumin can shift to the intravascular 
space within 12 hours of haemorrhage (269). These situations are
further complicated in malnourished patients where a low plasma
albumin concentration may reflect an expanded extracellular fluid
space (270).
In such complex clinical situations, an aid to interpretation of
changes in the concentrations of plasma proteins would be valuable
and, in particular, should enable direct comparison with the
concentration prior to fluid transfusion.
Correction for haemodilution is of paramount importance in 
cardiac surgery because of the large volumes of fluid involved.
Haemodilution is an integral component of the cardiopulmonary bypass 
technique and counteracts the increase in blood viscosity and 
vasoconstriction which accompany hypothermia, as well as improving 
renal function and reducing blood requirements (271). At the 
beginning of cardiopulmonary bypass, the patient's vascular system is 
effectively increased by the volume of the extracorporeal circuit 
primed with 2 litres of crystalloid solution. A further 1 litre of 
cardioplegic solution is infused into the aortic root a few minutes 
later (as detailed in Chapter 3) and this solution rapidly returns to
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the systemic circulation via the coronary arteries and coronary sinus 
unless vented.
Three existing formulae (A,B,C) were used to correct for 
haemodilution. Formula A is the most widely used correctional formula 
for haemodilution, eg Ref 252, although no justification of its 
efficacy could be found in the literature. It has presumably been 
adapted from a formula quoted by Gregersen in 1944 to correct for 
concentrations in the intensity of dyes in plasma : Dc = Dt x Po/Pt
where Dc and Dt are respectively the corrected and observed dye 
readings and P0 and Pt are respectively the initial and final 
concentrations of a protein in plasma (272). Formula B has been used 
to correct for the effects of haemodilution in other models of the 
acute phase response and is based on computer predictions of the in 
vivo effects of haemodilution (264). Formula C is based on simple 
arithmetical principles which take account of the differential rates 
of alteration in the concentration of plasma constituents compared to 
the elements of whole blood (265). Formula D was constructed on the 
rationale that alpha-2 macroglobulin is slowly metabolised and is not 
subject to transcapillary leakage in view of its large molecular 
weight (800,000). Indeed Werner and Cohnen have reported that alpha-2 
macroglobulin remains relatively constant after surgery (266) .
In the current study there was a marked drop in the PCV at the 
onset of bypass (Fig 6.5), as would be expected when the intravascular 
volume was effectively expanded by 2 to 3 litres of prime and
cardioplegic solution. The magnitude of the fall in PCV (41%) was
similar to that predicted from the in vitro experiment, as
demonstrated in Fig 6.2, when 3 ml of crystalloid fluid was added to 5
ml of whole blood.
By 12 hours the PCV had returned towards, but did not reach,
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preoperative values as the prime fluid was excreted as urine or lost 
to the interstitial spaces. A subsequent fall in PCV between 24 and 
72 hours results in part from a continued blood loss through
traumatised tissues but also from a "dilutional anaemia" arising from 
a relative hypervolaemia as fluid returns to the vascular volume from 
the interstitial tissues (273).
Formula A undercorrected for the effects of haemodilution both 
in vivo and in vitro. The inability of this formula to correct for 
haemodilution in vitro increased with the volume of diluent added and
can be explained by its failure to take account of the differential
rates of decrease in the concentration of plasma constituents and
elements of whole blood as illustrated in Fig 6.2. The inability of
Formula A to correct for haemodilution in vivo is not simply due to 
surgical blood loss which entails the loss of whole blood and
therefore would not, at least initially, affect the concentration of 
plasma constituents. Using Formula A there was a 23% decrease in
plasma albumin concentration after the onset of CPB but only a 3% fall 
in plasma caeruloplasmin at the same time, suggesting that differences 
in the magnitude of decreases in the protein concentrations cannot be 
entirely explained by dilution. Loss of albumin, through 
transcapillary leakage, is an early component of the acute phase 
response and has been reported after cardiac surgery (268). The large 
molecular weight of caeruloplasmin (160,000), in comparison to albumin 
(69,000), may prevent a similar loss.
Using Formula A, in vivo, albumin and caeruloplasmin
concentrations return towards pre-bypass levels by 12 hours. This is 
due to a combination of factors, including loss of intravascular water 
through urinary excretion and to the interstitial space, and may also 
be due to redistribution of albumin from the interstitial to the
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intravascular space as discussed in Chapter 7. With Formula A there 
is very little change in caeruloplasmin concentration over the first 
12 hours of study, as would be expected for this acute phase protein 
whose plasma concentration does not normally increase until 24 hours 
after tissue injury (see Chapter 7).
Between 24 to 72 hours after cardiac surgery, a decrease in 
plasma albumin concentration of around 25% occurs (274). There was a 
decrease in measured plasma albumin concentration of approximately 20% 
during this period but after application of Formula A there was only a 
2% to 4% fall in plasma albumin in the week following surgery.
Similarly the use of Formula A after 24 hours resulted in 
substantially greater increases in plasma caeruloplasmin than would 
otherwise be expected as discussed in Chapter 7.
Formula B manifestly fails to correct for haemodilution both in 
vitro (Figs 6.3 and 6.4) and in vivo (Figs 6.6 and 6.7). The 
magnitude of error increased with progressive dilution and this
formula was even more inaccurate than Formula A. 5
The in vitro study showed that Formulae C and D provided the
most accurate correction for the effects of haemodilution. Regardless 
of the volume of diluent added, these formulae adequately corrected 
albumin and caeruloplasmin concentration back to pre-dilutional values 
as shown in Figs 6.3 and 6.4. The same formulae, when applied in 
vivo, provided an immediate (ie one minute) correction of the plasma 
concentration of albumin and caeruloplasmin back to preoperative 
values but subsequently overcorrected for the effects of
haemodilution. This overcorrection was apparent by two hours and 
peaked at 12 hours, at which time Formulae C and D overestimated 
predicted plasma albumin concentrations, by 11% and 30% respectively, 
assuming there had been no true change in the intravascular mass of
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albumin. It could be argued that if there is a predominant loss of 
plasma water from the circulation due to increased transcapillary 
permeability, which accompanies the response to trauma (268), then 
Formulae C and D do reflect true alterations in the concentration of 
plasma albumin. Formulae C and D erroneously imply, however, that 
plasma albumin concentration remained elevated until at least the 
third postoperative day, by which time plasma albumin concentration 
has decreased by at least 10% (266,274).
The inability of Formulae C and D to correct for haemodilution 
in vivo demonstrates again that the correlations between PCV and 
plasma constituent concentration in a closed in vitro model do not 
hold in vivo where alterations in the concentration of plasma proteins 
occur independently of changes in PCV. In vivo, while red blood cells 
are confined to the vascular space (5 litres), proteins can be 
distributed to the interstitial space (12 litres) and water to the 
intracellular volume (28 litres).
In summary there is no correction formula which consistently 
temporally corrects for the effects of haemodilution in vivo.
Formulae C and D provide the best correction for haemodilution in the
in vitro situation and for the very early in vivo period but 
subsequently produce a marked overcorrection. Despite its limitations, 
Formula A is the most easily applicable formula when correction for
considerable haemodilution is necessary and allows comparison with the 
large body of literature which has previously used this formula.
Formula A will subsequently be used in this thesis when correction for 
haemodilution is necessary in the first 24 hours following CPB, after 
which no formula will be used. As the inaccuracies of Formula A will 
consistently apply to both temperature groups this will not invalidate 
comparative studies between the groups.
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SUMMARY and CONCLUSIONS
The ability of four formulae (three based on PCV and one on 
alpha-2 macroglobulin) to correct for postoperative dilutional changes 
in plasma albumin and caeruloplasmin was assessed in four patients 
undergoing coronary artery surgery. CPB is a stringent test of the 
efficacy of the formulae to correct for haemodilution as a large 
volume of fluid is added to the circulation in a relatively short 
period of time. Plasma albumin was measured eight times in the 
perioperative period in the four patients and the clinical situation 
was mimicked in vitro by adding various volumes of diluent to whole 
blood. None of the formulae consistently corrected for predicted 
changes in plasma albumin concentration in vivo; two of the formulae 
corrected for in vitro changes in plasma albumin but the same formulae 
produced considerable over-correction when applied in vivo.
1. There is no simple arithmetical formula, based on PCV, which 
can accurately and consistently correct for the effects of 
haemodilution in vivo.
2. Alterations in the concentrations of plasma proteins during 
CPB, and in particular albumin, may not be totally accounted 
for by dilution but also reflect different volumes of 
distribution.
3. When a correction factor has to be applied to account for 
large volume changes, Formula A should be used; despite its 
limitations, particularly in the early post bypass period, it 
provides the least inaccurate correction for haemodilution and 
allows comparison with the existing body of literature. From 
24 hours no correction factor is necessary.
Packed cell volume (%) 
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1 Alteration in packed cell volume from the in vitro study.
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CHAPTER 7
THE ACUTE PHASE RESPONSE. PART 1: PLASMA PROTEINS
"The mind likes a strange idea as little as the body likes a strange
protein, and resists it with similar energy."
Wilfred Trotter (1872-1939). Collected papers. "Has the intellect a 
function ?"
INTRODUCTION
The acute phase response is a stereotyped response to tissue 
injury characterised by typical alterations in the concentrations of 
certain plasma proteins and trace metals. The response is an attempt 
to redress the disturbed homeostasis which follows tissue injury and 
the magnitude of the response is proportional to the degree of tissue 
trauma (263,264). The acute phase response to cardiac surgery is 
poorly documented and it is not known if systemic hypothermia at the 
time of injury is capable of modifing the response. The aim of this
chapter was to document the acute phase protein response to CPB and
the effects of two levels of intraoperative hypothermia on this 
response.
PATIENTS and METHODS
Twenty male patients undergoing elective coronary artery surgery 
were randomised to an intraoperative blood temperature of 28°C or 
20°C, as detailed in Chapter 3.
Blood samples were obtained two days before operation, on the 
morning of operation, and on skin incision. Further samples were 
obtained one minute after the commencement of total cardiopulmonary
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bypass (TIME *01) and at 30, 60, 90, 120 minutes, 3, 5, 7, 9, 12, 15, 
24, 36 hours and on the second, third and seventh postoperative days. 
All samples, except the first, were obtained with the patients in the 
supine position for-at least one hour.
Control of perioperative fluid balance is detailed in Chapter 3 
and correction for haemodilution was based on a simple PCV correction: 
corrected concentration = measured concentration x initial PCV
new PCV
as described in Chapter 6 . Samples obtained after 15 hours were not 
corrected for haemodilution.
BIOCHEMICAL ANALYSES
The samples were immediately centrifuged and the serum stored 
for analysis of C-reactive protein, albumin, prealbumin, transferrin, 
ferritin and caeruloplasmin.
C-reactive protein was measured by Fluorescence Polarisation
p
immunoassay using an Abbott TDX analyser and Abbott reagents. The 
between batch coefficient of variation was <5% across the working 
range of the assay.
Albumin, transferrin, prealbumin and caeruloplasmin were 
analysed by immunoturbidimetric methods on an Encore^- centrifugal 
analyser (Baker Instruments). Antisera for albumin and transferrin 
were obtained from the Scottish Antibody Production Unit (Carluke,
p
Scotland, UK), for prealbumin from Serotec (Oxford, England, UK) and 
for caeruloplasmin from Atlantic Antibodies (Scarborough Main, USA) . 
The between batch coefficients of variation across the working range 
of the assays were respectively <8%, < 8%, < 12% and <10%.
Ferritin was measured by immunoradiometric assay using kits 
supplied by RIA-GNOST^ (Mabing, West Germany). The detection limit of
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the assay is 1 mg/L and the between batch coefficient of variation 
<15% across the working range of the assay.
Statistical analysis was based on a paired t-test to compare 
serial differences within the same group and an unpaired t-test to 
compare differences between groups. Differences were considered 
statistically significant when the probability of their arising by 
random sampling error was less than 1 in 20 (p<0.05) and highly
significant if this probability was less than 1 in 100 (p<0 .01).
RESULTS
The clinical and operative features of the two groups are listed 
in Table 7.1. The mean plasma protein concentration at various time 
points is given in Table 7.2 and percentage changes in concentration 
at the same time points in Table 7.3. There was no significant 
difference in the groups with respect to age or anthropometric indices 
as judged by height, weight and body surface area. The 20°C group 
received significantly more grafts than the 28°C group, resulting in a 
non-significant increase in cross clamp and bypass time in the colder 
group.
There was no significant difference between the two groups in 
perioperative fluid requirements in terms of crystalloids or blood
transfusion.
There were decreases in the concentrations of most plasma
constituents, of up to 10%, between the two preoperative samples 
although this was not statistically significant for any analyte. 
There was a further fall in the concentration of most plasma
constituents, except ferritin and caeruloplasmin, between the second 
preoperative sample and that taken at skin incision but this was
statistically significant only for the decrease in packed cell volume
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(PCV) in both groups (Table 7.3).
There were significant decreases in the PCV and the plasma 
concentration of albumin and transferrin but not prealbumin, ferritin 
or caeruloplasmin one minute after the start of bypass (Table 7.3).
PCV (Table 7.3, Fig 7.1). There was a significant decrease in 
the PCV in both groups prior to CPB. The PCV decreased again one
minute after the onset of CPB by 33% in the 28°C group and 39% in the
20°C group. In both groups the PCV returned towards preoperative 
values by 15 hours but decreased again between 24 and 72 hours. 
Despite some recovery after transfusion the PCV was still 15% to 20% 
lower than preoperative values in both groups at day 7 (p<0 .01).
C-REACTIVE PROTEIN (Table 7.3, Fig 7.2). CRP was detected in 
the preoperative blood sample in eight of the 10 patients in the 28°C 
group (14,12,23,11,11,18,20,13 mg/L) and in six of the 10 patients in 
the 20°C group (27,10,12,11,16,15 mg/L). CRP subsequently became 
undetectable (<10 mg/L) in the majority of patients until seven hours 
in the 28°C group (detectable in nine out of 10 patients) and 12 hours
in the 20°C group (detectable in nine out of 10 patients). CRP levels
rose exponentially after seven hours in both groups reaching a peak at 
72 hours. The first significant rise in the mean CRP concentration in 
the 28°C group was at nine hours and in the 20°C group at 12 hours. 
The rise was more marked and the peak value greater in the 28°C group 
but not significantly so (p= 0.09). The CRP concentration peaked at 
three days and remained significantly elevated at seven days.
ALBUMIN (Table 7.3, Fig 7.3). Albumin concentration decreased 
by approximately 10% in both groups immediately after the commencement 
of CPB. In the 20°C group albumin concentration then increased but 
continued to fall in the 28°C group reaching a minimum concentration 
at 30 minutes, by which time it was significantly lower than in the
122
20°C group (31 g/L v 36 g/L :p< 0.05). In both groups albumin 
concentration returned towards pre-bypass concentrations by 15 hours 
but decreased again on the first postoperative day and declined to 
minimum values on the third postoperative day. At day seven the 
albumin concentration was still 25% lower than the preoperative
concentration in both groups (p<0.05).
TRANSFERRIN (Table 7.3, Fig 7.4). In both groups of patients
plasma transferrin decreased by 11% after the onset of bypass.
Transferrin concentration returned to preoperative values by 15 hours
but fell to 70% of preoperative concentrations between 24 and 48 
hours. There was no significant difference between the groups and on 
day seven the transferrin concentration was 20% below the preoperative 
concentration.
PREALBUMIN (Table 7.3, Fig 7.5). There was no significant 
change in prealbumin concentration in any sample between the 
preoperative period and that taken at 15 hours in either group. 
Prealbumin concentrations fell significantly on the first 
postoperative day and continued to decline to minimum values on the 
third postoperative day. At day seven the prealbumin concentration in 
both groups was still less than 60% of preoperative values. There was 
no significant difference between the two groups.
CAERULOPLASMIN (Table 7.3, Fig 7.6). There was no fall in 
plasma caeruloplasmin concentration prior to or immediately after the 
onset of CPB. Caeruloplasmin concentrations increased from 24 hours 
and continued to increase until day seven when they were 30% higher 
than baseline concentrations (p<0.01). There was no significant 
difference between the groups.
FERRITIN (Table 7.3, Fig 7.7). In contrast to most other plasma 
constituents, there was no decrease in ferritin concentration pre or
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post bypass but an increase which continued throughout the 
perioperative period. At day seven the plasma ferritin concentration 
was more than three times the preoperative concentration in both 
groups and still rising. The increase in ferritin concentration was 
more rapid in the 28°C group over the first five hours but this did 
not reach statistical significance.
DISCUSSION
The acute phase response is an early, complex and non-specific 
response to tissue injury resulting from trauma, infection or 
malignancy. The magnitude of the response is approximately 
proportional to the severity of tissue injury and can therefore be 
used to quantify tissue trauma (275,276). The response has been well 
described following general surgical procedures but poorly documented 
following CPB and it is not known whether the response can be modified 
by hypothermia.
The term "acute phase" was introduced by Abernethy and Avery 
when describing the appearance of a protein (C-reactive protein) in 
the sera of patients with acute febrile illnesses which was not 
normally detectable (277). The acute phase response is believed to be 
an attempt to redress disturbed homeostasis after tissue injury (67) 
and its magnitude is proportional to the degree of tissue injury 
(275,276). The response is initiated by a number of cytokine peptides 
released from macrophages and other cell types activated by tissue 
injury. Amongst the most important cytokines controlling the acute 
phase response are interleukin-1 (62), interleukin-6 (63) and tumour 
necrosis factor (64). The response constitutes typical changes in the 
concentrations of certain plasma proteins and trace elements and is 
one component of a myriad of physiological and biochemical changes
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including fever, leukocytosis, increased secretion of hormones and 
loss of nitrogen occurring after trauma.
The liver plays a key role in the acute phase response. It 
increases the synthesis of all the major acute phase proteins, which 
have an integral role in host defence and tissue repair (eg. 
C-reactive protein, ferritin, caeruloplasmin), while sacrificing 
production of those which act primarily as transport proteins 
(albumin, transferrin and prealbumin). Lebreton coined the term 
"negative acute phase reactants" to describe the reduction in the 
plasma concentrations of these latter proteins (278). Furthermore, 
the liver is probably responsible for the dramatic changes in the 
plasma concentrations of iron and zinc in the early stages of the 
acute phase response (see Chapter 8).
Cardiac surgery involves a unique form of tissue trauma 
combining the additional insults of CPB and hypothermia with 
conventional surgical tissue injury. CPB initiates "whole body 
inflammation" through stimulation of vasoactive substances in blood as 
it passes through the extracorporeal circuit (5,6) but the systemic 
metabolic consequences are poorly defined. The aims of this study 
were i) to characterise the effects of CPB on the acute phase response 
to conventional surgical insult and ii) to determine whether the 
response was modified by a more profound level of intraoperative 
hypothermia.
All blood samples, except the first, were obtained with the 
patient in the supine position for at least one hour to exclude 
postural fluid shifts which can alter the plasma volume by up to 15% 
(267). There was a non-significant fall in the concentration of most 
plasma constituents of up to 10% between the two preoperative samples, 
consistent with an increase in plasma volume which occurs after an
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overnight rest in the supine position (267).
The effect of anaesthetic agents on plasma protein 
concentrations was considered by comparing alterations in the 
concentrations of plasma proteins between the second preoperative 
sample (taken approximately two hours before surgery) and that 
obtained after anaesthesia but immediately prior to skin incision. 
There were variable decreases in the concentrations of most plasma 
constituents between these samples which was in part due to 
administration of intravenous fluids, as witnessed by significant 
falls in the PCV, in both groups over this period. Although the
magnitude of the decreases was variable for different analytes (Table
7.3), it was similar in both temperature groups for the same analyte. 
The variable decreases in the plama concentration of some proteins, 
accompanied by a simultaneous increase in the plasma concentrations of 
ferritin and caeruloplasmin, are presumably due to the effects of
anaesthetic agents on hepatic metabolism of the latter.
The differing magnitudes of decreases in the concentrations of 
plasma proteins immediately after the onset of CPB (Table 7.3) cannot 
be explained simply by haemodilution or inadequacy of the correction 
formula, otherwise similar magnitudes of decreases would be equally 
expected for all plasma constituents. The largest decreases, of
around 10%, were observed in the concentrations of plasma albumin (mol 
wt: 69,000) and transferrin (mol wt: 90,000) but no such decrease
was observed for prealbumin (mol wt: 52,000), caeruloplasmin (mol wt:
160,000) or ferritin (mol wt: 500,000).
PCV. The maximum fall in PCV in both groups of 33% and 39%, 
soon after the onset of CPB, is similar to the arithmetically
predicted fall in PCV of 37.5% when 3 litres of fluid is added to a
fixed vascular volume of 5 litres as explained in Chapter 6 . The
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recovery in PCV during CPB and the early postoperative period is due 
to excretion of the priming fluid as urine and loss into the 
interstitial spaces (267), explaining the frequently observed 
peripheral oedema and weight gain after cardiac surgery (279). The 
fall in PCV between 24 and 72 hours is due in part to continued blood 
loss into traumatised tissue but also a relative hypervolaemia as 
fluid returns from the interstitial spaces causing a "dilutional 
anaemia" (273).
CRP. CRP epitomises the acute phase response. It is normally 
present in trace quantities in plasma but its concentration begins to 
rise within eight hours of tissue trauma to reach a maximum level at 
48-72 hours. CRP synthesis is controlled by the cytokine peptides, 
although its exact role remains undetermined, it is believed to bind 
to ligands (micro-organisms and modified host tissues) enhancing 
phagocytosis and increasing the activity of the immune system 
(67,280). The magnitude of the CRP response is proportional to the 
degree of tissue trauma (275,276). There is a significantly greater, 
but delayed, rise in CRP in cardiac surgical patients compared to 
those undergoing cholecystectomy (281). The peak rise in CRP was on 
the third postoperative day as previously reported for cardiac surgery 
(134), although some workers have reported the maximum increase on the 
second postoperative day (135). There was a trend towards a slower 
and smaller peak rise in the colder temperature group (p= 0.09) in the 
current study, with the first significant rise in the mean CRP 
concentration occurring three hours earlier in the 28°C group.
ALBUMIN. There was a greater decrease in albumin concentration 
30 minutes after commencement of CPB in the 28°C group (p<0.05) than 
in the 20°C group. Fleck has reported an increase in the permeability 
of small blood vessels in the very early stages of the acute phase
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response and suggested that such a mechanism could explain early- 
perioperative decreases in the plasma concentration of low molecular 
weight proteins such as albumin and transferrin (268). Attenuation of 
increased permeability, in the colder temperature group, could explain 
the smaller fall in plasma albumin and transferrin in this group after 
30 minutes of CPB. It does not explain , however, the lack of change 
during CPB in the plasma concentration of prealbumin whose molecular 
weight is less than that of albumin and transferrin. Prealbumin is 
bound to retinol binding protein and vitamin A on an equimolar basis 
and the dynamics of this complex may be different from the solitary 
protein molecule.
The restoration of plasma albumin towards preoperative levels by 
15 hours presumably reflects alterations in its distribution, between 
the extra- and intravascular spaces, as such changes are too rapid to 
be explained by alterations in rates of synthesis or breakdown. In 
addition to loss of "water" through urine and to the interstitial 
space, as described earlier, two further mechanisms operate to restore 
plasma albumin concentration towards normal. Using radio-labelled
tracers ( ) Beattie and colleagues demonstrated that during CPB
albumin is transferred from the interstitial space to the
intravascular volume, at a rate of 0.2 g/minute, and accompanies the 
loss of clear fluid during CPB (279). During a pump run of
approximately 80 minutes, 16 grams of albumin (equivalent to 40% of 
the potentially rapidly exchangeable pool) would be transferred from 
the interstitial to the vascular compartment. Secondly Wasserman and 
colleagues reported that haemorrhage in dogs resulted in an early 
extra- to intravascular transfer of albumin followed by increased 
synthesis of new albumin and a reduction in the catabolism of existing 
albumin (282). These findings were substantiated in man by Skillman
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and co-workers who submitted 13 volunteers to an acute blood loss, of 
approximately 15% of the circulating volume (269). They found a net 
increase in total plasma albumin, of between 10%-20% within 12 hours, 
and attributed this increase largely to a shift in albumin from the 
interstitial to intravascular space (269). It has been postulated 
that a consequent decrease in the interstitial mass of albumin leads 
to a decrease in the interstitial concentration of hepatic lymph which 
stimulates increased albumin synthesis by the liver (283). It is 
possible that the acute dilutional effects of CPB on plasma protein 
concentration may mimic some effects of haemorrhage.
The decrease in plasma albumin in the week following CPB is 
similar to that previously reported after cardiac surgery (274,279) 
and of a greater magnitude than that following other major surgical 
procedures (266,284,285). This decrease in plasma albumin following 
surgical trauma has been exhaustively investigated and attributed to 
decreased synthesis (286), increased metabolism (287), and 
redistribution to the interstitial space (261). Although these 
mechanisms are relevant to all surgical procedures, two additional 
mechanisms may be involved after cardiac surgery: (i) redistribution
of fluid from the extravascular space to the intravascular volume, 
causing post-perfusion hypervolaemia (273) , as witnessed by a fall in 
the PCV a few days after cardiac surgery and, (ii) denaturation of 
plasma proteins during CPB which causes physical destruction and 
increased plasma clearance (288,289).
PREALBUMIN and TRANSFERRIN. The carrier proteins prealbumin and 
transferrin, like albumin, may be considered as "negative" acute phase 
reactants. Changes in their plasma concentration follow a similar 
time course to albumin with minimum concentrations on the third 
postoperative day. The relatively short half-lives of prealbumin (2
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days) and transferrin ( eight days) in comparison to albumin (20 days) 
has led to widespread acceptance of these proteins as markers of 
nutritional status. The magnitude of the falls in prealbumin and 
transferrin, respectively 50% and 30% by day 3, are of a similar 
magnitude to that reported for other operations such as thyroidectomy 
and cholecystectomy (266,284,285). At day seven the plasma 
concentrations of albumin, transferrin and prealbumin were still 
respectively reduced by 25%, 20% and 45% compared to preoperative 
concentrations. This magnitude of reduction is greater than expected 
for most other operations (as above) and the only comparable 
situations to produce similar changes at seven days are gastrectomy 
(290) and severe traumatic injury (291). Neither the prealbumin nor 
the transferrin response was modified by a more profound level of 
intraoperative hypothermia.
CAERULOPLASMIN. In addition to its function as the principal 
transport protein of plasma copper, caeruloplasmin is an important 
scavenger of oxygen-derived free radicals (80) and stimulator of the 
immune system (79). Plasma caeruloplasmin increased steadily from the 
first postoperative day and was still increasing at seven days, by 
which time it was approximately 30% greater than baseline 
concentration. Caeruloplasmin is well characterised as an acute phase 
reactant protein whose concentration rises relatively slowly following 
injury. The increases in caeruloplasmin observed in this study were 
of a greater magnitude than those reported for other major surgical 
procedures (266,284,285). The caeruloplasmin response was not 
affected by the different intraoperative temperatures.
FERRITIN. Serum ferritin concentrations are an indication of 
body iron stores in normal subjects (292) but are also influenced by 
inflammation (70) and surgery (71) . The physiological significance of
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post traumatic increases in plasma ferritin is uncertain, although it 
has been postulated that ferritin may be important in augmenting the 
oxidative metabolism of circulating neutrophils thereby contributing 
to host defences (293). The plasma ferritin concentration was
significantly increased within 60 minutes of the beginning of CPB and 
preceded the rise in CRP. This is presumably due to the release of
ferritin from the reticuloendothelial stores as it is too rapid to be
accounted for by increased synthesis. The magnitude of the ferritin 
response is proportional to the severity of tissue injury. Two-fold 
increases in serum ferritin occur three days after arthroscopy (71) 
while six-fold increases have been described four days after
hysterectomy (294). Plasma ferritin levels had still not reached peak 
levels seven days after surgery in our patients, at which time they 
were almost 300% above baseline concentrations. There was no 
significant difference in the ferritin response in the two groups.
SUMMARY and CONCLUSIONS
The plasma protein component of the acute phase response was 
determined in 20 male patients undergoing elective coronary artery 
surgery and randomised to an operative blood temperature of 28°C or 
20°C. The plasma protein changes observed were typical of the acute 
phase response with increases in plasma CRP, caeruloplasmin and 
ferritin and decreases in plasma albumin, transferrin and prealbumin. 
The magnitude of changes in concentration was greater than those 
described for other operations. With the exception of a greater fall 
in plasma albumin in the 28°C group and a trend towards a slower 
increase in CRP in the 20°C, group a more profound level of 
intraoperative hypothermia did not influence the protein component of 
the acute phase response to CPB.
NUMBER OF PATIENTS 
AGE
HEIGHT (cm)
WEIGHT (Kg)
BODY SURFACE AREA (m2)
BYPASS TIME (mins)
CROSS CLAMP TIME (mins)
NUMBER OF GRAFTS
LOWEST BLOOD TEMPERATURE (°C)
28°C 20°C
10 10
54(2) 53(1) NS
168(2) 170(2) NS
81(4) 76(2) NS
1.93(0.04) 1.87(0.03) NS
85(6) 97(9) NS
48(5) 59(7) NS
2.8(0.25) 3.7(0.25) <0.05
28(1) 20(1) <0.001
Table 7.1 Clinical and operative features of the two temperature groups.
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CHAPTER 8
THE ACUTE PHASE RESPONSE. PART 2:
TRACE METALS AND THEIR PROTEIN BINDING RATIOS
CHAPTER 8 
THE ACUTE PHASE RESPONSE. PART 2:
TRACE METALS AND THEIR PROTEIN BINDING RATIOS
"...... ; it can only be carried out through blood and iron".
Otto Von Bismarck (1815-1898). Speech, Reichstag. 14th May 1872. 
INTRODUCTION
Alterations in the serum concentrations of the trace elements 
iron, zinc and copper are an integral component of the acute phase 
response following tissue injury (295). Classically there is a rapid 
and profound decrease in the serum concentrations of iron and zinc 
within hours of tissue injury but a slower and more sustained rise, 
over days, in the serum concentration of copper.
The effects of CPB on serum iron have been described previously 
(136) but the effects of CPB on the serum concentrations of zinc and 
copper are unknown. Iron, zinc and copper are transported in plasma 
bound to their respective carrier proteins, transferrin, albumin and 
caeruloplasmin. The binding of these metals to their transport 
proteins is independent of changes in the concentration of the binding 
protein and the effects of surgery on the affinity of these trace 
metals for their transport proteins has not been described. 
Furthermore there is no information on the potential of intraoperative 
hypothermia to modify any of these responses.
PATIENTS and METHODS
Twenty male patients undergoing elective coronary artery surgery 
were randomised to an operative blood temperature of 28°C or 20°C.
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The patients and timing of blood samples are described in Chapter 6 
and operative techniques in Chapter 3.
Iron was measured by standard automated colorimetric analysis 
using ferrozine as the colour reagent. Zinc and copper were measured 
by flame atomic absorption spectrophotometry. The techniques for 
measurement of proteins are described in Chapter 7.
In addition to measurement of their serum concentrations, the 
binding of the trace metals to their carrier proteins was calculated, 
as a molar ratio, as follows:
trace metal serum concentration x molecular weight of carrier protein 
carrier protein (serum concentration)
Iron:transferrin molar ratio = Fe (umol/L) x .09
transferrin (G/L)
Zinc:albumin molar ratio = Zn (umol/L) x 0.069
albumin (G/L)
Copper:caeruloplasmin molar ratio.= Cu (umol/L) x 160
caeruloplasmin (mg/L) 
assuming transferrin has a molecular weight of 90,000, albumin 69,000 
and caeruloplasmin 160,000. More recent estimates of the molecular 
weight of transferrin would be approximately 78,000 but the classical 
figure of 90,000 will not alter the interpretation of ratios in a 
comparative study within and between groups.
Correction for haemodilution was based on a PCV correction, up 
to 24 hours, as described in Chapter 6 .
Statistical analysis was based on a paired t-test to compare 
serial differences in the same group and a non-paired t-test to 
compare differences between groups. Differences were considered
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significant if their probability of arising from random sampling error 
was less than 1 in 20 (p<0.05) and highly significant if this
probability was less than 1 in 100 (p<0 .01).
RESULTS
The clinical and operative features of the two groups are listed 
in Table 7.1. The mean serum trace metal concentrations at various 
time points are given in Table 8.1 and percentage changes in
concentration at the same time points in Table 8.2.
IRON (Table 8.2, Fig 8.1). In both groups of patients serum 
iron increased after the commencement of CPB and continued to rise
until five hours, when it was more than double preoperative values (p< 
0.01). The rise was lower in the 20°C group for the duration of CPB 
and significantly so at 90 minutes. The serum iron concentration fell
rapidly after five hours in both groups and particularly so in the
28°C group. The decrease in serum iron was greater in the 28°C group 
where the concentration decreased by 60% between five and 15 hours 
compared to a 36% fall in the 20°C group over the same period. At day 
seven the concentration of serum iron was 40% of the preoperative 
concentration in the 28°C group (p< 0.006) and 50% of the preoperative 
concentration in the 20°C group (p= 0.02).
IRON:TRANSFERRIN MOLAR RATIO (Table 8.2, Fig 8.2). The
iron:transferrin molar ratio demonstrated an increased binding of iron 
to its carrier protein during the perioperative period until five
hours. Significant increases in this binding ratio were apparent by 
90 minutes in the 28°C group but not until three hours in the 20°C
group. In the 28°C group there was an increase in the
iron:transferrin binding ratio of 42% within 60 minutes of the onset 
of CPB compared to a 22% increase in serum iron concentration over the
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same period. Changes in the binding ratio were similar but slower in 
the 20°C group: two hours after the start of CPB the molar binding
ratio had increased by 27% compared to a 13% increase in serum iron. 
Compared to the 20°C group the iron:transferrin molar binding ratio 
was significantly higher in the 28°C group at 60 and 90 minutes after 
the onset of CPB.
ZINC (Table 8.2, Fig 8.3). The serum zinc concentration 
increased in both groups after the commencement of CPB until 90 
minutes, although the rise was significant only in the 28°G group. 
The serum zinc concentration subsequently fell in both groups to 
approximately half of preoperative values by 48 hours and then 
recovered to appproximately 90% of preoperative concentrations by day 
seven.
ZINC:ALBUMIN MOLAR RATIO (Table 8.2, Fig 8.4). Changes in the 
zinc:albumin molar ratio preceded changes in the concentration of 
serum zinc. There were significant increases in this molar ratio even 
by the time of skin incision. The molar ratio peaked in both groups 
at 90 minutes (p<0.01) and then rapidly decreased to reach minimum 
values at 9-12 hours. The binding ratio subsequently increased in a 
sustained fashion so that in both groups it was significantly higher 
(p<0.05) than baseline values at seven days (compared to serum zinc 
which was lower than baseline values at day seven and significantly so 
in the 20°C group).
COPPER (Table 8.2, Fig 8.5). There was a significant fall in 
the serum concentration of copper in both groups at the onset of CPB. 
which remained significantly lower than baseline levels until 15 
hours. At 24 hours a sustained rise in the concentration of copper 
began so that by day seven the concentration was 30% greater than 
baseline concentrations in both groups (p<0 .01).
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COPPER:CAERULOPLASMIN MOLAR RATIO (Table 8.2, Fig 8 .6). The 
copper:caeruloplasmin binding ratio decreased by almost 20% in both 
groups (p<0.01) within 30 minutes of CPB in contrast to the more 
modest falls in serum copper. In both groups the molar ratio returned 
to baseline levels by three hours. There was no further significant 
change in the copper:caeruloplasmin ratio for the remainder of the 
study despite significant increases in the serum copper concentration.
DISCUSSION
Alterations in the serum concentrations of iron, zinc and copper 
are an integral component of the acute phase response, whether 
precipitated by trauma, infection or malignancy, and the magnitude of 
these changes is proportional to the severity of the stress (295-297). 
Typically there is a marked decrease in the serum concentrations of 
iron and zinc within hours of the noxious stimulus but a slower and
more sustained increase in the serum concentration of copper.
Alterations in the serum concentrations of iron and zinc are mediated
by cytokines such as interleukin-1 which promote their uptake into 
liver (62). Serum copper concentrations reflect alterations in the 
concentration of its carrier protein caeruloplasmin to which it is 
almost exclusively bound (77).
Alterations in serum iron, zinc and copper should be interpreted 
in relation to changes in the concentration of their transport 
proteins. At least 80% of zinc is bound to serum albumin and the
remainder to alpha-2 macroglobulin, although it is almost exclusively 
changes in the former which account for changes in serum zinc 
concentration in response to stress (296). Alterations in the serum 
concentrations of proteins may be due to dilution, synthesis, 
catabolism or redistribution and can therefore obscure independent
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changes in the serum concentration of the bound trace metals. 
Expressing results in terms of the metal to protein binding ratio 
therefore allows interpretation of quantitative changes in the binding 
of the metal to its transport protein, irrespective of changes in 
protein concentration.
The aims of this study were to document the effects of CPB on 
(i) the serum concentrations of iron, zinc and copper 
(ii) the trace metal's affinity for its binding protein and 
(iii) to determine whether the responses were modified by a more 
profound level of intraoperative hypothermia.
IRON. In contrast to the typical acute phase response, an
increase in serum iron concentration, to a maximum at 5 hours after
the commencement of CPB, preceded the typical dramatic fall after 
tissue injury (297). This early increase has been observed 
previously, following cardiac surgery, and attributed to trauma to red
blood cells (136). The increase in serum iron was less during CPB in
the colder temperature group, and significantly so at +90 minutes (17 
umol/L v 24 umol/L: p= 0.03), implying a reduction in red cell trauma, 
either through a protective effect of hypothermia or possibly due to 
reduced exracorporeal flow rates. Serum iron subsequently fell to 
barely detectable concentrations as expected after major surgery (72). 
The profound fall in the concentration of serum iron as part of the 
acute phase response is mediated by cytokines such as interleukin-1 
(62). The beneficial effects of hypoferraemia on host defence 
mechanisms, by depriving invading micro-organisms of an element 
essential for growth and reproduction, is well recognised (297) and 
has been reiterated recently (298). It is of interest that Hairston 
and colleagues demonstrated that serum from patients after CPB 
encouraged bacterial growth and attributed this to immunodepression
138
caused by denatured proteins (299). An alternative explanation could 
be that large quantities of circulating iron, during CPB, enhance 
bacterial growth in such serum.
IRON:TRANSFERRIN MOLAR RATIO. This ratio mimicked and 
exaggerated changes in the serum iron concentration. It demonstrated 
an increased binding of iron to transferrin over the first five hours 
of CPB in both groups. This occurred too rapidly to be explained by 
the action of interleukin-1. There were significant increases in the 
molar binding ratio by 90 minutes in the 28°C group and by two hours 
in the 20°C group. Whatever the mediator, this early increase in iron 
binding would be consistent with the teleological concept of host 
defence mechanisms ensuring that circulating iron is not readily 
accessible to potential pathogens. After five hours there were highly 
significant decreases in the binding ratio consistent with iron being 
stripped from transferrin and being taken up into liver (62).
ZINC. In contrast to the usual response, there was an early 
increase in serum zinc in both groups reaching a peak at 90 minutes. 
This early rise in serum zinc concentration is not specific for 
cardiac surgery, as a similar situation has been reported after 
cholecystectomy although the magnitude of the increase may be greater 
after cardiac surgery (281). The increase was less in the colder 
temperature group and significantly so at 60 minutes (13 [SE 0.8] 
umol/L v 15 [SE 0.5] umol/L :p< 0.05). The decrease in serum zinc to 
approximately 50% of baseline values by nine hours is typical of the 
acute phase response (295). This fall in serum zinc is mediated by 
interleukin-1 which promotes zinc uptake into the liver where it is 
complexed to metallothioneins involved in the production of new 
proteins (62). Teleologically, low serum concentrations of zinc may 
be another component of non-specific host defence mechanisms depriving
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micro-organisms of a trace element essential for growth and 
replication (76).
ZINC:ALBUMIN MOLAR BINDING RATIO. Alterations in this ratio 
demonstrated a marked increase in the binding of zinc to albumin 
during CPB. Significant changes in zinc binding were apparent by the 
time of skin incision and are presumably due, at least in part, to the 
effects of anaesthesia. These changes in binding preceded significant 
changes in the serum concentrations of zinc, iron and the
iron:transferrin molar ratio. Again changes in the zinc binding ratio 
occurred too rapidly to be explained by the actions of interleukin-1
and may be due to changes in hormone concentrations. The zinc ".albumin 
molar ratio demonstrated that zinc was subsequently stripped from 
albumin, consistent with its uptake into liver where it is 
incorporated into numerous zinc metallothioneins. There was a 
progressive rise in the zinc:albumin molar ratio after 36 hours so 
that by day seven there was a significant increase in the
metal:protein binding ratio compared to preoperative values, and in 
contrast to the serum zinc concentration which was still lower than
baseline concentrations at day seven.
COPPER. As part of the acute phase response, and in contrast to 
serum iron and zinc, there is typically a sustained increase in the 
concentration of serum copper due to interleukin-1 mediated increases 
in caeruloplasmin synthesis (77). In the current study there were 
significant decreases in serum copper concentration soon after the 
onset of CPB which persisted until 24 hours. Serum copper 
subsequently increased steadily so that by seven days it was 30% above 
baseline values in both groups. This increase in serum copper is due 
to increased production of the acute phase protein caeruloplasmin as 
described in Chapter 7.
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COPPER:CAERULOPLASMIN MOLAR BINDING RATIO. Examination of 
copper binding to caeruloplasmin demonstrated that copper was actively 
removed from its transport protein during CPB. This may be related to 
the role of copper both as an anti-inflammatory agent (78) and as a 
scavenger of oxygen free radicals (80) which are generated during CPB 
(300). By three hours after CPB there was no further significant 
change in the binding ratio of copper to caeruloplasmin and there was 
no obvious effect of different intraoperative temperatures on either 
serum copper or its binding ratio to caeruloplasmin.
SUMMARY and CONCLUSIONS
Alterations in the serum concentrations of the trace elements
iron, zinc and copper, and in their binding ratios to their carrier -
proteins were examined in 20 male patients undergoing elective ^
coronary artery surgery and randomised to an intraoperative blood 
temperature of 28°C or 20°C.
Alterations in serum iron following cardiac surgery have been
described previously but not changes in serum zinc or copper. J 
Examination of the metal:protein binding ratios allowed assessment of 
the affinity of the metals for their carrier proteins, irrespective of 
changes in the transport protein concentrations, and have not 
previously been described after surgical operations. The potential 
for intraoperative hypothermia to modify surgically induced changes in 
serum trace metals or their binding to carrier proteins is unknown.
Decreases in serum iron and zinc, typical of the acute phase 
response, were preceded by early rises. Significant alterations in 
their respective molar binding ratios preceded significant changes in 
the serum concentrations of the metals and ocurred earliest with the 
zinc:albumin binding ratio. Changes in this ratio therefore
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constitute one of the earliest markers of the stress response, being 
apparent by the time of skin incision. Changes in the serum 
concentrations of iron and zinc and their molar binding ratios may be 
a useful adjunct to studies of the acute phase response as the 
measurements are easy to perform and the facilities to do so widely 
available, in contrast to the situation for cytokine peptides.
A similar overall pattern of response was observed in both 
temperature groups, although elevations in the serum concentrations of 
iron and zinc were significantly less in the colder temperature group 
during CPB.
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THE ENDOCRINE RESPONSE. PART 1: PLASMA HORMONES
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CHAPTER 9
THE ENDOCRINE RESPONSE. PART 1: PLASMA HORMONES
"Somehow there is a constant and shifting balance of forces in which 
hormones, ferments, enzymes, memories, ideas, emotions and moods all 
play a part..."
Abraham Myerson (1881-1948). Speaking of Man. Foreword.
INTRODUCTION
There is an extensive literature pertaining to the endocrine 
response to surgery, its correlation with the magnitude of tissue 
injury and its manipulation by various anaesthetic agents. During 
cardiac surgery the endocrine response to tissue injury is 
additionally modified by CPB, haemodilution and hypothermia. Previous 
studies of the endocrine response during CPB have produced conflicting 
results regarding both the direction and the magnitude of changes in 
the plasma concentrations of hormones. Furthermore there has been no 
study of the effects of different levels of intraoperative hypothermia 
on the endocrine response to CPB and few studies have examined the 
plasma endocrine response in the week following cardiac surgery.
In the widest sense, the endocrine response involves a large 
number of hormones but this chapter is concerned with the effects of 
CPB and two levels of intraoperative hypothermia on the plasma 
concentration of the counter-regulatory hormones (cortisol,
adrenaline, noradrenaline) and thyroid hormones (thyroxine, 
triiodothyronine, thyroid stimulating hormone). The role of the 
counter-regulatory hormones adrenaline, noradrenaline and cortisol, in 
mediating the metabolic response to trauma is discussed in Chapter 12.
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This is the first prospective study to report the effect of two 
levels of perfusion cooling on the endocrine response to CPB.
PATIENTS and METHODS
The operative techniques are described in detail in Chapter 3 
and the patients in Chapter 7.
The anaesthetic technique is of particular relevance to the 
endocrine response and a standard regimen was followed as described in 
Chapter 3. Premedication consisted of 20 mg of temazepam on the night 
before surgery. In the anaesthetic room, sleep was induced with 
midazolam and fentanyl and intubation was performed after the 
administration of a muscle-relaxing agent (atrocurium or pancuronium). 
During surgery anaesthesia was maintained with a combination of 
morphine, fentanyl and midazolam and boluses of atrocurium or 
pancuronium. The total anaesthetic dose of morphine was less than 2 
mg/Kg body weight and fentanyl less than 20 ug/Kg body weight.
On return to the Cardiac Intensive Care Unit boluses of morphine 
(1-2 mg), midazolam (1-2 mg) and vercuronium (2 mg) were used to 
maintain analgesia and permit mechanical ventilation until the patient 
was fully rewarmed, haemodynamically stable and ready for extubation.
Statistical analysis was based on a paired t-test to compare 
serial differences within the same group and an unpaired t-test to 
compare differences between groups. Differences were considered 
statistically significant when the probability of their arising by 
random sampling error was less than 1 in 20 (p<0.05) and highly
significant if this probability was less than 1 in 100 (p<0 .01).
ANALYSIS OF HORMONES
The timing of blood samples is described in Chapter 6 . After
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measurement of the PCV the samples were centrifuged to separate plasma 
which was stored at -50°C for the following analyses.
CATECHOLAMINES. The assay for catecholamines was performed in 
the University Department of Materia Medica at Stobhill Hospital and 
is based on a modification of the technique described by Passon and 
Peuller (301). This method uses the isolated enzyme,
catechol-o-methyl transferase, to transfer a radioactive methyl group
from S-adenosyl-L- methionine (SAM) to an endogenous catecholamine
acceptor model forming a radioactive 0 -methyl catecholamine
derivative. In the presence of SAM ( H-methyl) adrenaline is
o
converted to H-metadrenaline and noradrenaline to
H-normetadrenaline. This technique enables detection of circulating 
adrenaline and noradrenaline at the picomole level of sensitivity.
CORTISOL. Cortisol was measured by an,in-house radioimmunoassay 
(Glasgow Royal Infirmary) using antisera obtained from the Scottish 
Antibody Production Unit, Carluke ML8 5ES. Separation of the assay 
was performed using a solid phase technique (302). The detection 
limit of the assay was 40 nmol/L and the between batch coefficient of 
variation <10% across the working range of the assay.
THYROXINE and TRIIODOTHYRONINE. Total Thyroxine (T4) and 
Triiodothyronine (T3) were measured by an in-house radioimmunoassay 
(Glasgow Royal Infirmary) using antisera obtained from the Scottish 
Antibody Production Unit, Carluke ML8 5ES. Separation of the assays 
was performed using a solid phase technique with a between batch 
coefficient of variation of <8%, for both hormones, across the working 
range of the assay.
THYROID STIMULATING HORMONE. Thyroid Stimulating Hormone (TSH) 
was measured by an in-house immunoradiometric assay (Glasgow Royal 
Infirmary) using antisera obtained from the Scottish Antibody
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Production Unit, Carluke ML8 5ES. The assay used a sucrose wash step 
with a detection limit of 0.1 mU/L and a between batch coefficient of 
variation of <15% across the working range of the assay.
RESULTS
The clinical and operative features of the two groups are listed 
in Table 7.1. The mean plasma hormone concentrations at various time 
points are given in Table 9.1 and percentage changes in concentration 
at the same time points in Table 9.2. There was no significant 
difference in the groups with respect to age or anthropometric indices 
as judged by height, weight and body surface area. The 20°C group 
received significantly more grafts than the 28°C group resulting in a 
non-significant increase in the cross clamp and bypass time in this 
group.
ADRENALINE (Table 9.2, Fig 9.1). The adrenaline results are 
based on analysis of samples in 12 patients ( six patients per group). 
There was no increase in plasma adrenaline prior to skin incision. 
Subsequently there was a significant rise in adrenaline concentration 
between skin incision and the sample taken one minute after onset of 
CPB, in both groups. In the 28°C group adrenaline continued to rise 
throughout CPB, reaching a maximum at the end of CPB (90 minutes). In 
contrast, in the 20°C group, there was no further rise in adrenaline 
concentration after the initial increase at the onset of CPB. The 
increases in adrenaline concentration during CPB were statistically 
significant only in the 28°C group. In both groups plasma adrenaline 
returned to baseline values by the third postoperative day.
NORADRENALINE (Table 9.2, Fig 9.2). The noradrenaline results 
are based on analysis of the same samples, as for adrenaline, in the 
same 12 patients ( six patients per group). In both groups there was
a slight fall in noradrenaline between the two preoperative samples. 
Noradrenaline subsequently increased between skin incision and the 
onset of CPB and this was significant in both groups. In the 28°C 
group noradrenaline continued to increase for the duration of CPB and 
peaked at the end of CPB (90 minutes). In the 20°C group there was no 
further increase in noradrenaline concentration after the onset of CPB 
so that the mean noradrenaline concentration remained within the 
normal reference range in contrast to the 28°C group. In both groups 
noradrenaline decreased after five hours but did not return to 
baseline levels until 48 hours in the 20°C group and 72 hours in the 
28°C group.
CORTISOL (Table 9.2, Fig 9.3). The cortisol response was 
similar in both groups over the course of the study. There was a 
decrease in the concentration of plasma cortisol of approximately 40% 
in both groups between the pre-anaesthetic sample and that obtained at 
skin incision. The cortisol concentration increased from its nadir at 
skin incision and continued to rise throughout CPB so that by three 
hours it was markedly increased (p<0.05) over preoperative 
concentrations. The highest plasma cortisol concentration in both 
groups was reached at 12 hours (being more than double baseline 
values). Cortisol concentrations remained elevated over baseline 
values in both groups until day seven; in the 28°C group this increase 
was greater than 50% (p<0.05) whereas in the 20°C group the increase 
was less than 20% (NS).
TRIIODOTHYRONINE (Table 9.2, Fig 9.4). There was an 11% fall in 
T3 by time of skin incision in both groups. At the onset of CPB T3 
decreased by 25% in the 28°C group (p=0.03)and by 47% in the colder 
group (p=0.01), so that in the latter group T3 concentration fell 
below the lower limit of the normal range. There was some recovery in
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T3 concentration in both groups by five hours followed by a further 
decrease to a nadir at 24 hours when the concentration of T3 was less 
than half the preoperative concentration and below the lower, limit of 
the reference range in both groups. T3 concentrations subsequently 
increased slowly but by day seven were still 17% below preoperative 
concentrations in both groups.
THYROXINE (Table 9.2, Fig 9.5). T4 fell by 10%-15% in both 
groups at the onset of CPB and then returned towards preoperative 
values by 3 hours, before falling again to minimum values at 24 hours. 
T4 subsequently increased towards preoperative values by day three and 
continued to increase, so that by day four it was 10-15% higher than 
preoperative values in both groups. Changes in T4 concentration were 
similar in magnitude in both groups at all time points.
THYROID STIMULATING HORMONE (Table 9.2, Fig 9.6). There was an 
increase in TSH in excess of 20% in both groups, between the two 
preoperative samples. TSH increased further in both groups by skin 
incision and continued to rise for the duration of CPB, reaching peak 
levels at 90 minutes, being more than double baseline values (p<0.01). 
TSH concentration subsequently declined to preoperative values at 15 
hours with a secondary small increase between 24 and 36 hours. The 
magnitude of the changes was similar in both groups at all time 
points.
DISCUSSION
Although numerous studies have addressed various aspects of the 
endocrine response to CPB the magnitude and the direction of the 
response remain controversial. Most studies to date have investigated 
the effects of pulsatile and nonpulsatile perfusion on the endocrine 
response while the effects of hypothermia have not been addressed.
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CATECHOLAMINES. The catecholamines, adrenaline and
noradrenaline, are important counter-regulatory hormones and their 
role in the catabolic response to trauma, accidental and surgical, has 
been studied extensively in recent years (303). In general the
magnitude of increase in adrenaline and noradrenaline correlates with 
the severity of trauma (304,305). The evidence for elective surgical 
procedures is conflicting, however, with some groups documenting 
postoperative increases in both catecholamines (306) and others only 
in adrenaline (307). The duration of the catecholamine response also 
appears to be related to the severity of injury persisting for a few 
hours after elective surgery (307) and 2-3 days after severe injuries 
(304).
Although increased catecholamine secretion following CPB has *
been recognised for more than 25 years (308), the development of more * 
sensitive assays has allowed better understanding of the catecholamine 
response. Plasma noradrenaline is predominantly derived from overflow 
from post-ganglionic nerve endings and adrenaline from the adrenal * 
medulla (303). Myocardial ischaemia promotes a "cardiocardiac reflex" ; 
involving local release of noradrenaline from the myocardium and
reflex mediated release of adrenaline from the adrenal medulla
(309,310).
It has been reported that morphine in excess of 4 mg/ Kg body 
weight (188) and fentanyl in doses of 50-100 ug/Kg of body weight 
(189) can prevent increases in catecholamine secretion prior to, but 
not during, CPB implying that CPB is a particularly potent stimulus to 
catecholamine secretion (311). In the current study there was no rise 
in adrenaline or noradrenaline prior to skin incision although the 
patients received only moderate doses of morphine (1-2 mg/Kg) and 
fentanyl (<20 ug/Kg).
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Most investigators have reported large rises in adrenaline and 
noradrenaline during CPB. In a particularly detailed study of 28 
patients undergoing open heart surgery at 28°C, Reves and colleagues 
documented a ninefold rise in adrenaline and a twofold rise in 
noradrenaline (147). This group made two previously unreported 
observations: (i) the peak rise in adrenaline and noradrenaline
occurred during the "cross-clamp" period (ie period of exclusion of 
the heart and lungs from the circulation) and, (ii) there was little 
difference in catecholamine concentrations in simultaneous estimates 
of arterial and venous catecholamine concentration.
In the current study there was a large increase in adrenaline 
and noradrenaline in both groups immediately after the onset of CPB. 
Previous workers have attributed similar findings to a compensatory i 
increase in catecholamine secretion due to the fall in blood pressure 
consequent on haemodilution at the commencement of CPB (312). In the 
present study the increases in adrenaline and noradrenaline secretion 
during CPB in the 28°C group were of a similar magnitude to that -: 
reported by Reves1 group and followed an identical time course 
reaching a peak at the end of CPB (147). These workers postulated 
that exclusion of the lungs from the circulation during CPB removes an 
important catecholamine metabolic pathway (147), while myocardial 
ischaemia during aortic cross-clamping stimulates reflex release of 
adrenaline and noradrenaline (309,310). The heart and lungs were 
excluded from the circulation for a longer period in the 20°C group 
[59 (SE 7) minutes in the 20°C group and 48 (SE 5) minutes in the 28°C 
group] and reduced plasma catecholamine concentrations in the 20°C 
group therefore imply diminished catecholamine production during the 
period of hypothermia. This is consistent with experimental work in 
dogs which has demonstrated that profound hypothermia can reduce
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adrenal gland production of adrenaline, noradrenaline and cortisol 
(49,50) but no such similar work exists in humans.
The magnitude of the increases in plasma catecholamine 
concentration during CPB is similar to that after myocardial 
infarction, sepsis or severe injuries (313). High concentrations of 
plasma catecholamines generated during CPB have been positively 
incriminated as an important factor in the pathogenesis of 
postoperative hypertension (314). The consequences of perfusing the 
post-ischaemic heart with such high catecholamine concentrations 
remain to be elucidated, although Reves and colleagues reported that 
re-perfusion of the well protected heart with high concentrations of 
plasma catecholamines does not appear to produce biochemical evidence 
of myocardial damage (315).
CORTISOL. Plasma concentrations of cortisol have been shown by 
numerous investigators to be significantly elevated during and 
following surgery without CPB (316,317). The peak plasma cortisol 
concentration is usually reached about six hours after injury with a 
return to normal concentrations by 12 hours (318). Although an 
increase in the plasma concentration of cortisol is an invariable 
facet of the metabolic response to injury, the magnitude of the 
increase does not bear a simple relationship to the severity of 
injury. A maximum cortisol response is produced by moderate to severe 
trauma; with further severity of trauma there is a significant 
negative relationship with the plasma concentration of cortisol (319)
In contrast to the concordance of the effects of general 
surgical procedures on plasma cortisol concentrations, the effect of 
CPB has produced conflicting results (138,141,142,320,321). It was 
initially reported that CPB produced a fall in the concentration of 
plasma cortisol (138,141,320) either as a result of anaesthesia or
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haemodilution, and this "adrenal hypofunction" led to widespread and 
empirical steroid administration during CPB. Despite evidence that 
CPB produces an elevation in the free (ie physiologically active) 
cortisol concentration (138,141), the prophylactic use of steroids has 
persisted in some centres (322).
There was a decrease in the plasma cortisol concentration of 
approximately 40% between the blood sample taken two hours prior to 
skin incision and that at skin incision in both groups of patients. 
This decrease is too large to be explained by haemodilution alone (see 
Chapter 6) and is presumably due to the anaesthetic agents used. The 
doses of morphine and fentanyl used in these patients, however, were 
smaller than those conventionally regarded as being able to attenuate 
the stress response to surgery (188,189,311). Large doses of morphine 
(188), alfentanil(147) and halothane (311) can suppress adrenal gland 
activity prior to CPB, giving rise to the concept of "stress-free" 
anaesthesia. This term is misleading, however, as cortisol 
concentration increases rapidly on surgical stimulation and continues 
to rise throughout CPB, as reported by Stanley and colleagues (311), 
and as evidenced in the present study.
Taylor and co-workers reported that pulsatile CPB produced a 
significant rise in plasma cortisol concentration compared to 
nonpulsatile CPB (142), implying physiological superiority of the 
former. These findings were disputed by Kono and colleagues who 
failed to demonstrate any intraoperative increase in plasma cortisol 
concentration in patients undergoing pulsatile or nonpulsatile CPB 
(321). In the latter study, however, no correction for haemodilution 
was made and the patients received large anaesthetic doses of 
halothane which is known to suppress adrenal gland function (323). 
The results of the current study are in accordance with Taylor's
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findings that pulsatile CPB preserves the adrenal response to injury, 
as increases in the plasma concentration of cortisol occurred in both 
groups during CPB. Indeed considering the inadequacies of correction 
for haemodilution (Chapter 6), based on changes in PCV, the true 
adrenal response may be underestimated.
The effect of temperature on plasma cortisol concentrations has 
aroused considerable scientific interest since the early 1950's when 
the clinical potential of topical hypothermia was recognised (56,154). 
Swann and co-workers (324) examined the effects of topical hypothermia 
in patients undergoing cardiac surgery prior to the availability of 
CPB. They found that topical cooling was an initial stimulant of 
adrenal secretion which prevented further rises in plasma cortisol 
during the surgical procedure but did not prevent a rebound increase 
in cortisol secretion during rewarming. Ganong and colleagues 
demonstrated, by cannulation of the adrenal vein in dogs, that 
hypothermia resulted in a reduction in plasma cortisol concentration 
by reducing cortisol secretion from the gland (325). In a further 
elegant study in dogs, the same workers demonstrated hepatic 
metabolism of cortisol by temporarily excluding the liver from the 
circulation and showed that liver function was depressed by 
hypothermia (326).
There was no difference in plasma cortisol concentration during 
CPB between the 28°C and 20°C groups. These findings are similar to 
those of Kucera (327) who found no difference in plasma cortisol 
concentrations in children submitted to hypothermic circulatory arrest 
using operative temperatures between 20°C and 27-32°C. In the present 
study, and that reported by Kucera (327), it is feasible that cortisol 
production was reduced in the colder temperature group but that a 
concomitant depression of liver function resulted in the maintenance
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of plasma cortisol concentrations.
Whether moderate or profound hypothermia attenuates the 
endocrine response which would be expected during normothermic CPB is 
a matter for speculation. In a historically controlled study Knutschen 
found significantly lower levels of plasma cortisol in patients 
operated on at 28°C compared to those operated on at normothermia 
during CPB but a significant reversal of this situation during 
rewarming (144).
A striking observation in the current study was the persistence 
of significantly . elevated cortisol concentrations of greater than 
50% in the 28°C group until day 7, in contrast to the non-significant 
increases of less than 20% in the 20°C group over the same time 
period. There are, however, no comparable studies examining the plasma 
steroid response after CPB until the seventh postoperative day. This 
observation is discussed further in Chapter 10.
THYROID HORMONES. The thyroid hormones are the major regulators 
of cellular metabolism and of these T3 is the most important
(328,329). The classical response of thyroid hormones to a wide 
variety of stresses including infection, malignancy and surgical 
operations is a fall in T3 ( accompanied by normal or elevated reverse 
T3), a normal or decreased T4 and normal or decreased TSH levels 
(330). These changes have been described as the "sick euthyroid 
syndrome" and attributed to a reduction in the conversion of T4 to T3 
with a decrease in reverse T3 deiodination in peripheral tissues 
(330). A similar pattern of thyroid response occurs after general 
surgical procedures (331-333) and, similarly, a "low T3 T4 syndrome" 
has been reported after CPB (143,334-336). Free T4 is known to 
increase for the duration of CPB (143) mediated by the effects of 
heparin, either on T4 affinity for its binding hormone (337) or by
155
promoting its release from the large liver stores of T4 (338). During 
CPB there is a transient increase in free T3 which subsequently, and 
similarly to T3, becomes markedly reduced (143).
The present study demonstrated a decrease in T4 and T3 
concentration during CPB. The magnitude of the decreases in T3 was 
greater in both groups than T4 (Table 8.2) being 56% for T3 and 22-27% 
for T4 on the first postoperative day. Throughout the postoperative 
period, and in comparison to preoperative concentrations, the decrease 
in T3 was consistently more than double the concomitant decrease in 
T4. These large and highly significant postoperative falls in T3 were 
similar in both temperature groups and comparable to those reported by 
Paschen and colleagues (334).
T3 is the most important hormone regulating cellular metabolism
(328,329) and low levels of T3 after operation could be explained from 
a teleological viewpoint as an attempt to reduce energy expenditure 
after trauma (339). In vitro T3 increases cellular uptake of 
carbohydrates and amino acids (340) and reduces muscle protein 
catabolism in starved rats (341). Furthermore, thyroid hormones are 
partially responsible for regulation of myocardial contractility 
through an adenyl cyclase system (342) which regulates intracellular 
calcium (the other adenyl cyclase system is catecholamine-dependent). 
It is of interest that administration of T3 in dopamine-dependent 
shock has been reported to have a beneficial effect on arterial blood 
pressure (343).
There are conflicting reports regarding the TSH response to CPB. 
The current study demonstrated significant increases in TSH in both 
groups during CPB. Only one other group of workers has reported an 
increase in TSH during CPB (334), while many groups have reported a 
decrease (143,335,336). Low TSH concentrations during CPB have been
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ascribed to heparin administration (344), release of large doses of 
glucocorticoid (345) and dopamine administration (346). The reasons 
for the differing results may reflect different techniques of CPB but
are hard to elucidate as descriptive methods are often inadequate, eg 
whether CPB was pulsatile or nonpulsatile (334) and whether any 
correction was made for haemodilution (336). Taylor and colleagues 
(347) demonstrated that the pituitary gland responds to thyrotrophin 
releasing hormone stimulation during pulsatile CPB but not during 
nonpulsatile perfusion; unfortunately their study did not compare 
differences in unstimulated TSH secretion between pulsatile and 
nonpulsatile bypass.
It is well recognised that hypothermia stimulates thyroid 
activity in certain mammals (348) but the situation in man has 
produced conflicting results. Moderate reductions in core 
temperature, by a few degrees, in humans has been reported 
alternatively to stimulate (349) and to have no effect on thyroid 
function (350). In contrast, profound cooling (to 20°C) during 
circulatory arrest stimulated marked increases in TSH concentrations 
in four of seven patients studied (351). In the current study the 
magnitude of the decreases in T3 was similar at all time points for 
the two temperature groups as were the decreases in T4. It remains
unclear whether the large increases in TSH during CPB were due to the
effects of perfusion cooling or simply due to pulsatile CPB itself,
but a more profound level of intraoperative hypothermia did not appear 
to influence the TSH response.
SUMMARY and CONCLUSIONS
The plasma endocrine response to two levels of intraoperative 
hypothermia was studied in 20 male patients undergoing elective
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coronary artery surgery. This is the first study to report the 
effects of two levels of intraoperative hypothermia on the endocrine 
response to cardiopulmonary bypass.
Pre-CPB increases in catecholamines and cortisol were less than 
expected and presumed to be due to the anaeshetic agents fentanyl and 
morphine although these were used in doses not conventionally thought 
to reduce the metabolic response to surgery.
The catecholamine response was similar to that previously 
described in the 28°C group. In both groups there was a significant 
increase in plasma adrenaline and noradrenaline immediately after the 
onset of CPB attributable to a fall in blood pressure consequent on 
haemodilution at this time. In the 28°C group there was a progressive 
rise in adrenaline and noradrenaline throughout CPB, as previously 
described, but these latter increases were not observed in the 20°C 
group.
There was a decrease in cortisol prior to CPB, presumably due to 
the effects of anaesthetic agents, followed by a normal/exaggerated 
response to surgical stress and the response was similar in both 
groups. It was postulated that although a more profound level of 
intraoperative hypothermia may reduce cortisol secretion, plasma 
concentrations are maintained through a concomitant attenuation of 
hepatic metabolism in the colder temperature group. Cortisol 
concentration remained significantly elevated only in the 28°C group 
at day seven.
There was a marked fall in T3 and T4 in both groups and 
decreases in the former were consistently double those of the latter. 
The TSH response was increased during CPB in both groups. There was 
no significant difference in thyroid function between the temperature 
groups.
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CHAPTER 10
THE ENDOCRINE RESPONSE. PART 2: URINARY EXCRETION OF HORMONES
"Carry his water to th' wise woman"
William Shakespeare (1564-1616). Twelfth Night. III. iv. 114. 
INTRODUCTION
In contrast to numerous studies detailing the plasma endocrine 
response to CPB, as discussed in Chapter 9, the urinary excretion of 
hormones and their metabolites after cardiac surgery is less well 
documented. Measurement of plasma concentrations of hormones is 
necessary to detect rapid and/or subtle changes in the endocrine 
response to surgery but provides little information on quantitative 
changes. Measurement of urinary excretion of hormones, over fixed 
time periods, provides quantitative information on the magnitude of 
the endocrine response.
As indicated in Chapter 9, no previous study has prospectively 
addressed the effects of two levels of intraoperative hypothermia on 
the endocrine response to CPB. The urinary excretion of adrenaline, 
noradrenaline, dopamine and cortisol was determined in 20 male 
patients preoperatively and on the first, second, third and seventh 
days following coronary artery surgery. The role of the 
counter-regulatory hormones adrenaline, noradrenaline and cortisol, in 
mediating the metabolic response to trauma is discussed in Chapter 12.
PATIENTS and METHODS
The 20 male patients have been described in Chapter 7 and the 
operative details in Chapter 3.
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The twenty-four hour urine collections were obtained 24-48 hours 
prior to surgery and on the first, second, third and seventh 
postoperative days.
Adrenaline, noradrenaline and dopamine were measured by reversed 
phase high performance liquid chromatography with electrochemical 
detection in a modification of the method described by Davidson and 
Fitzpatrick (352). The measurements were performed by Mr William 
Borland in the Department of Biochemistry, Royal Infirmary, Glasgow. 
The between batch precision was: adrenaline 6.9%, noradrenaline 7.0%
and dopamine 6 .1% and the mean recoveries of catecholamines added to 
urine were: adrenaline 99.3%, noradrenaline 98.8% and dopamine
102.6%.
Urinary free cortisol was measured by an in-house 
radioimmunoassay (Glasgow Royal Infirmary) using antisera obtained 
from the Scottish Antibody Production Unit, Carluke ML8 5ES. 
Separation of the assay is performed using a solid phase technique 
(302). The detection limit of the assay was 40 nmol/L and the between 
batch coefficient of variation < 10% across the working range of the 
assay.
Statistical analysis was based on a paired t-test to compare 
serial differences within the same group and an unpaired t-test to 
compare differences between groups. Differences were considered 
statistically significant when the probability of their arising by 
random sampling error was less than 1 in 20 (p<0.05) and highly
significant if this probability was less than 1 in 100 (p<0 .01).
RESULTS
Patient details and operative procedure are described in Table 
7.1. There was no significant difference between the two temperature
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groups with respect to age, bypass or cross clamp times but a highly 
significant difference in the lowest intraoperative blood temperature.
URINARY ADRENALINE (Table 10.1,Fig 10.1). Urinary adrenaline 
excretion increased from preoperative levels to maximal excretion, in 
both groups, on the first postoperative day with a 514% increase in 
adrenaline excretion in the 28°C group (p<0.001) and a 269% increase 
in the 20°C group (pCO.Ol). By the second postoperative day 
adrenaline excretion was still more than double preoperative values in 
the 28°C group (p<0.01) but had almost returned to the baseline value 
in the colder temperature group. In the 28°C group adrenaline 
excretion returned to the baseline level by day 3.
URINARY NORADRENALINE (Table 10.1, Fig 10.2). Urinary 
noradrenaline excretion increased to maximum levels on the first and 
second postoperative days in both groups. The increase was almost * 
treble in the 28°C group (p<0.01) and was by 165% in the 20°C group 
(p=0 .01) on the first postoperative day; the same magnitude of 
increase persisted in each group on the second postoperative day. 
Noradrenaline excretion remained elevated on the third postoperative 
day, by 77% in the 28°C group (p=0.01) and 32% in the 20°C group 
(p=0.57). In both groups noradrenaline excretion returned to 
preoperative values by the seventh postoperative day.
URINARY DOPAMINE (Table 10.1, Fig 10.3). Urinary dopamine 
excretion is based on seven patients in the 28°C group and nine 
patients in the 20°C group, as the remaining patients received 
inotropic dopamine in the early postoperative period producing very 
high dopamine concentrations in the urinary collections. There was a 
200% increase in urinary dopamine excretion over the first and second 
postoperative days in the 28°C group (p=0.03, p=0.02 respectively)
compared to a 50% increase in the 20°C group over the same period
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(p=0.03, p=0.01 respectively). The statistical significance of the
increases in the 28°C group was not greater than that of the 20°C
group, presumably because of the smaller group size. In both groups 
dopamine excretion was still elevated, but not significantly so, on 
the third postoperative day. A 20% increase in dopamine excretion
persisted in the 28°C group, but not the 20°C group, until the 7th
postoperative day.
URINARY CORTISOL (Table 10.1, Fig 10.4). In both groups there 
was a highly significant increase in cortisol excretion on the first 
postoperative day representing a 25-fold increase in the 28°C group 
and a 19-fold increase in the 20°C group. On the second postoperative 
day there was an eleven-fold increase in cortisol excretion in both
groups. By day three cortisol excretion was still five times greater 
than the preoperative value in the 28°C group (p<0.01) and three times 
greater in the 20°C group (p<0.05). By day seven cortisol excretion 
remained elevated in both groups but only significantly so in the 28°C 
group, being three times greater than the preoperative value (p<0.05).
DISCUSSION
Since 1970 there have been more than 200 publications concerning 
the plasma endocrine response to surgery of which approximately 30 
have pertained to CPB. In contrast there have been relatively few 
reports concerning postoperative changes in the urinary excretion of 
the same hormones or their metabolites. In particular, there has been 
no study of the effects of two levels of intraoperative hypothermia on 
the subsequent urinary excretion of catecholamines and cortisol.
Detection of rapid changes in plasma hormone concentrations is 
not possible with urinary collections but requires frequent blood 
sampling. In contrast, changes in the urinary excretion of hormones
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and their metabolites following trauma are more prolonged than 
alterations in the plasma concentrations of the same hormones and
provide a more composite picture of the magnitude and duration of the 
endocrine response (318,353).
Wilmore has incriminated catecholamines as major mediators of 
the metabolic response to injury, particularly burns, and estimated 
that noradrenaline may quantitatively account for more than 80% of the 
adrenergic response (89). Post-traumatic increases in the plasma 
concentration of catecholamines are proportional to the severity of 
tissue injury (89,304). Whereas the plasma concentration of
catecholamines returns to normal within 12 hours of tissue injury, 
urinary excretion of adrenaline, noradrenaline and their metabolites 
remains elevated for a number of days (305,318,354-356). The role of « 
of the counter-regulatory hormones in mediating various components of • 
the post-traumatic metabolic response is discussed further in Chapter 
1 2 .
There have been relatively few reports of urinary catecholamine , 
excretion after CPB and none have examined the effects of different
levels of intraoperative hypothermia on the catecholamine response.
One recent report attempted to quantify the urinary adrenergic
response to CPB but interpretation of the results was hampered as 12
of the 13 patients studied required catecholamine infusions (357).
In the current study there were smaller postoperative increments 
in urinary adrenaline and noradrenaline excretion in the 20°C group. 
Furthermore, in the 20°C group urinary catecholamine excretion
returned to preoperative values earlier than in the 28°C group. These 
findings are consistent with the hypothesis, proposed in Chapter 9, 
that a more profound level of intraoperative hypothermia may attenuate 
the catecholamine response to CPB and that the effect can persist
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until the third postoperative day.
Dopamine is the immediate precursor of noradrenaline and is 
metabolised in a similar fashion to the other catecholamines. Plasma 
dopamine concentration increases exponentially with the severity of 
tissue injury and this increase is believed to be secondary to a rise 
in noradrenaline (358). There has been no previous report regarding 
the effects of surgery on urinary dopamine excretion. Although it has 
been suggested that the kidney may itself be responsible for some of 
the dopamine it excretes (359), recent work has confirmed that urinary 
dopamine is largely derived from plasma dopamine (360). In the
current study four patients ( three from the 28°C group and one from
the 20°C ) were excluded from urinary dopamine analysis after
receiving inotropic dopamine infusions (dopamine in a concentration >
_ i -I
5ug Kg minute i). Postoperative increases in dopamine excretion 
were greater in the 28°C group and remained elevated for longer than 
in the 20°C group.
Cortisol is present in plasma in both a free and bound form. 
The free, physiologically active, component is water soluble and 
excreted in urine as urinary free cortisol, as in the current study. 
Urinary excretion of the plasma bound cortisol components depends on 
the rate of reduction of cortisol in the liver, subsequent conjugation 
of the relatively insoluble free compounds, and on renal function.
Following trauma or major surgery, plasma concentrations of 
cortisol usually peak within 5- 6 hours and return to within a normal 
range by 10 hours, whereas urinary excretion of cortisol and its 
metabolites remains elevated for up to a week depending on the 
severity of tissue injury (45,179,305,318). Furthermore plasma
concentrations of cortisol do not bear a simple relationship to the
magnitude of trauma; maximum plasma cortisol concentrations are
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reached with sub-maximum injuries so that there is no further increase 
in the plasma cortisol concentration with increasing severity of 
injury (319). In contrast the duration of elevated urinary cortisol 
excretion does correlate with the severity of injury (361).
In the current study, the magnitude of increases in urinary 
cortisol excretion was similar in the two temperature groups until the 
third postoperative day. This is consistent with the plasma cortisol 
response, which was similar in the two temperature groups, and the 
premise that timed urinary collections can accurately reflect the 
situation in plasma. By day seven, however, urinary cortisol 
excretion remained significantly elevated only in the 28°C group, 
similar to the findings of Swan and colleagues who reported elevations 
in urinary cortisol excretion until the seventh postoperative day in 
21 patients undergoing cardiac surgery using topical hypothermia (45).
An attenuation of the endocrine response with a more profound 
level of intraoperative hypothermia and the persistence of the effect 
until at least the the third postoperative day for catecholamines, and 
the seventh postoperative day for cortisol is of major theoretical 
interest. It suggests that the final mediators of the endocrine 
response are elaborated at the time of surgical insult as the 
operative and subsequent clinical course of the two temperature groups 
was otherwise identical.
Whereas the acute phase response is controlled by cytokines, 
catecholamine and cortisol secretion are controlled by the 
neuroendocrine response via the hypothalamo-pituitary-adrenal axis and 
sympathetic systems. As discussed in Chapter 12, cytokines may also 
have some synergistic effects on these systems. Further work is 
required to identify if the various control systems are modified by 
intraoperative hypothermia.
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SUMMARY and CONCLUSIONS
The endocrine response to CPB and the effects of two levels of 
intraoperative hypothermia (28°C and 20°C) on this response were 
assessed by measuring the urinary excretion of adrenaline,
noradrenaline, dopamine and cortisol in 24 hour urine collections
obtained preoperatively and on the first, second, third and seventh
postoperative days. This is the first study to report the effect of 
surgery on urinary dopamine excretion.
Over the last two decades estimation of the endocrine response
v
to surgery by measurement of urinary excretion of hormones has largely 
been abandoned in favour of measurement of plasma hormone 
concentrations, although the former provides a more integrated 
assessment of the endocrine response. The urinary excretion of 
adrenaline, noradrenaline, dopamine and cortisol was found to reflect . 
the situation in plasma.
The current study demonstrated that a more profound level of
intraoperative hypothermia attenuates, but does not abolish, the i 
endocrine response to surgery with smaller increases in the
postoperative excretion of adrenaline, noradrenaline and dopamine
which also return to baseline excretion rates more quickly. An 
attenuation of the cortisol response is not seen until the third 
postoperative day but is still evident on the seventh postoperative 
day and is consistent with the response observed in plasma.
The results imply that controlling mechanisms of the endocrine
response are elaborated at the time of surgery and are susceptible to
manipulation at this time.
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CHAPTER 11
NITROGEN BALANCE AND WHOLE BODY PROTEIN TURNOVER
I balanced all, brought all to mind,
The years to come seemed waste of breath,
A waste of breath the years behind,
In balance with this life, this death.
William Butler Yeats (1865-1939). An Irish Airman Foresees His Death.
INTRODUCTION
Injury elicits a complex metabolic response in surgical
patients. Prominent amongst the physiological and biochemical changes
is an increase in nitrogen excretion (60,61) due to an alteration in
whole body protein metabolism. Studies of nitrogen balance provide
important information on body protein metabolism in the clinical
setting but give no information on the rate of protein synthesis or
breakdown. Hence, methods using isotopically labelled amino acids
have been developed to allow direct measurement of rates of whole body
protein turnover (WBPT), synthesis (WBPS) and breakdown (WBPB).
Methods involving stable isotopes of nitrogen and carbon ( ^ N  and^^C)
have been most widely used and protein metabolism after elective
surgery (100), trauma (104), and sepsis (106) has been studied.
Such techniques involve making basic assumptions about protein
metabolism and the distribution of isotopic label throughout the body.
1 5N tracer techniques commonly use the non-essential amino acid
glycine and analyse the ^ N  enrichment of a urinary nitrogenous end
product. In this method it is assumed that the tracer mixes freely
1 ^throughout a single, homogeneous, metabolic pool. C tracer methods
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involve labelling of the precursor pool and amino-acid flux is then
calculated from the plateau enrichment of an amino acid in plasma,
usually leucine. Rates of protein synthesis and breakdown are
calculated from the proportion of the tracer irreversibly lost to
breath C02 and therefore not used for protein synthesis. In both
these methods, short protocols using primed constant infusions of
labelled amino acids have been developed to reduce problems associated
with re-entry of tracer from protein breakdown.
Amino-acid disposal by pathways other than protein synthesis or
breakdown can introduce errors in the measurement of protein turnover
1 ^when using labelled amino-acids. The use of C leucine to estimate
protein turnover is subject to error since the flux of leucine through
alternative pathways is increased in certain circumstances, eg. when
leucine becomes a substrate for energy production in skeletal muscle.
Glycine is used in several metabolic pathways in the body, but since
the label is rapidly distributed throughout the alpha amino groups
of most amino-acids, the potential error associated with glycine
1 smetabolism is minimised. Indeed, results using N glycine compare 
well with results obtained from uniformly labelled protein tracers 
(362).
The greatest potential source of error in the use of labelled
amino-acids for the measurement of WBPT is the assumption of the
existence of a single metabolic pool through which the label is
1 5rapidly distributed. Measurement of WBPT using the stable isotope N 
is based on the excretion of isotopically enriched urea and/or 
ammonium in urine (the "end-product11 method). The major assumption of 
this stochastic method, widely popularised by Picou and Taylor-Roberts 
(95), is of a single homogeneous nitrogen pool which derives nitrogen 
from food intake and the breakdown of body protein and loses nitrogen
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by synthesis into new structural proteins or by excretion as waste 
products. Calculation of rates of whole body protein turnover, in the 
steady state and at isotopic equilibrium, assume equal distribution of 
the isotope, like all other metabolic nitrogen from this homogeneous 
pool, between the synthesis of new proteins and excretory waste 
products.
Fern and Garlick studied this at length and concluded that the 
concept of a single pool was an oversimplification and that under 
certain circumstances compartmentation of the label could be 
demonstrated (362,363). They argued that since the major nitrogenous 
end products are ammonium and urea, and since urea is synthesised in 
the liver and ammonium is largely synthesised from glutamine derived 
from skeletal muscle, figures obtained for WBPT would be biased 
towards the end product used in the calculation. These workers 
suggested that since skeletal muscle protein turnover contributes 
approximately 50% of the whole body figure, an average of results 
using ammonium and urea end products- the End Product Average (EPA)- 
should yield a more accurate picture of whole body protein kinetics.
This use of an EPA to calculate WBPT in the non-stressed 
individual seems valid (362,363). However, it is well accepted that 
stress results in an overall increase in hepatic protein synthesis and 
an increase in muscle protein breakdown. This alteration in body 
homeostasis might be expected to produce an alteration in the 
metabolism of urea and ammonium which could, in certain circumstances, 
cause inaccuracy in either end product method as well as the EPA. 
Thus, elevation in hepatic protein synthesis might lead to an 
alteration in urea synthesis, while an increase in muscle protein 
breakdown could alter the rate of ammmonium production from glutamine. 
A figure for WBPT based only on the EPA could therefore obscure
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independent alterations in the two major protein compartments.
WBPS, WBPB and the relevance of the EPA have been assessed in 
circumstances in which alterations of protein metabolism in the two 
major pools of the body, visceral and skeletal muscle, might be 
expected to diverge. Indeed recently Wilmore’s group reported a 
reduction in "post-traumatic proteolysis" in patients undergoing 
open-heart surgery (10). These workers used only moderate hypothermia 
(28°C) and large doses of anaesthetic agents which themselves could 
modify the metabolic response to injury (10).
In the current study the effects of two conventionally used 
levels of intraoperative hypothermia (28°C and 20°C) on the protein 
turnover response to coronary artery surgery were assessed by nitrogen 
balance, WBPS and WBPB calculated from isotopic enrichment of urinary 
urea and ammonium, and the EPA.
PATIENTS and METHODS
Nitrogen balance and WBPT studies were performed pre and 
postoperatively in 20 adult male patients undergoing elective coronary 
artery surgery. The theoretical considerations and practical details 
of these studies are described in detail in Chapter 3.
In addition to routine hospital investigations all patients 
underwent anthropometric assessment.
Operative techniques were standardised as detailed in Chapter 3.
Urinary nitrogen was measured by a standard microkjeldahl method 
1 s(218). iJN enrichment of urinary urea and ammonium was measured by 
automated continuous flow isotope ratio mass spectrometry (220) as 
explained in Chapter 3. WBPS and WBPB rates were calculated by the 
stochastic method of Picou and Taylor-Roberts (95) detailed in Chapter 
3.
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BACKGROUND TRACER ENRICHMENT
The timing of postoperative protein turnover measurement period
was determined by the need to measure whole body protein dynamics at
the time of the maximum inflammatory response. Commencing the second
WBPT measurement only 24 hours after surgery resulted in low levels of
tracer remaining in the samples used to assay postoperative
"baseline". All postoperative baseline samples were analysed for
residual ^ N  in urea and ammonium and results were compared with
baseline samples taken at the start of the first infusion. The mean
N enrichment in urea above the preoperative baseline was 0.00505 +/-
0.00318 (n=20; 1 SD) atom percent excess (APE) and in ammonium
0.00486+0.00189 APE. Tracer enrichment in the rapidly cycling
ammonium pool at 48 hours after the end of the first infusion would
largely be due to protein degradation while the greater residual
tracer enrichment due to the slower turnover of the urea pool was
apparent. As these values do not correspond to the "true"
postoperative baseline, the residual enrichment "under" the midpoint
of the second tracer plateau at 66 hours after operation was,
calculated assuming first order kinetics. This showed that the "true"
postoperative urea baseline was 0.00257 APE *^*N and that of ammonium 
1 50.0241 APE N. These figures were both within 95% confidence limits 
of their respective measured preoperative baseline enrichment (2 SD 
equal to +/- 0.00306 APE ^ N  for urea and 0.00310 APE for ammonium)
and, for the purposes of this comparative study, validates the use of 
the preoperative baseline to calculate both pre and postoperative 
tracer plateau enrichments.
STATISTICAL ANALYSIS
Statistical analysis was performed using Wilcoxon's signed rank
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test for paired data in the same patient and the Mann-Whitney U test 
to compare differences between groups. Differences were considered to 
be significant when the probability of their arising by random 
sampling error was less than 1 in 20 (p<0.05) and highly significant 
if this probability was less than 1 in 100 (p<0.01).
RESULTS
In both groups preoperative anti-anginal therapy, premedication 
therapy, anaesthetic techniques, operative procedure and early 
postoperative recovery were similar.
Anthropometric and surgical data for both patient groups are 
presented in Table 11.1; there was no significant difference between 
the two groups in age or nutritional status as determined by 
percentage predicted body weight, arm muscle circumference and triceps 
skin fold thickness.
Bypass times (ie period utilising extracorporeal circuit) and 
cross clamp times (ie period of exclusion of heart and lungs from the 
circulation) were similar in both groups.
The pre and postoperative rates of nitrogen excretion are 
summarised in Table 11.2 and illustrated in Figure 11.1. Individual 
values for nitrogen excretion in the two groups are given in Tables
12.1 and 12.2. The rates of WBPS, WBPB and the EPA, calculated from 
the N enrichment of urinary urea and ammonium, are shown in Table 
11.3 expressed as median values and ranges. The pre and postoperative 
values of WBPS and WBPB for individual patients are illustrated in Fig
11.2 to Fig 11.9. Accidental discard of a urine sample led to loss of 
ammonium data in one patient in the 28°C group. One patient from the 
28°C group is not represented in the figures because of outlying 
values.
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NITROGEN BALANCE (Tables 11.2, 12.1, 12.2, Figure 11.1). There 
was a 35% increase in postoperative nitrogen excretion in the 28°C 
group (p=0.02) and a 20% increase in the 20°C group (p=0.08).
WHOLE BODY PROTEIN SYNTHESIS (Table 11.3). T h e ' preoperative 
rate of WBPS was similar for each group calculated from the isotopic 
enrichment of urinary urea, ammonium and the EPA. Postoperatively
there was a 23% fall in WBPS in the 28°C group (p<0.01) and a 17% fall
n 15in the 20 C group (p<0.05) measured by N enrichment of urinary urea.
In contrast, when WBPS was measured from isotopic enrichment of
urinary ammonium there was an increase in the postoperative rates of
WBPS in both groups, by 25% in the 28°C group (p=0.12) and 22% in the
20°C group (p=0.04). The EPA showed little change in the
postoperative rate of WBPS in both groups with a 3% decrease in the
28°C group and a 2% decrease in the 20°C group.
WHOLE BODY PROTEIN BREAKDOWN (Table 11.3). The preoperative 
rate of WBPB was similar for each group when calculated from the 
isotopic enrichment of either urinary end product and the EPA. 
Postoperatively there was a decrease in WBPB in both groups measured 
from the isotopic enrichment of urinary urea (by 12% in the 28°C group 
and 5% in the 20°C group) but in neither group was this statistically 
significant. In contrast postoperative WBPB measured from the 
ammonium end product showed a 30% increase in the 28°C group (p=0.10) 
and a 21% increase in the 20°C group (p=0.01). The EPA showed a small 
increase in postoperative WBPB in both groups, by 5% in the 28°G group 
and 8% in the 20°C group.
DISCUSSION
Estimation of protein turnover using isotope tracers has been 
used to investigate nitrogen balance following elective surgery in a
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number of studies, with conflicting results (101-106). The widely 
held premise that a negative nitrogen balance after surgery resulted 
from increased skeletal muscle protein breakdown was questioned by the 
protein turnover studies of O'Keefe and colleagues which suggested 
that this resulted predominantly from a fall in protein synthesis with 
little alteration in protein breakdown (100). These findings have 
been confirmed following surgery of moderate severity (101) while it 
has been reported that after major surgery (102), trauma (103), burns 
(104) and sepsis (105), a negative nitrogen balance results from an 
increase in WBPB exceeding a simultaneous increase in WBPS.
The current study is the largest to date to examine the effects 
of major elective surgery on WBPT and had two aims:
i) to investigate the potential of a brief period of intraoperative 
hypothermia to modify alterations in protein metabolism after trauma.
ii) to investigate the phenomenon of precursor compartmentation. 
This was achieved by measuring the isotopic enrichment of urinary urea 
and ammonium, pre and postoperatively in the same patient, and by 
calculating an EPA.
N glycine is one of the most widely used stable isotope
tracers in metabolic studies of protein turnover and its value and
1 slimitations have been extensively reviewed (364-366). glycine
fulfills most of the criteria required for an isotopic tracer and is 
particularly useful for comparative studies in view of the large body 
of literature which already exists.
Rates of WBPS and WBPB are affected by preceding nutritional 
status (365), caloric intake (96,97) and activity levels (98,99). To 
obviate these variables as far as possible in this study all patients 
were nutritionally replete, had normal dietary intake prior to 
hospital admission, remained fasted for both phases of the study and
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were allowed to perform only minimal ward activities during the 
periods of study.
In this study the postoperative increase in nitrogen excretion 
was greater in the 28°C group being consistent with the hypothesis 
that a more profound level of intraoperative hypothermia attenuates 
post-traumatic nitrogen loss (10). Wilmore's group have demonstrated 
a reduction in nitrogen excretion after open-heart surgery with a 
combination of moderate hypothermia (28°C) and high-dose fentanyl 
anaesthesia (10). The latter can itself modify the metabolic response 
to trauma (189) and, furthermore, these workers did not examine
nitrogen balance in terms of alterations in protein kinetics. In the 
current study only modest doses of fentanyl anaesthesia were used 
(Chapter 3) and whole body protein metabolism was studied using the •
amino acid glycine, labelled with "^*N. ! 4 -
The preoperative rate of WBPS and WBPB was similar for each 
group when calculated from the isotopic enrichment of urinary urea,
ammonium and the EPA, validating the use of the latter to calculate .
WBPT in the steady, non-stressed state. In the postoperative period 
there was a significant decrease in the rates of WBPS which exceeded a
simultaneous decrease in the rates of WBPB in both groups when
measured from the isotopic enrichment of urinary urea. This pattern 
of response is consistent with the hypothesis that development of a 
negative nitrogen balance after elective surgery of moderate severity 
is predominantly due to a fall in WBPS (101,102,105). The magnitude 
of the decrease in WBPS was significantly greater in the 28°C group 
implying that a more profound level of intraoperative hypothermia can 
modify the postoperative fall in WBPS.
In contrast, when isotopic enrichment of urinary ammonium was 
used to measure WBPT in the postoperative period, there was a marked
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increase in WBPB exceeding a simultaneous increase in WBPS in both 
groups, although statistically significant only in the 20°C group. An 
increase in WBPB exceeding a simultaneous increase in WBPS has been 
reported to explain the negative nitrogen balance after major surgical 
and accidental trauma (102,103), burns (104) and sepsis (106). In the 
current study the more profound level of intraoperative hypothermia 
appeared to make little difference to the rates of WBPB and WBPS when 
judged by isotopic enrichment of urinary ammonium.
These results are not consistent with the concept of a single 
metabolic nitrogen pool as postulated in the stochastic model of Picou 
and Taylor-Roberts (95) and there is already evidence to suggest the 
existence of more than a single metabolic pool. At least 75% of total 
urinary nitrogen occurs in the form of urea in the post-absorptive i 
state with the remainder consisting mainly of nitrogen in creatinine 
and ammonia. Urea is predominantly synthesised in the liver from both 
hepatic and extra-hepatic sources of nitrogen while the N of urinary
ammonium is derived mostly from the amide N of glutamine , (367), the
main source of which is skeletal muscle (368). The abundance in
urinary ammonium may be biased towards the precursor pool of muscle in 
the same way that urea reflects the precursor pool in the liver.
Fern and Garlick have argued that if the single pool concept was 
valid in physical terms then administration of the same tracer source 
by different physical routes should result in the same rate of 
turnover for any end product derived from the pool, although this is
not the case (363). Likewise if the single pool concept was valid in
metabolic terms then administration of any tracer amino acid by the 
same physical route would give a similar rate of turnover for the 
pool. Again this is known not to be the case (363). Based on 
differences between the rates of WBPT derived from urinary urea and
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1 5ammonium after administration of ■LJN glycine, Fern and Garlick have 
proposed a two-pool model for compartmentation of metabolic nitrogen 
where urinary urea and ammonium are generated from two functionally 
distinct precursor pools of nitrogen (363). Urinary ammonium 
predominantly reflects activity in the skeletal muscle pool and 
urinary urea activity in the hepatic precursor pool. To resolve some 
difficulties in accounting for the activities of both precursor pools 
Fern and Garlick proposed the use of an EPA, based on isotopic 
enrichment of urinary urea and ammonium, to calculate WBPT (362,363).
In a two-pool model these results imply that in the visceral 
protein precursor pool, largely represented by liver, a decrease in 
protein synthesis exceeds a simultaneous fall in protein breakdown 
leading to a net fall in protein synthesis. In contrast, in the
peripheral protein precursor pool, largely represented by skeletal
muscle, an increase in protein breakdown exceeds a simultaneous 
increase in protein synthesis leading to a net increase in protein 
breakdown.
These results are in accordance with the concept of "hepatic 
reprioritization" following trauma, when there is an overall increase
in skeletal muscle breakdown (369) to provide amino acids both as a
source of fuel and for hepatic synthesis of the acute phase reactants 
(Chapter 12). Although it is generally assumed that there is an 
overall increase in hepatic protein synthesis after trauma, there is 
little direct evidence to support this concept in man, and the results 
of the current study imply a net decrease in hepatic protein synthesis 
after surgery. Although the liver increases production of some acute 
phase proteins such as CRP after surgery, these increases are 
quantitatively small compared to the fall in synthesis of proteins 
such as albumin ("negative acute phase proteins") as discussed in
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Chapter 7.
It appears that while a more profound level of intraoperative 
hypothermia may attenuate the postoperative fall in protein synthesis, 
it does not modify skeletal muscle breakdown. This impies that the 
latter is one of the most basic and fundamental responses to tissue 
injury and is consequently less susceptible to modulation. This 
observation is discussed further in Chapter 12.
SUMMARY and CONCLUSIONS
Nitrogen balance and whole body protein kinetics were measured 
by standard techniques pre and postoperatively in 20 male patients 
undergoing elective coronary artery surgery and randomised to an 
intraoperative blood temperature of 28°C or 20°C. The aims of the 
study were to assess the ability of intraoperative hypothermia to 
modify changes in post-traumatic protein metabolism and to investigate 
the phenomenon of precursor compartmentation by measuring isotopic 
enrichment of urinary urea and ammonium and by calculating an EPA.
There was a significant postoperative increase in nitrogen - 
excretion only in the 28°C group.
In the preoperative and therefore non-stressed state the EPA 
produced similar results to the values for WBPT when measured by 
either urinary end product. In the postoperative state the EPA 
suggested little overall change in WBPT but obscured large changes in 
synthesis and breakdown within the visceral and peripheral precursor 
pools. Isotopic enrichment of urinary urea suggested the development 
of a negative nitrogen balance was due predominantly to a fall in WBPS 
while isotopic enrichment of urinary ammonium suggested that a 
postoperative negative nitrogen balance was due to an increase in WBPB 
exceeding a concomitant rise in WBPS. It is possible that the failure
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by many groups to observe or comment on the activities of both 
precursor pools has led to conflicting conclusions on the aetiology of 
a post-traumatic negative nitrogen balance. Measurement of the 
isotopic enrichment of urinary urea implies that a negative nitrogen 
balance is due to a fall in protein synthesis while isotopic
enrichment of urinary ammonium implies it is due to an increase in
protein breakdown. Indeed using only one of these end product methods
would have led to similar erroneous conclusions in the current study 
and it is therefore essential to examine both end products in a 
post-traumatic state.
It appears that a more profound level of intraoperative
hypothermia can attenuate the postoperative fall in protein synthesis 
but not the postoperative increase in muscle breakdown, implying that 
the latter is a more fundamental resonse to trauma.
28°C 20°C
NUMBER OF PATIENTS 
AGE
% IDEAL BODY WEIGHT
% PREDICTED ARM MUSCLE 
CIRCUMFERENCE
% PREDICTED TRICEPS 
SKIN FOLD THICKNESS
BYPASS TIME (mins)
CROSS CLAMP TIME (mins)
BLOOD TEMPERATURE (°C)
10
55(5)
113(14)
105(7)
83(46)
93(26)
53(19)
28(1)
10
57(7)
113(15)
104(6)
99(22)
97(19)
55(15)
20(1)
NS
NS
NS
NS
NS 
NS 
<0.001
Table 11.1. Clinical, anthropometric and operative data of the two 
temperature groups.
28oC
NITROGEN EXCRETION (g/day)
Preop Postop
8.8(4.8) 11.9(16.2) : p=0.02
20oC 9.0(7.0) 10.8(13.6) : p=0.08
Table 11.2. Nitrogen excretion (g/day) pre and postoperatively in 
the two temperature groups expressed as median and range.
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CHAPTER 12 
SKELETAL MUSCLE METABOLISM
The brain has muscles for thinking as the legs have muscles for 
walking.
Julien Offroy de La Mettrie (1709-1751). L'homme Machine.
INTRODUCTION
The results of the protein turnover studies discussed in Chapter 
11 produced conflicting results regarding the exact aetiology of a 
postoperative negative nitrogen balance. Isotopic enrichment of 
urinary urea implied that the postoperative negative nitrogen balance 
was predominantly due to a fall in WBPS while urinary ammonium 
enrichment implied that an increase in WBPB was the predominant 
mechanism. To resolve this conflict the urinary excretion rates of 3 
"markers" of skeletal muscle breakdown 3 methylhistidine (3MeH), zinc 
and creatinine, were measured pre and postoperatively in 20 patients.
PATIENTS and METHODS
The patients have been described in Chapter 11. Measurements of 
urinary 3MeH, zinc and creatinine were made from the same urinary 
collections used to determine postoperative changes in nitrogen 
excretion and isotopic enrichment of urinary urea and ammonium.
3-METHYLHISTIDINE. Urinary 3MeH was analysed on a Hilger (Rank) 
Chromaspek M amino acid analyser and is based on a cation exchange 
resin, two buffer gradient dilution, ninhydrin detection method.
ZINC.' Urinary zinc was analysed by flame atomic absorption 
spectrophotometry.
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CREATININE. Urinary creatinine was analysed on a Hitachi 704 
discrete analyser based on the standard end point Jaffe reaction.
RESULTS
The clinical and operative features of both patient groups are 
described in Chapter 11 (Table 11.1).
The results of pre and postoperative urinary excretion of 3MeH, 
zinc and creatinine in the two temperature groups are presented in 
Table 12.1 and Table 12.2 and respectively illustrated in Figs 12.1, 2 
and 3.
There was a 59% increase in the mean postoperative 3MeH
excretion in the 28°C group (p=0.01) and an 82% increase in the mean 
postoperative excretion in the 20°C group (p=0.005). It should be 
noted however that the latter result may be biased by the very large 
increase in postoperative excretion of 3MeH in two patients in the 
20°C group (Fig 12.1).
There was a postoperative increase in mean zinc excretion in
both groups (Fig 12.2), by 22% in the 28°C group (p=0.20) and by 51%
in the 20°C group (p<0.001).
There was a significant increase in mean creatinine excretion in 
both groups postoperatively (Fig 12.3), by 31% in the 28°C group
(p=0.05) and by 35% in the 20°C group (p<0.001).
DISCUSSION
The development of a negative nitrogen balance is the hallmark 
of the catabolic response to tissue trauma resulting from injury 
(60,61) or surgery (107). As discussed in Chapter 11 the aetiology of 
a negative nitrogen balance after trauma may depend on the severity of 
the injury; after surgery of moderate severity a fall in WBPS is
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thought to be the predominant factor but after severe injury an 
increase in WBPB may be of greater importance (106). As indicated by 
the results in Chapter 11, however, it appears that interpretation of 
the development of a negative nitrogen balance is also dependent on 
whether isotopically enriched urea or ammonium is chosen as the end 
product. It is generally believed that following trauma there is an 
increase in skeletal muscle breakdown (369) to facilitate "hepatic 
reprioritization" of proteins. The aim of this chapter was to 
elucidate any other evidence of a postoperative increase in WBPB by 
examining postoperative changes in the urinary excretion of "markers" 
of skeletal muscle trauma.
Skeletal muscle protein breakdown was incriminated as the cause 
of a post-traumatic negative nitrogen balance by Cuthbertson, basedon 
clinical observations in patients with long bone fractures (60,61) and 
on the urinary excretion ratios of nitrogen, potassium and sulphur in 
rats with long bone fractures (370). Using stable isotopes Reiss 
subsequently demonstrated depletion of the skeletal muscle mass but 
relative preservation of visceral protein (liver and kidney) in 
animals with a profound catabolic response (371). From a teleological 
standpoint, release of amino acids from muscle following injury 
provides an alternative energy supply and, more importantly, a source 
of proteins for the liver to produce acute phase proteins involved in 
a variety of host defence mechanisms. In a recent review of protein 
turnover in trauma and sepsis, Hasselgren implicated muscle protein 
breakdown as the most important source of peripheral amino acid 
production but also suggested that reduced protein synthesis may occur 
(372).
Unfortunately there is no easily applicable technique to 
directly measure muscle protein breakdown in the clinical setting.
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The release of protein from muscle following trauma can be 
demonstrated by arteriovenous differences in amino acid concentration 
(108,373) but such techniques are technically difficult to perform 
accurately and require a high degree of analytic precision. 
Interpretation is complicated by re-utilisation of some amino acids 
and the origin of venous blood not only from muscle but also from 
bone, skin and adipose tissue (374). Furthermore, this technique 
provides a qualitative rather than absolute measurement of changes in 
arteriovenous amino acid concentrations as blood flow cannot be 
accurately measured.
It was thought that 3MeH might resolve these difficulties as it 
appeared to be a specific marker of muscle protein breakdown (see 
Chapter 2). Muscle 3MeH accounts for more than 90% of the total body 
content of 3MeH, is neither metabolised nor re-utilised for protein 
synthesis, and is rapidly excreted in urine (109,112). Consequently 
3MeH has gained wide popularity as a specific marker of muscle protein 
breakdown (116). 3MeH is not found exclusively in skeletal muscle as 
small pools exist in the gastrointestinal tract and skin (111) and 
Rennie has suggested that fast turnover in these pools may make 
significant contributions to urinary excretion of 3MeH (122, 375).
More recently Long's group have again confirmed the validity of 
urinary 3MeH as predominantly a marker of skeletal muscle breakdown 
with little contribution from the gastrointestinal tract (376).
Approximately 60% of body zinc is found in skeletal muscle. The 
main pathway of excretion is in faeces but a smaller fixed amount of 
zinc is excreted in the urine each day irrespective of dietary intake 
or urine volumes (239). An increase in urinary zinc excretion 
accompanies most catabolic states (377). After surgery increased 
urinary zinc excretion is largely derived from skeletal muscle (378).
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Fell and colleagues, using radioactive ^Zn, measured the urinary 
excretion of Zn and total Zn for a three week period after hip 
replacement (379). They demonstrated an increased urinary output of 
zinc after surgery and calculated that most of the postoperative 
increase in urinary zinc excretion was derived from zinc in skeletal 
muscle. Other groups of workers have confirmed that urinary zinc 
excretion reflects post traumatic skeletal muscle catabolism 
(380,381).
Urinary creatinine excretion has also been used as a marker of 
skeletal muscle trauma (382) based on the rationale that urinary 
creatinine is derived from creatine, 98% of which is found in skeletal 
muscle. Heymsfield has extensively reviewed the literature and 
confirmed that in non-stressed individuals, on a stable diet and 
without evidence of renal impairment, urinary creatinine excretion is 
an indicator of the skeletal muscle mass (383). Changes in urinary 
creatinine excretion have therefore been used by various groups as an 
indicator of skeletal muscle breakdown following trauma (382,384) and 
surgery (380,385).
The results from the current study demonstrated a postoperative 
increase in the urinary excretion of 3MeH, zinc and creatinine in both 
temperature groups. The magnitude of the postoperative increase in 
3MeH, zinc and creatinine excretion was statistically greater in the 
20°C temperature group implying a greater degree of skeletal muscle 
breakdown in this group. This was surprising in view of a smaller 
postoperative negative nitrogen balance in this group but in 
accordance with the results of isotopic enrichment of urinary 
ammonium, discussed in Chapter 11, which implied a greater increase in 
postoperative WBPB in the 20°C group. The discordant demonstrations 
of a greater degree of postoperative WBPB, without a proportionally
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greater increase in nitrogen excretion, in the 20°C temperature group 
could have a number of possible explanations:
(i) Nitrogen balance is the net result of protein synthesis and 
breakdown in the visceral and peripheral protein pools. The former is 
largely accounted for by liver and the latter by skeletal muscle. An 
increase in skeletal muscle breakdown does not by itself determine 
nitrogen balance. It was suggested in Chapter 11 that a more profound 
level of intraoperative hypothermia may attenuate the postoperative 
fall in protein synthesis and this may modify the increase in negative 
nitrogen balance which would otherwise be expected on the basis of an 
increase in skeletal muscle breakdown.
(ii) The counter-regulatory hormones play an integral role in 
the catabolic response to tissue injury. Wilmore incriminated 
catecholamines as major mediators of the metabolic response to injury 
and estimated that noradrenaline accounted for at least 85% of the 
response (89). Further evidence of hormonal involvement in the 
catabolic response was the demonstration that infusion of adrenaline, 
cortisol and glucagon into healthy volunteers produced an elevation in 
energy expenditure and a negative nitrogen balance through increased 
protein catabolism (386-388). It had therefore been anticipated that 
a more profound level of intraoperative hypothermia, accompanied by a 
smaller postoperative increase in catecholamine secretion (Chapter 
10), might lead to a reduction in muscle protein breakdown. Failure 
to observe such a reduction is in accordance with Hulton's 
observations that although catecholamine blockade can reduce 
post-traumatic creatinine excretion and amino-acid efflux, it does not 
alter overall nitrogen loss (389). Hulton concluded that hormonal 
blockade inhibits net skeletal muscle protein catabolism without 
altering whole body nitrogen loss (389). It is apparent that
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catecholamines are not therefore the sole determinants of either 
skeletal muscle breakdown or a post-traumatic negative nitrogen 
balance. There were no facilities to measure glucagon, another 
counter-regulatory hormone, in the current studies but it is known to 
be at least involved in the regulation of skeletal muscle breakdown 
(386-388).
(iii) Cytokine peptides are known to be involved in 
post-traumatic muscle proteolysis but the exact mediators are unknown. 
A major advance was the demonstration that a circulating factor 
obtained from the serum of postoperative or septic patients induced 
muscle proteolysis in rat muscle incubated in vitro (390). This 
substance was isolated as a peptide fragment of 4,200 daltons and 
called "proteolysis inducing factor". At the same time it was 
demonstrated that the cytokine interleukin-1 induced prostaglandin E2 
synthesis and consequent proteolysis in incubated rat muscle in vitro 
at normothermia or even more markedly in a hyperthermic (39°C) 
environment (66). Other workers using recombinant DNA could not 
reproduce these findings and suggested that the earlier results were 
due to impurities in the biological samples. This complex area has 
been extensively reviewed by Hasselgren and colleagues (372) and by 
Pomposelli and co-workers (391) who suggest that the main stimulant to 
muscle proteolysis is probably tumour necrosis factor although 
interleukin-1 has a synergistic action (390) and may also have a 
further indirect action through stimulation of the endocrine response. 
High concentrations of catecholamines can inhibit interleukin-1 
production in vivo (392) and it is feasible that the higher 
catecholamine concentrations observed in the 28°C group resulted in a 
relative inhibition of cytokines with a consequent reduction in 
skeletal muscle proteolysis.
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(iv) During perfusion cooling there is a differential cooling of 
various organs, eg heart, liver and mid-oesophagus cool quickly but 
not skeletal muscle (28). It is possible that the more profound level 
of intraoperative hypothermia results in shunting of blood through 
skeletal muscle without effective cooling of the large skeletal muscle 
mass and this is currently under investigation.
Whatever the mechanism(s) controlling skeletal muscle breakdown, 
it appears to be more resistant to modification by profound 
intraoperarive hypothermia than components of the acute phase, 
endocrine and protein metabolism responses. This is in keeping with 
the results reported in Chapter 11, where postoperative isotopic 
enrichment of urinary ammonium implied an increase in skeletal muscle 
breakdown. It is possible that the latter represents a more 
fundamental part of the pathophysiological response to trauma and is 
not susceptible to modification.
SUMMARY and CONCLUSIONS
The urinary excretion rates of 3 "markers" of skeletal muscle 
breakdown, 3 methylhistidine (3MeH), zinc and creatinine were measured 
pre and postoperatively in 20 patients in whom nitrogen balance and 
protein turnover studies had been performed.
The finding of a greater increase in muscle protein breakdown in 
the 20°C group correlated with the increase in WBPB determined from 
isotopic enrichment of urinary ammonium , but was in conflict with a 
smaller negative nitrogen balance in the same group.
These findings reinforce the importance of both protein 
synthesis and breakdown in determining nitrogen balance and a number 
of hypotheses to explain the apparent discrepancy between the 
endocrine response and muscle breakdown have been postulated.
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CHAPTER 13
POSTOPERATIVE CHANGES IN ENERGY EXPENDITURE
Water, water, everywhere 
nor any drop to drink.
Samuel Taylor Coleridge 1772-1834. The Ancient Mariner, ii. 121-122. 
INTRODUCTION
The effect of surgery on changes in energy expenditure is 
controversial. Some groups have reported little alteration in energy 
expenditure following operation (128,393) while others have reported 
variable increases up to 25% (130,253,394-396). There has been no 
report on changes in energy expenditure following cardiac surgery or 
on the ability of intraoperative hypothermia to modify any such 
alterations.
The Doubly Labelled Water (DLW) technique permits measurement of 
total energy expenditure (TEE) by administration of stable isotopes of 
hydrogen and oxygen (224-230). The technique is based on the 
observation that oxygen is lost from the body in respired carbon 
dioxide and in water, while hydrogen is lost only in water (223-226). 
It follows that any difference in the turnover of isotopic hydrogen 
and oxygen labelled water is equivalent to carbon dioxide production 
from which energy expenditure can be calculated. The technique 
provides an integrated assessment of TEE over specific time periods in 
contrast to the factorial computations of energy expenditure derived 
from indirect calorimetry.
This is the first report in the literature of the use of DLW to 
measure energy expenditure in uncomplicated major surgery.
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PATIENTS and METHODS
The DLW study was performed in 16 patients undergoing coronary 
artery surgery who were subsequently randomised to an intraoperative 
blood temperature of 28°C or 20°C.
As described in Chapter 3, TEE was measured in 10-day periods 
before and after surgery.
To examine the relationship of TEE to basal metabolic rate (BMR) 
two patients underwent indirect calorimetry three times in the 
preoperative period. Attempts to measure BMR in the same patients in 
the postoperative period were discontinued as the patients were unable 
to lie comfortably for the forty minutes required to perform indirect 
calorimetry, due to discomfort from their sternotomy wounds. 
Calculations:
The principles of the DLW method (223-226), including 
theoretical assumptions and practical considerations, are detailed in 
Chapter 3.
Lean body mass (LBM) was calculated assuming constant hydration: 
LBM = Total Body Water (TBW)/0.73 assuming that lean tissue contains 
73% water while fat contains negligible amounts (233).
Energy expenditure was measured using Weir's formula (221), 
after calculating total C02 production from the formula of Lifson and 
Mclintock (224,234).
1. Because the DLW method provides a measure of C02 production,
rather than 02 consumption, the calculation of TEE requires 
some estimation of the average respiratory quotient (RQ) over 
the study period. Although RQ values may vary widely over 
short periods, mean values show little variation over longer 
periods (397,398) except in cases of severe energy imbalance. 
As in other studies using DLW, a mean RQ 0.85 was assumed over
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the study period (398). Even in the unlikely situation of the 
true RQ having been 0.7 or 1.0 over the study period, this 
would still have produced a maximum error of +/- 3% in TEE 
(398) as explained on Page 80.
2. The calculations used to estimate C02 production include a 4%
correction for deuterium fractionation at epithelial surfaces
assuming that 50% of water output is lost as vapour (224,234).
3. There was concern in the preoperative component of the study
that although all patients came from the West of Scotland,
different sources of fluid intake might vary in background 
isotope enrichment and therefore produce changes in the
isotopic abundance of body water after administration of DLW. 
This concern was reduced by measuring the baseline enrichments 
of the patient's urine prior to administration of DLW and also 
by providing a sufficient dose of DLW so that background 
fluctuations would have relatively little influence on the
final enrichment of the body water pools. In the 
postoperative period all study patients received fluid from 
the same source and the natural abundance of isotopes in the
urine of other patients receiving fluid from the same source,
but not DLW, showed only minor variations.
4. The rate of C02 production was derived from differences in the
isotope decay constants multiplied by TBW, measured in moles 
(224). There was no significant difference in the body water 
pool of the study population over the experimental period. In 
any case, it has been demonstrated that even a 50% change in 
TBW would affect calculations of energy expenditure by a 
maximum of 10% (399).
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STATISTICAL ANALYSIS
Statistical analysis was based on a paired t-test to compare 
serial differences within the same group and an unpaired t-test to 
compare differences between groups. Differences were considered 
statistically significant when the probability of their arising by 
random sampling error was less than 1 in 20 (p<0.05) and highly
significant if this probability was less than 1 in 100 (p<0.01).
RESULTS
Results are presented in Tables 13.1, 13.2, 13.3 and 13.4.
There were nine patients in the 28°C group and seven in the 20°C 
group. One patient randomised to the 20°C group had only a single 
vessel suitable for coronary grafting at operation, and it was 
therefore decided prudent to cool the blood temperature to 28°C rather 
than 20°C. The 20°C group received significantly more grafts than the 
28°C group resulting in a significant increase in the cross-clamp and 
bypass times in this group (Table 13.1).
The groups were very similar with respect to body weight and 
LBM, calculated from TBW (Table 13.2).
Table 13.3 gives the calculated first-order rate constants for 
1 R  9
0 and H decay (ko and kH) and Table 13.4 the resulting rates of C02 
production from which TEE has been calculated (Table 13.2). The mean 
preoperative TEE was similar in both groups. The mean difference of 
the product of the oxygen and hydrogen decay rates (ko - kH) and body 
water was greater in the postoperative period than in the preoperative 
period but not significantly so. This difference is equivalent to the 
rate of C02 production in moles and can be converted into energy 
expenditure as described in Chapter 3. There was a non-significant 
increase in the mean 10-day postoperative TEE, calculated in total
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calories, in both groups, of 6.7% in the 28°C and 5.1% in the 20°C
group. When changes in postoperative TEE were calculated according to 
LBM the increases were respectively 5.8% and 3.3%.
In two patients the mean BMR, calculated from three daily 
indirect calorimetry measurements, was 1530 (1510, 1530, 1550
Kcal/day) and 1710 (1700, 1710, 1720 Kcal/day) Kcal/day. The
respective figures for mean TEE in these patients over the same period 
were 2023 and 2230 Kcal/day being respectively 32% and 30% higher. 
Attempts to repeat BMR measurements in the same patients in the 
postoperative period were abandoned as neither patient could lie 
comfortably for the duration of the study (minimum of 40 minutes).
DISCUSSION
Alteration in the metabolic rate in a variety of disease states 
was first described by Dubois in 1924 (133) and following trauma by 
Cuthbertson in 1932 (175). There is still, however, no consensus on 
the effect of major surgery on energy expenditure. Kinney's group 
reported minimal changes in energy expenditure following elective 
surgical procedures but a gradual increase in the metabolic rate with 
increasing severity of injury (128,393). In contrast, other groups 
have reported modest increases in postoperative energy expenditure of 
up to 10% (394,395) while other workers have reported increases of up
to 25% (130,253,396).
The reason for such discrepancies include differences in the 
severity of the clinical illness and the type of operative procedure, 
the pre-existing nutritional status of the patients, and the method of 
nutritional support employed, as all are known to influence energy 
expenditure (124). Another explanation for such differences can be 
found in the methods used to measure energy expenditure. In the
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hospital setting energy expenditure is usually calculated from an 
estimation of resting energy expenditure (REE) as it is often 
impractical to determine the BMR. The latter requires that the 
subject has been totally fasted for 12 hours, is studied in the early
morning in a darkened, quiet room and is completely at rest in a
recumbent position (400). These requirements are often impractical in 
the clinical situation and it is more common to measure REE which 
includes the BMR, energy required for the digestion of food (specific 
dynamic action of food) and minimal physical activity (400). REE is 
calculated by measurement of indirect calorimetry over a thirty minute 
period, multiplication of this figure by 48 to give a value over 24 
hours, and adjustment of the resulting figure by an "activity factor"
to provide an estimate of TEE (128). A fundamental criticism of these
techniques is that the true relationship of BMR or REE to TEE is 
unknown.
A further practical difficulty with indirect calorimetry is the 
inability of .many patients to tolerate nose clips or face masks. This 
may result in alterations in the respiratory pattern and consequently 
calculations of energy expenditure (256). Hood or canopy systems 
ameliorate, but do not eliminate this problem (256, 401).
Another reason for the variability in the effects of surgery on 
postoperative energy expenditure reported in the literature is, 
presumably, the practical difficulty of ensuring that the patient is 
not incapacitated by wound discomfort. In the current study two 
patients who had completed three indirect calorimetry runs 
uneventfully in the preoperative period could not tolerate the 
procedure after surgery, due to discomfort from their sternotomy 
wound. This is one of the major advantages of the DLW technique which 
merely requires collection of a small quantity of body fluid - in this
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case urine - for calculation of energy expenditure.
Further concerns about the validity of indirect calorimetry 
measurements include the potentially large errors associated with the 
current practice of establishing a patient's REE from a single 
indirect calorimetry measurement which may be considerably higher than 
second or third measurements (402). This was not evident, however, in 
either patient in the current study who performed three preoperative 
indirect calorimetry runs where the values were remarkably similar.
The DLW technique can circumvent many of these problems. DLW is 
a non-invasive, stable isotope technique for measuring TEE over 
specific time periods with the advantages of being theoretically 
simple, safe and of minimal inconvenience to the patient. The method 
was described in 1955 (224), used for the study of energy expenditure 
in small animals since then (225), and applied to man by Schoeller and 
van Santen in 1982 (226). The technique involves the administration
O
of two stable (and, therefore, non-radioactive) isotopes, H20 and 
1 8H2 0, as labelled water and is based on the fact that oxygen in body 
water is in equilibrium with that in bicarbonate (and therefore C02)
through the action of carbonic anhydrase (223). After mixing with
2 18 body water H is lost from the body only as water, whereas 0 is lost
both as water and C02, so that the difference in the rate of excretion
of the two isotopes in body fluids is due to C02 production from which
energy expenditure can be calculated. The DLW technique has been
demonstrated to have an accuracy to within 2%-5% of C02 production
rates calculated by whole-body indirect calorimetry (227-230).
Furthermore the initial dilution of either isotope in body water
reflects the body water pool size and therefore allows estimation of
body composition.
Despite the obvious attractions of the DLW technique, clinical
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application has been delayed because of the expense of the 
isotope. While deuterium labelled water is cheap, sufficient 
isotope for the current study cost approximately 300 pounds per 
patient (for both phases of the study). With increasing popularity of 
the technique and expanding facilities for isotope production, costs 
are likely to fall. Most studies to date in humans have examined 
healthy volunteers, babies, pregnant women and patients receiving 
total parenteral nutrition. DLW has been applied to only one surgical 
population to investigate the effects of operation on energy 
expenditure but interpretation was complicated by the fact that all 
seven patients were female with active Crohn's disease and required 
total parenteral nutrition (396). That study reported a 25% increase 
in postoperative energy expenditure.
There has been no previous study of alterations in energy 
expenditure in patients undergoing cardiac surgery or the effects of 
different levels of intraoperative hypothermia on any such changes. 
The current report is the largest study of DLW to date and 
demonstrated a postoperative increase in TEE by 6.7% in the 28°C group 
and by 5.1% in the 20°C group. When calculated according to LBM the 
postoperative increases were respectively 5.8% and 3.3%.
It is probable that the modest postoperative increase in TEE in 
the current study was due predominantly to an increase in BMR as 
general activity levels were reduced in the postoperative period. 
Attempts to measure BMR in the postoperative period were abandoned as 
the patients could not lie comfortably at rest because of discomfort 
from their sternotomy wound. It is also possible that at least part 
of the increase in TEE was due to withdrawal of beta-blockade therapy 
in the postoperative period. As discussed in Chapter 5 beta-blockers 
may reduce energy expenditure through anti-sympathetic actions.
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Although the exact control of changes in the post-traumatic 
metabolic rate is not fully elucidated, the counter-regulatory 
hormones are strongly incriminated (386-388). Infusion of 
counter-regulatory hormones in healthy volunteers can mimic some 
components of the metabolic response and in particular an elevation in 
energy expenditure (386-388). The increase in postoperative TEE was 
slightly less in the 20°C group and could be consistent with the 
smaller postoperative increases in counter-regulatory hormones 
observed in this group (Chapter 10).
In two patients studied six times by indirect calorimetry, the 
daily BMR was remarkably constant and approximately 70% of the TEE 
measured by DLW. The BMR is generally thought to account for 75%-90% 
of TEE (124). Although some workers have recommended a postoperative 
caloric intake 1.76 times the BMR (253), the current results are in 
accordance with the recommendations of Long and colleagues, who 
suggested postoperative energy requirements can be adequately met with 
a caloric intake 1.24 times the BMR (403).
SUMMARY and CONCLUSIONS.
TEE was measured using a novel stable isotope technique over two 
10-day periods, pre and postoperatively, in 16 patients randomised to 
an intraoperative blood temperature of 28°C or 20°C during coronary 
artery surgery.
The BMR, measured three times preoperatively in two patients, 
was remarkably constant and accounted for 70% of measured TEE.
There was a modest increase in postoperative TEE in both groups 
but no significant difference between the groups. The postoperative 
rise in TEE was assumed to result predominantly from an increase in 
BMR.
NUMBER OF PATIENTS 9 7
AGE 53(2) 53(3) NS
HEIGHT (cm) 175(1) 170(2) NS
WEIGHT (Kg) 79(3) 76(6) NS
BYPASS TIME (mins) 78(8) 99(6) <0.05
CROSS CLAMP TIME (mins) 46(5) 63(3) <0.05
NUMBER OF GRAFTS 2.7(0.3) 3.6(0.3) <0.05
LOWEST BLOOD TEMPERATURE (°C) 28(1) 20(1) <0.001
Table 13.1 Clinical and operative features of the two temperature groups
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CHAPTER 14 
CLINICAL OUTCOME
Primum non nocere
Latin maxim from Hippocratic school (circa 450 BC).
INTRODUCTION
Improvements in surgical practice and anaesthetic techniques, 
accompanied by refinements in extracorporeal perfusion technology, 
have led to a marked fall in the mortality of elective coronary artery 
surgery over the last decade to approximately 1-2% (404). The use of 
systemic hypothermia is a standard part of the CPB technique for 
coronary artery surgery, largely influenced by the need to ensure 
adequate myocardial protection. After almost three decades of open 
heart surgery, however, there is no consensus as to the optimal 
intraoperative temperature and various levels of systemic hypothermia 
from 30°C to 20°C have been recommended (11-14).
The basic aim of this thesis was to investigate the effects of 
two levels of intraoperative hypothermia (28°C and 20°C) on the 
metabolic response to CPB. Although it was not a fundamental 
objective of these studies to determine the effect of different levels 
of intraoperative hypothermia on the postoperative clinical course, 
this chapter examines the effects of an intraoperative blood 
temperature of 28°C or 20°C on subsequent clinical outcome.
PATIENTS and METHODS
Sixty of the patients studied in this thesis were randomised to 
an intraoperative blood temperature of 28°C or 20°C.
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The postoperative course of each patient was monitored for 
complications until death or discharge from hospital. In particular 
the following parameters were recorded (and where necessary defined).
CLINICAL COURSE
VENTILATION TIME: postoperative period of mechanical ventilation in
hours.
INOTROPE REQUIREMENTS: the administration of dopamine in inotropic
quantities (> 5 ug/Kg/minute) for a systolic blood pressure, measured 
by radial artery catheter, consistently less than 100 mmHg and 
accompanied by poor peripheral perfusion and oliguria.
VASODILATOR REQUIREMENTS: the administration of vasodilator agents
(sodium nitroprusside or glyceroltrinitrate) for a systolic blood 
pressure, measured by radial artery catheter, consistently greater 
than 140 mmHg in the early postoperative period despite adequate 
sedation and analgesia.
BLOOD TRANSFUSION: The total number of units of blood used during the
perioperative period to ensure a haemoglobin value of > 1 0  g/dl.
COMPLICATIONS
DEATH
RE-OPENING: need for surgical re-exploration due to excessive
bleeding, low cardiac output or cardiac arrest.
POSTOPERATIVE ARRHYTHMIA: sustained arrhythmia (usually atrial
fibrillation) requiring drug treatment or cardioversion.
RESPIRATORY FAILURE: inability to wean a patient from mechanical
ventilation within 24 hours of surgery or inability of patient to 
maintain self-ventilation after extubation, requiring a further period 
of mechanical ventilation (usually accompanied by a deterioration in
203
arterial blood gases and abnormal chest X-ray)
RENAL FAILURE: urine volume of <200 ml/24 hours despite diuretic
and/or renal dopamine (ie <5ug/Kg/min) therapy.
PERIOPERATIVE MYOCARDIAL INFARCTION: a postoperative rise in creatine
kinase > 2000 accompanied by ECG changes (eg q waves >0.1mm). 
SEPTICAEMIA: spiking temperature and/or hypotension in the presence
of positive blood cultures.
PNEUMONIA: clinical and radiological signs accompanied by positive
sputum cultures and need for antibiotics.
URINARY TRACT INFECTION; quantitative culture of >100,000 
organisms/ml.
WOUND DEHISCENCE: complete instability of the sternum requiring
re-suturing.
WOUND INFECTION: discharge from wound, associated with positive j
culture of discharge.
DECUBITUS ULCER: sacral or heel sore.
OBVIOUS CEREBRAL DEFICIT: obvious cerebral insult with localising
neurological signs (does not include postoperative confusion):
PULMONARY EMBOLUS: clinical signs confirmed by lung scan (VQ scan).
STATISTICAL ANALYSIS
Statistical analysis was performed using the Mann-Whitney U test 
to compare differences in age, body weight, number of grafts, 
cross-clamp and bypass times, ventilation times and blood requirements 
in the two groups. A chi-square test, with Yates's correction factor, 
was used to compare the significance of differences in the incidence 
of various complications between the groups. Differences were 
considered to be significant when the probability of their arising by 
random sampling error was less than 1 in 20 (p<0.05) and highly
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significant if this probability was less than 1 in 100 (p<0.01). 
RESULTS
A summary of relevant postoperative parameters and complications 
is given in Table 14.1, 14.2 and 14.3.
CLINICAL and OPERATIVE FEATURES (TABLE 14.1)
The groups were very similar with respect to age and body 
weight.
The 20°C group received significantly more grafts [3.2(0.7) v 
2.7(0.8): p<0.05] resulting in a significant increase in the mean
cross-clamp time by 11 minutes and the mean bypass time by 19 minutes.
POSTOPERATIVE PARAMETERS (TABLE 14.2)
Despite the longer cross-clamp and bypass times in the 20°C 
group, the mean postoperative ventilation periods were similar in the 
two groups and fewer patients in the 20°C group required inotropic 
support (Table 14.2).
Postoperative blood requirements were less, by approximately one 
unit of packed red cells (400 ml), in the 20°C group.
POSTOPERATIVE COMPLICATIONS (TABLE 14.3)
There was no significant difference in the incidence of 
postoperative complications between the groups except for a reduction 
in the incidence of atrial fibrillation in the 20°C temperature group 
(1 v 6; p< 0.05).
DISCUSSION
Various levels of intraoperative hypothermia have been proposed
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for coronary artery surgery (11-14), effective myocardial protection 
being the prime consideration. There is, however, little objective 
evidence to demonstrate the overall superiority of any particular 
level of systemic cooling. The aim of this chapter was to determine 
any beneficial or prejudicial effect on clinical outcome of an 
intraoperative blood temperature of 28°C or 20°C.
The temperature groups were well matched with respect to age and 
body weight. The 20°C temperature group received significantly more 
grafts than the 28°C group, however, producing a significant increase 
in the mean cross clamp time (by 11 minutes) and the mean bypass time 
(by 19 minutes). This was unexpected as the patients were randomised 
only on the basis that they required at least two coronary grafts. It 
is a matter of speculation whether the surgeon1s prior knowledge of 
the allocated intraoperative temperature may have influenced his 
decision on the number of vessels requiring bypass grafts.
Clinical outcome was defined in easily measurable terms of 
postoperative recovery and occurrence of complications. Length of 
hospital stay was not used as a parameter of outcome because patients
came from all over Scotland and final discharge was frequently
determined by the practice and geographical location of the referral
centre.
There was no death in either temperature group. The immediate 
postoperative recovery pattern was similar in the two groups in terms 
of ventilation periods, the majority of patients being extubated 
within 12 hours of surgery. Despite a longer bypass and cross clamp 
time in the 20°C group, only three patients (10%) required inotropic 
support compared to six patients in the 28°C group (20%) although this 
difference failed to reach conventional levels of statistical
significance.
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All forms of arrhythmia occur after cardiac surgery and the most 
common are supraventricular tachycardias, particularly atrial 
fibrillation, which occurs in up to 20% of patients (213). The most 
frequent predisposing factor for arrhythmia is hypokalaemia and 
therefore in this study only sustained arrhyhmias occurring in the 
presence of a serum potassium between 4.5-5.5 mmol/L and requiring 
digitalisation or other drug therapy are included. There was a 
significantly lower incidence of atrial fibrillation in the 20°C 
temperature group (lv6: p<0.05). The pathophysiology of postoperative 
atrial arrhythmias remains controversial but inadequate myocardial 
protection of the right atrium has been incriminated (405). It is 
feasible that a more profound level of intraoperative hypothermia 
enhanced myocardial protection by a direct effect and/or a reduction 
in non-coronary collateral blood.
Hypertension after coronary artery surgery is so frequent that 
it may be considered the rule rather than the exception. Numerous 
explanations have been advanced including inadequate sedation and 
analgesia, increased peripheral vascular resistance (406) and 
increased catecholamine secretion (147). As discussed in Chapters 9 
and 10 there were greater increases in catecholamine secretion in the 
28°C group. In the postoperative period 57 of the 60 patients studied 
required vasodilator therapy. As the choice of vasodilator sodium 
nitroprusside or glycerol trinitrate was left to the discretion of the 
anaesthetist, the total requirements of both groups is not directly 
comparable and it is unknown whether attenuation of the catecholamine 
response in the colder group reduced the total requirement for 
vasodilator therapy.
There was a reduction in the mean requirement for blood 
transfusion, of approximately one unit, in the postoperative period in
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the 20°C group although this failed to reach conventional levels of 
statistical significance. It is known that a more profound level of 
intraoperative hypothermia significantly impairs blood coagulability, 
predominantly through an effect on platelets (44), and rewarming to 
37°C prior to discontinuation of CPB presumably adequately reverses 
the tendency to reduced coagulability in the colder group. There was 
an unusually high incidence of three re-openings in patients in the 
28°C group due to excessive bleeding and none in the 20°C group.
There was one case of respiratory failure in a patient whose 
blood gases deteriorated after the second postoperative day due to the 
adult respiratory distress syndrome. This patient required a further 
seven-day period of mechanical ventilation.
The incidence of perioperative myocardial infarction is reported 
at 0-30% after coronary artery surgery depending on the criteria used 
for diagnosis (213). The criteria in this centre to diagnose 
perioperative myocardial infarction, a large rise in creatine kinase 
accompanied by changes in the electrocardiogram, are equivalent to 
those required for a "medical diagnosis" of myocardial infarct, and 
indicate transmural infarction. There was no definite case of 
perioperative infarct in this study (although on these criteria small 
non-transmural infarcts are unlikely to be detected).
Two patients in the 28°C group developed an unstable sternum 
requiring re-suturing. Two additional patients in each group 
developed minor sternal wound infections from which Staphylococcus 
epidermidis was isolated. The potential pathogenicity of this 
coagulase negative organism is being increasingly recognised (407).
Up to 60% of patients undergoing coronary artery surgery may 
develop neurological or neuropsychological deficits (408) but 
recognition of such abnormalities requires sophisticated
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neuropsychological examination. Only one patient in this study 
developed an obvious cerebral deficit (409), this being a left-sided 
hemiparesis. The patient made an excellent recovery with no 
clinically obvious residual deficit.
SUMMARY and CONCLUSIONS
Clinical outcome was followed in 60 patients randomised to an 
intraoperative blood temperature of 28°C or 20°C. Despite a longer 
mean cross-clamp and bypass time in the 20°C group there was a trend
towards reduced inotropic and blood requirements in this group. The
only significant difference between the groups was a reduction in the
incidence of postoperative atrial fibrillation in the 20°C group,
presumably reflecting improved myocardial protection.
NUMBER OF PATIENTS 30 30
AGE (years) 53.8 [5.1] 53.8 [5.8] NS
WEIGHT (Kg) 77.5 [9.6] 76.2 [11.3] NS
NUMBER of GRAFTS 2.7 [0.8] 3.2 [0.7] p< 0.05
CROSS CLAMP TIME (minutes) 45.4 [16.5] 56.9 [18.8] p< 0.05
BYPASS TIME (minutes) 79.8 [23.5] 99.1 [25] p< 0.05
TABLE 14.1 Clinical and operative features of the two temperature
groups expressed as mean and SD.
28°C 20°C
NUMBER OF PATIENTS 30 30
VENTILATION TIME (HOURS) 11.1(0.9) 10.6(0.6) NS
INOTROPIC SUPPORT 6 3 NS
VASODILATOR THERAPY 24 23 NS
BLOOD TRANSFUSION (UNITS) 4.1(0.5) 3.2(0.3) NS
TABLE 14.2 Clinical features of the two temperature groups with
respect to ventilation, requirements for inotropes 
and/or vasodilators and need for blood transfusion 
expressed as mean and SD.
28°C 20°C
NUMBER OF PATIENTS 30 30
DEATH 0 0
RE-OPENING 3 0
RESPIRATORY FAILURE 0 1
RENAL FAILURE 0 0
PERIOPERATIVE MYOCARDIAL INFARCTION 0 0
ATRIAL FIBRILLATION 6 1 p< 0.05
SEPTICAEMIA 0 0
PNEUMONIA 1 1
URINARY TRACT INFECTION 0 0
WOUND DEHISCENCE 2 0
WOUND INFECTION 2 2
DECUBITUS ULCER 0 1
NEUROLOGICAL SIGNS 0 1
PULMONARY EMBOLUS 0 0
TABLE 14.3 Incidence of complications in the two temperature groups.
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